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1. Summary  
 
The correct regulation of epigenetic modifications is crucial for cell plasticity and the 
establishment of cell identity in vertebrates. However, the underlying molecular 
mechanisms are far from being understood. Recent development in this direction 
indicated a role for DNA repair proteins in this context, the investigation of which was 
the overall aim of my PhD thesis. 
The Thymine DNA Glycosylase (TDG) was discovered as an enzyme excising uracil 
(U) and thymine (T) mismatched with G, deamination products of cytosine and 5-
methylcytosine (5-mC), respectively, thereby initiating a base excision repair (BER) 
process that restores the canonical G•C base pairs (Neddermann and Jiricny, 1994; 
Wiebauer and Jiricny, 1990). Yet, TDG has also been implicated in transcriptional 
regulation, both in the role as a co-activator and co-repressor (Chen et al., 2003; Kim 
and Um, 2008; Missero et al., 2001; Tini et al., 2002). The interaction of TDG with the 
retinoic acid receptor (RAR) is a well studied example of a physical as well as a 
functional interaction, where TDG acts as a co-activator for RAR-targeted gene 
expression (Leger et al., 2014; Um et al., 1998). In this respect, TDG has also been 
postulated as a candidate enzyme that directly demethylates 5-methylcytosine        
(5-mC) in DNA (Jost, 1993; Jost et al., 1995; Zhu et al., 2000), in the context of 
regulating gene expression. The underlying evidence, however, was highly 
controversial and, unlike for specialized plant DNA glycosylases, a direct activity of 
TDG or any other vertebrate DNA glycosylase on 5-mC could never be substantiated. 
Only recently, it became clear that TDG is indeed critically involved in DNA 
demethylation. The mechanism, however, turned out to be more complex than direct 
excision of the methylated base and involves several enzymatic steps, including ten-
eleven translocation (TET) proteins. A currently favored view of how active DNA 
demethylation is accomplished is that TET proteins iteratively oxidize 5-mC to          
5-hydroxymethylcytosine (5-hmC), 5-formylcytosine (5-fC) and 5-carboxylcytosine  
(5-caC), and that TDG then excises 5-fC and 5-caC, thereby initiating a repair 
process that integrates a non-methylated C (He et al., 2011; Maiti and Drohat, 2011). 
Consistently, 5-caC appears to be the long sought canonical substrate for TDG (Maiti 
et al., 2013) and no other activity has yet been described to excise either 5-fC or      
5-caC. 
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The exact mechanisms for the recruitment, targeting, regulation and – probably 
context-dependent – action of TET and TDG are still unclear. It emerges though that 
TDG, together with the TET proteins, is a key player in the epigenetic maintenance of 
regulatory genomic elements with developmental relevance. My work aimed at 
providing further mechanistic insight into the epigenetic function of this multifaceted 
DNA repair enzyme.  
In a first part, I was involved in a team effort to characterize the phenotype of the first 
Tdg knockout mouse to be reported, which ultimately established the function of 
TDG-dependent DNA repair in epigenetic control. Unexpectedly and contrarily to all 
other knockouts of a DNA glycosylase, deletion of Tdg caused embryonic lethality. 
Further characterization of TDG-proficient and TDG-deficient cells revealed no 
notable defects in DNA repair, but instead a misregulation of developmental genes in 
differentiating mouse embryonic stem cells (ESCs) and mouse embryonic fibroblasts 
(MEFs). This was associated with a decrease in activating and an increase in 
repressive chromatin marks and a stochastic accumulation of DNA methylation in 
CGI promoters of developmental genes in TDG-deficient cells. These discoveries led 
to the proposal of a mechanistic model, implicating TDG-dependent DNA repair in the 
establishment and maintenance of an active chromatin state at gene promoters in 
cells undergoing cell lineage commitment (Appendix III).   
We then wanted to understand the precise role of TDG-mediated active DNA 
demethylation in cell differentiation. We generated genome-wide DNA methylation 
profiles of TDG-proficient and TDG–deficient mESCs and in vitro differentiated 
neuronal progenitor cells (NPs) as well as terminally differentiated MEFs. Confirming 
earlier observations on candidate gene loci, we identified a large number of 
differentially methylated regions (DMRs) but only in differentiated cells. Surprisingly, 
the DMRs that overlapped with CGIs were almost exclusively hypomethylated in 
TDG-deficient NPs. As these same CGIs were also prone to acquire DNA 
methylation in TDG-proficient NPs, these results suggested a failure of TDG-deficient 
cells to establish de novo methylation at these sites upon differentiation. Measuring 
global levels of 5-mC and its oxidized derivatives 5-fC and 5-caC confirmed elevated 
levels of the latter in TDG-deficient mESCs, that further increased during retinoic acid 
(RA)-induced differentiation. We observed the same alterations at the very CGI 
DMRs, implicating an engagement of TDG activity in ongoing cycles of DNA 
3 
 
methylation and active demethylation at these sites. Our data thus showed that CGIs 
undergoing epigenetic transitions during cell differentiation are kept in a state of high 
epigenetic plasticity, whereby the catalytic function of TDG is required to maintain the 
balance between DNA methylation and demethylation (Appendix I). 
In subsequent work, I wanted to characterize the genomic sites, where TET proteins 
and TDG engage to effect cyclic DNA methylation – demethylation. The goal was to 
provide insight into the genome-wide functional interaction and coordination between 
these proteins and relevant biological outputs. I therefore established procedures for 
chromatin-immunoprecipitation-coupled next generation sequencing (ChIP-seq) for 
TET1, TET2 and TDG and generated the respective ChIP-seq datasets from a 24 
hour RA-induced mESC differentiation setup with mESCs expressing wildtype TDG, 
catalytically inactive TDG or no TDG. Bioinformatic analyses then revealed clear but 
differential correlation of TET and TDG association with gene regulatory elements, 
especially gene promoters and active enhancers. Notably, sites of 5-fC enrichment in 
TDG-deficient cells, CGIs as well as bivalent chromatin domains showed a 
preferential co-occupancy with all three proteins, indicating that highly dynamic active 
DNA demethylation may involve the TET1-TET2-TDG trio as a whole. Contrarily, 
sites were uniquely TDG shows chromatin association, were more often located in 
active enhancers. Moreover, a vast majority of TET1 and TET2 chromatin association 
events were independent on TDG protein or activity, consistent with TDG acting 
downstream of the TET proteins and the recruitment of these demethylation factors 
occurring in a sequential order. Remarkably, there was also a strong correlation 
particularly of TET1-TET2-TDG co-occupancy with the occurrence of the dynamic 
histone variants H3.3 and H2A.Z. This led us to hypothesize that the targeted 
oxidation and excision of 5-mC by the TET-TDG system at gene regulatory elements 
may in fact serve the purpose to generate single-stranded DNA breaks to trigger 
nucleosomal dynamics and, thus, the epigenetic plasticity required at certain 
enhancers or promoters in differentiating cells. The predominant occurrence of TET1-
TET2-TDG at bivalent CGIs suggests that this process is specifically targeted to 
developmental genes, presumably to facilitate their transcription. These results 
further indicate a functional separation between distinct TDG protein fractions 
(Appendix II). 
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Preliminary evidence supports a role for TDG in the regulation of transcription, by 
directly affecting the assembly and progression of the transcription machinery 
(Supplementary Results 4.4). TDG’s catalytic activity seems to be important for 
early elongation by RNA Polymerase II (RNA Pol II). At this early stage of 
transcriptional elongation, TDG might be in a complex with BRD4, which binds to 
acetylated histones and is a serine 2-kinase for the C-terminal domain (CTD) of RNA 
Pol II (Devaiah et al., 2012). This may directly link TDG’s role in chromatin dynamics 
to the regulation of RNA Pol II-mediated transcription. Furthermore, the increased 
association of TDG to 3’UTRs of different splice variants of the RARβ locus indicated 
that TDG might be involved in co-transcriptional processes, like mRNA end 
processing or splicing.  
Taken together, the work presented in my thesis contributes to the understanding of 
the epigenetic function of TDG-mediated active DNA demethylation with respect to 
time (during differentiation) and space (at gene regulatory elements). My concluding 
model depicts an attractive concept of a role for TDG in the maintenance of 
chromatin plasticity at critical genomic regions destined to undergo epigenetic 
regulation in response to developmental or environmental cues. In mESCs, these 
appear to be mainly CGI promoters and enhancers of developmental genes. The 
TET-TDG DNA demethylation machinery is recruited to these sites upon initiation of 
differentiation, presumably by developmental stage-specific transcription factors. 
There, TDG will excise TET-generated 5-fC and/or 5-caC and subsequent BER will 
produce single-strand breaks that will facilitate increased nucleosomal dynamics. 
This will enhance accessibility for the transcription machinery or for further chromatin 
modifying complexes. We propose that by the targeted demethylation of DNA, TDG 
assists in the maintenance of an open chromatin state and facilitates transcription.  
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2. Introduction 
2.1 The Genome and Its Organization  
Deoxyribonucleic acid (DNA) contains the genetic code, where every cell in an 
organism stores the information about its metabolism. This information can be copied 
and inherited to daughter cells and is mainly stored in “genes”, which are subject to 
tight regulation. The building blocks of DNA are the nucleotides: They consist of a 
base, the moiety containing the actual genetic information, and a sugar (deoxyribose) 
linked to a phosphate group. The bases are connected to the sugar-phosphate 
backbone by N-glycisidic bonds. In DNA there are four canonical bases: the purines 
Adenine (A) and Guanine (G) and the pyrimidines Cytosine (C) and Thymine (T); C 
methylated on the C5 position (5-methylcytosine; 5-mC) can be considered as a fifth 
base in the genome. In the cell nucleus, DNA exists as double-stranded α-helix, in 
which two anti-parallel complementary single-strands are paired. Complementarity is 
achieved through base pairing: A pairs with T via two hydrogen-bonds and C pairs 
with G via three hydrogen-bonds (Figure 1; (Ghosh and Bansal, 2003; Watson and 
Crick, 1953)).  
 
Figure 1: DNA base pairing according to Watson and Crick, with the hydrogen bonds indicated by the dashed 
lines. The bases are depicted in blue (pyrimidines) and red (purines) and sugar moieties are shown in green. The 
asterisk depicts the position, where A could have a third hydrogen bond (Szathmary, 2003). 
The human genome consists of roughly 3 giga bases (Li, 2011) which translates to 
approximately 2 meters of DNA in every human cell. Thus, multiple rounds of 
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compaction are needed in order to fit the DNA into the nucleus of a cell which is only 
a few micrometers (μm) in size. For this reason, DNA is packed into chromatin, first 
by winding 147 base pairs (bp) of DNA around eight histone proteins (dimers of H2A, 
H2B, H3 and H4 each). This first compaction forms the nucleosome subunit and is 
called the primary chromatin structure. Further compaction with the help of linker 
histones (H1), which covers between 20 and 90 bp, induces zigzagging of the 
chromatin fibre. Continued looping of this roughly 30 nm thick structure can ultimately 
condense the DNA into a chromatin structure, which in its most compact form 
appears as a metaphase chromosome ((Sajan and Hawkins, 2012); Chapter 2.3). 
 
2.1.1 Genetic Maintenance 
The faithful maintenance and transmission of the DNA from one cell to another is of 
fundamental importance for living organisms. This, however, represents a major 
challenge, since DNA is under constant attack by physical and chemical agents of 
both exogenous and endogenous origin. Estimation of DNA damage events in a 
single human cell ranges from 104 – 106 per day (Ciccia and Elledge, 2010; 
Hoeijmakers, 2009; Lindahl, 1993). Different kinds of DNA base damage can 
interfere with DNA-templated processes, such as replication and transcription, and 
thereby generate genetic mutations or induce cell death. These deleterious effects 
are counteracted by safe-guarding DNA repair mechanisms, which evolved manifold 
in order to assure the integrity of the genome; the most important DNA repair 
pathways are described in Chapter 2.2 (reviewed in (Scharer, 2003)). 
 
2.1.2  Epigenetic Maintenance 
The different cell types of a multicellular organism contain the same genetic 
information – differences in cell morphology and function are established by 
epigenetic mechanisms. These effect cell-type-specific modifications on the DNA and 
histone proteins which program a specific reading of the genome. These 
modifications are thus referred to as epigenetic modifications; they include for 
instance methylation of the DNA, different chemical modifications on histone proteins 
as well as incorporation of non-canonical histone proteins. The greek prefix epi 
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means on top, hence suggesting that epigenetic modifications add a level of 
information onto the primary sequence information of the DNA. Genetic traits are thus 
determined first by the encoding DNA sequence including possible polymorphisms, 
and second, by their epigenetic state. In the revived field of epigenetics, many 
questions remained unanswered until now: How environmental cues are integrated 
into epigenetic instructions and whether and how these marks are inherited over 
generations is still not clear (Heijmans et al., 2008; Nilsson and Skinner, 2014; Wei et 
al., 2014). The mechanism of the so called “epigenetic memory”, which is responsible 
for the establishment and maintenance of stable patterns of epigenetic marks during 
ontogenesis is, although its existence is widely accepted, far from being understood 
(Cheedipudi et al., 2014). Accordingly, how and when histone modifications are 
deposited on newly assembled nucleosomes, how these modifications are 
maintained over time and how nucleosome reassembly throughout successive 
rounds of cell divisions is coordinated are questions that are heavily investigated at 
the moment (Alabert and Groth, 2012; Corpet and Almouzni, 2009). Although we 
know how DNA methylation is maintained in replicating cells, much less is known 
about whether and if yes, how DNA methylation patterns are inherited across 
generations.  
 
2.2 Types of DNA Damage and Appropriate DNA Repair 
Endogenous DNA damage concerns mostly DNA bases and can arise, for instance, 
from hydrolysis or reactive oxygen species (ROS), the latter resulting from 
endogenous metabolic processes. The reaction of ROS with DNA can give rise to 
more than 100 oxidative modifications in DNA (Beckman and Ames, 1997), most 
prominently the G or T oxidation products, 8-oxoguanine and thymine glycol, 
respectively. The former is a mutagenic, the latter a DNA and RNA polymerase 
blocking lesion. Contrarily, hydrolysis may lead to the cleavage of the N-glycosidic 
bonds between the base and the phosphate sugar backbone, leaving an 
apurinic/apyrimidic site or abasic site (AP-site). AP-sites are prone to generate 
mutations during replication (Choi et al., 2010). Moreover, AP-sites can lead to the 
formation of cytotoxic single-strand breaks and are thus highly deleterious for a cell. 
Furthermore, hydrolytic deaminations can occur at the exocyclic amino groups of C, 
5-mC, A and G; generating U, T, hypoxanthine and xanthine bases, respectively 
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(Lindahl, 1993; Loeb and Preston, 1986). The most important DNA repair pathways 
for specific types of lesions will be briefly introduced below and are illustrated in 
Figure 2. Most relevant to this work is the DNA base excision repair pathway (BER), 
which is discussed in detail in a separate chapter (2.2.1). 
 
Mismatch Repair (MMR) 
Misincorporation of nucleotides by DNA polymerases during DNA replication or repair 
events is a major source of DNA mismatches. The average fidelity of the DNA 
polymerases Polδ and Polε with an inherent proofreading activity is in the order of 1 
error in 107 nucleotides synthesized. Contrarily, low fidelity DNA polymerases like 
Polκ or Polη, generate mismachtes in the range of up to 1 in 10 synthesized 
nucleotides. The fact that the overall mutation rate in a human cell is only around 1 in 
1010 nucleotides is thus largely owed to the ability of cells to recognize and correct 
DNA polymerase errors. The relevant mismatch correction activities are tightly 
associated with DNA replication and act downstream of the replication fork (Kunkel, 
1992; Kunz et al., 2009b). Mismatched bases are usually not damaged and are per 
se not easy to distinguish from correctly paired bases. The mismatches are rather 
detected by unusual base-base pairing interactions. Importantly, repair has to be 
directed to the nascent DNA strand, since this is where the error was caused by DNA 
polymerases. It is not entirely clear, how strand discrimination and strand-directed 
repair is achieved in eukaryotes; presumably strand discontinuities serve this 
purpose. Upon the encounter of a mismatch, the mismatch recognition complexes 
MutSα or MutSβ bind the mismatch. MutSα and MutSβ are heterodimeric complexes 
consisting of the MSH2 and MSH6 or MSH3 proteins, respectively, and can be 
distinguished due to their complementary modes of mismatch recognition. 
Subsequently, the MutL complexes (MutLα/β/γ) are recruited to MutSα/β. The 
function of the MutL complexes is not fully understood; however, they are also 
heterodimeric complexes, consisting of hMLH1 and hPMS2, hPMS1 or hMLH3, 
respectively. Upon the assembly of DNA replication proteins like the proliferative cell 
nuclear antigen (PCNA) and replication factor C (RFC) at the MutS/MutL complex, 
MutLα can act as an endonuclease, nicking the discontinuous strand 3’ and 5’ of the 
assembled complex. This generates an entry point for the exonuclease EXO1. EXO1 
is activated by MutSα and degrades the newly synthesized strand in 5’-3’ direction 
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towards and past the mismatch. DNA re-synthesis is achieved by Polδ and the nick is 
sealed by DNA ligase I (reviewed in (Kunz et al., 2009b)). Defects in MMR genes, 
like MSH2 and MLH1, can predispose to cancer, such as in the hereditary non-
polyposis colon cancer (HNPCC) familial form of colon cancers (Bronner et al., 1994; 
Leach et al., 1993).  
 
Nucleotide Excision Repair (NER) 
NER is the major pathway that removes bulky base lesions that thermodynamically 
destabilize the DNA, applying a “cut out and refill” mechanism. Accordingly, NER 
displays a remarkably broad substrate spectrum. Examples include UV-induced 
photoproducts (cyclopyrimidine dimers, 6-4 photoproducts), certain oxidative lesions 
(cyclopurines) as well as adducts formed by environmental mutagens like benzo [a] 
pyrene, which is found in cigarette smoke, or adducts formed by cancer 
chemotherapeutic drugs, such as cisplatin (reviewed in (Scharer, 2013)). Common to 
all of these lesions is their distorting effect on the DNA helical structure – there 
appears to be a positive correlation between the efficiency of repair and the degree 
of helical distortion caused by a lesion (Gunz et al., 1996; Sancar, 1996). There are 
two subpathways of NER: global genome NER (GG-NER) and transcription-coupled 
NER (TC-NER). GG-NER can occur anywhere in the genome and is initiated by the 
GG-NER-specific factor XPC-RAD23B, whereas TC-NER assures the rapid repair of 
lesions in the transcribed strand of active genes and is initiated by a stalled RNA 
polymerase and the TC-NER-specific factors CSA, CSB and XAB2. Both 
subpathways require the subsequent core NER system to restore the intact DNA, 
engaging roughly 30 proteins. After damage recognition, the general transcription 
and NER factor TFIIH is recruited to the site of the lesion. TFIIH consists of multiple 
proteins, whereof the helicases XPB and XPD are particularly important in NER, 
since they unwind the DNA around the lesion. This triggers the recruitment of XPA, 
the ssDNA binding protein RPA and the endonuclease XPG in order to form the 
preincision complex. Next, the endonuclease ERCC1-XPF is recruited to the NER 
complex by interaction with XPA. Once the two endonucleases (XPG and ERCC1-
XPF) are positioned, dual incision is initiated. The first incision is made by ERCC1-
XPF 5’ to the lesion, the lesion-containing oligonucleotide is thereby released from 
the NER factors with TFIIH bound to it. DNA repair synthesis is then initiated by DNA 
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polymerases Polδ, Polε or Polκ together with the standard replication factors. Finally, 
XPG cleaves 3’ of the lesion, allowing the final release of a 24-32 oligonucleotide as 
well as the sealing of the remaining nick by DNA Ligase I (reviewed in (Scharer, 
2013)). Defects in NER factors are associated with several genetic disorders: (i) 
xeroderma pigmentosum is linked to defects in one of the seven xeroderma 
pigmentosum complementation groups (XPA through XPG) and is a GG-NER defect, 
(ii) Cockayne Syndrome is caused by defects in CSA, CSB, XPB, XPD and XPG and 
reflects a TC-NER defect, and (iii) trichothiodystrophy is caused by defective subunits 
of TFIIH (reviewed in (Scharer, 2013)). 
Interestingly, several NER factors have been recently implicated in epigenetics as 
well as in regulation of transcription. For instance, the NER complex together with 
Gadd45 was shown to be recruited to promoters of rRNA genes by TAF12, which 
caused DNA demethylation at these sites (Schmitz et al., 2009). Also, the NER 
complex was suggested to facilitate a chromatin state that allows for transcription at 
active promoters, even in the absence of genotoxic attack (Le May et al., 2010). 
Furthermore, the endonucleases XPF and XPG were shown to promote chromatin 
looping together with CTCF, as well as DNA nicking, which finally caused DNA 
demethylation, indicating important additional functions of NER proteins in 
transcription control (Le May et al., 2012). 
 
Double-strand break repair 
DNA double-strand breaks (DSB) can be generated during endogenous processes, 
for instance during replication, either by the replication toward a single-strand break 
(SSB) in the template strand or by the collapse of a replication fork (Cox et al., 2000). 
Additionally, they can arise from sugar lesions that frequently disrupt the DNA 
backbone, thereby generating SSBs and DSBs, if these lesions occur in a clustered 
manner (Singh et al., 2011). Exogenous agents, such as ionizing radiation (e.g. X-
rays), can also lead to the formation of DSBs (Mahaney et al., 2013). Taking the 
severity of the lesion into account, it is not astonishing that a single unrepaired DSB 
in a yeast cell can lead to cell death (Sandell and Zakian, 1993). The challenge of 
DSB repair lies in the acquisition of an appropriate homologous template, since no 
conventional template on the opposite strand is available for repair. There are two 
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pathways that repair DSBs that deal differently with this. Homologous recombination 
(HR) uses stretches of DNA homology on sister chromatids, present in S and G2 
phases of the cell cycle, as repair templates and is thus an accurate repair pathway 
(reviewed in (van Gent et al., 2001)). HR involves the resolution of a complex repair 
intermediate connecting the broken and intact DNA duplexes, known as Holiday 
junction. Contrarily, in nonhomologous end joining (NHEJ), two broken DNA ends are 
simply rejoined during G1 phase. This involves DSB recognition, end processing and 
bridging as well as ligation steps and can be achieved with or without micro-
homologies at the DNA ends. Therefore, the NHEJ pathway is not necessarily 
accurate and small deletions may result at the site of the resealed DSB (reviewed in 
(Scharer, 2003)).  
Defective DSB repair can predispose to cancer. For instance, loss of function 
mutations of breast cancer 1 or 2 (BRCA1/2), which is involved in cell cycle 
checkpoint activation and DSB repair, was shown to increase the susceptibility for 
breast or ovarian cancer drastically (O'Donovan and Livingston, 2010).  
 
 
Figure 2: The most common DNA-damaging agents, the lesions they cause and the DNA repair 
pathways that restore the original state (Scharer, 2003). 
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2.2.1 DNA Base Excision Repair (BER) 
DNA is constantly engaged in chemical reactions in its cellular environment, which 
can cause damage to the coding bases, the most vulnerable moieties in DNA. The 
types of damages include deamination, oxidation and alkylation and are usually non-
distorting (Lindahl and Wood, 1999; Scharer, 2003). Base lesions can be pro-
mutagenic when altering the Watson-Crick pairing properties of the base, meaning 
that they can give rise to genetic mutations if not repaired. Examples for this include 
the hydrolytic deamination of C or 5-mC which generates U or T, causing C-G  U-A 
or C-G  T-A transition mutations if replicated prior to repair, respectively. Another 
example is 7,8-dihydro-8-oxoguanine (8-oxoG) which arises through oxidation of G, 
and favors base-pairing with A, thereby giving rise to G-T  T-A transversion 
mutations, if unrepaired. Base lesions caused by alkylation, such as N7-
methylguanine (7-meG) or N3-methyladenine (3-meA), are 
cytotoxic because they can block replicative DNA 
polymerases (Lindahl and Wood, 1999). All these damages 
are mainly repaired by BER, which is initiated by damage-
specific DNA glycosylases recognizing a cognate type of 
damaged base (Chapter 2.2.2; reviewed in (Jacobs and 
Schar, 2012)). The excision of the base occurs by flipping 
the base into the catalytic pocket of the DNA glycosylase 
where the N-glycosidic bond between the base and the 
sugar phosphate backbone of the DNA is hydrolyzed, 
leading to an AP-site in the DNA strand (Figure 3). Some 
DNA glycosylases display a very high affinity to AP sites; the 
dissociation from their product can be facilitated by the 
recruitment of downstream BER factors or also by 
posttranslational modifications (PTMs; (Hardeland et al., 
2002; Parikh et al., 1998; Waters et al., 1999). Hence, the 
release of the base and downstream repair events are well 
orchestrated. The AP endonuclease (APE1) subsequently  
Figure 3: The damaged base [A] is recognized by a DNA glycosylase, which flips the base into its 
catalytic pocket and thereby kinks the DNA [B]. After base excision, APE1 is recruited to the 
glycosylase [C], which triggers the release of the glycosylase from the AP-site [D]. Pol β fills the gap, 
the nick is sealed by Lig III [E], thus restoring the initial state [F] (Jacobs and Schar, 2012). 
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hydrolyzes the phophodiester bond 5’ to the AP-site to generate a nick with a 3’-OH 
and a 5’- deoxyribose-5-phosphate (5’-dRP) end. In the major BER pathway (short-
patch repair), Polymerase β (Polβ) will then incorporate a single nucleotide after it 
processed the 5’ end of the nick in order to reconstitute the necessary 5’-phosphate 
(5’-P). This is achieved with Polβ’s additional AP lyase activity that excises the initial 
5’ dRP. Some DNA glycosylases are bifunctional and possess an additional AP lyase 
activity, so that the AP lyase activity of Polβ is not required. The remaining nick in the 
DNA backbone is then sealed by DNA ligase III (Lig III), which is bridged to Polβ by 
X-ray repair cross-complementing group 1 (XRCC1). Generally, the processing of the 
AP-site appears to be coordinated by protein-protein interactions: APE1 interacts with 
Polβ and XRCC1 directly; Polβ interacts with LigIII through XRCC1 (reviewed in 
(Scharer, 2003)). 
There exists also a minor BER pathway (long-patch repair), where DNA synthesis is 
achieved by DNA polymerases δ/ε which introduce 2-6 nucleotides. The resulting 
oligonucleotide overhang is cleaved by flap endonuclease 1 (FEN1) and the nick is 
sealed by DNA Ligase I (Lig I; (Dianov and Lindahl, 1994; Pascucci et al., 1999; 
Scharer, 2003)). 
 
2.2.2 DNA Glycosylases 
The first DNA glycosylase was discovered in 1974. It was assumed that there must 
be a mechanism in cells that eliminates deoxyuridine monophosphate (dUMP) which 
is either misincorporated during DNA replication or arises by hydrolytic deamination 
of C (Lindahl, 1974). This led to the discovery of the uracil N-glycosidase (UDG) in 
extracts of Escherichia coli cells, which then ignited the identification of other DNA 
glycosylases in all kingdoms of life. Up to date, eleven DNA glycosylases have been 
identified in mammals and they can be classified into four structurally distinct super-
families. These are (i) the uracil DNA glycosylases (UDGs), (ii) the helix-hairpin-helix 
(HhH) glycosylases, (iii) the 3-methyl-purine glycosylase (MPG) and (iv) the 
endonuclease VIII-like (NEIL) glycosylases (reviewed in (Jacobs and Schar, 2012)). 
Different DNA glycosylases evolved to recognize specific types of base damage. 
However, they all use a common base flipping mechanism to accomplish catalysis, 
independent of the size of the catalytic pocket. Thereby, the base is pushed into the 
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catalytic pocket of the enzyme through intercalation of the latter in the minor groove 
of DNA. There are both very specific and and rather unspecific catalytic pockets. For 
instance, the uracil-N glycosylase (UNG) and the single-strand specific 
monofunctional uracil DNA glycosylase 1 (SMUG1) establish specific contacts with 
the uracil (U) to be excised (Mol et al., 1995a; Mol et al., 1995b; Savva et al., 1995). 
UNG has a very tight-fitting catalytic pocket which contributes to its high substrate 
specificity (Krokan et al., 2001). In contrast, the MUG and TDG catalytic pockets can 
accommodate a variety of pyrimidine and purine derivatives without contacting the 
base to be hydrolyzed (Barrett et al., 1999), giving them a rather broad substrate 
spectrum. In case of the latter enzymes, damage recognition specificity is additionally 
ensured by interactions with the complementary DNA strand opposing the damaged 
base. This may explain the double-strand dependency of MUG proteins and the 
preference for a G opposite the damaged base (Barrett et al., 1998). Lately, this view 
has been challenged though, since TDG was found to form numerous contacts with 
the strand containing the AP-site, involving several phosphodiester groups, the 
abasic sugar as well as the Gs of both strands in the CpG dinucleotide containing the 
damaged base (Maiti et al., 2008). Furthermore, the recognition of 5-caC in TDG’s 
catalytic pocket appears to be an exception, as it is highly specific compared to other 
substrates and its excision apparently functions in a pH-dependent manner (Maiti et 
al., 2013; Zhang et al., 2012).  
 Mechanistically, there are two classes of DNA glycosylases. Monofunctional DNA 
glycosylases perform only base excision and use a strategically positioned water 
molecule as a nucleophile to cleave the N-glycosidic bond (reviewed in (Scharer, 
2003)). Contrarily, bifunctional glycosylases combine base excision with an additional 
AP-lyase step. They use a catalytic lysine side chain of the enzyme which is suitably 
positioned as a nucleophile to attack the N-glycosidic bond. This generates a 3’-OH 
and 5’-P end, which can directly be further processed (Bruner et al., 2000; Jacobs 
and Schar, 2012; Lau et al., 1998; Scharer, 2003). 
Some DNA glycosylases, such as TDG and to a lesser extent also UNG, have a 
higher affinity for the product AP-site they generated compared to the actual 
substrate (Parikh et al., 1998; Waters et al., 1999). TDG thus additionally displays a 
strong product inhibition and remains bound to the product, until either APE1 is 
recruited and/or TDG gets posttranslationally modified by Small Ubiquitin-like 
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Modifier (SUMO), which induces a conformational change and causes TDG’s 
dissociation (Hardeland et al., 2002; Steinacher and Schar, 2005; Waters et al., 
1999). Thus, the release of DNA glycosylase from the AP-site can be considered the 
rate limiting step in BER initiated by TDG. In contrast, the turnover of UNG is 
extremely rapid and orders of magnitude higher than that of other uracil-DNA 
glycosylases (600-1000 nucleotides per minute; (Krokan et al., 2002)). Differences 
persist also in the timed action of glycosylases: whereas UNG is replication-
associated and removes Uracil misincorporated by replicative polymerases, TDG is 
downregulated during S phase (Hardeland et al., 2007). TDG is highly expressed in 
G2 and G1 phases of the cell cycle, when UNG is downregulated, thus these two 
UDG family members underlie strictly anticyclic cell cycle regulation (Hardeland et al., 
2007). 
 
2.2.3 The Thymine DNA Glycosylase (TDG) 
TDG is the most relevant DNA glycosylase for this work, thus I am specifically 
focusing on its biochemical and biological characteristics in this chapter. 
Base Excision Mechanism 
TDG belongs to the super-family of monofunctional uracil-DNA glycosylases (UDGs) 
and the family of MUG enzymes (reviewed in (Cortazar et al., 2007)). The current 
model is that upon contact with DNA, TDG undergoes a conformational change in its 
N-terminal domain, which results in a clamp-like structure that allows TDG to slide 
along the DNA (Steinacher and Schar, 2005). How exactly the damaged base is 
recognized is not entirely clear yet (reviewed in (Jacobs and Schar, 2012)). Once a 
G-mismatched substrate is encountered, the substrate base is flipped out of the DNA 
helix into the catalytic pocket of the enzyme. This is achieved by an insertion loop 
wedging into the DNA helix. This wedge stabilizes the base stack and forms specific 
hydrogen bonds with the widowed G (Barrett et al., 1998; Barrett et al., 1999; Maiti et 
al., 2008). The release of TDG from its product is facilitated by its PTM with SUMO. 
C-terminal SUMOylation of TDG significantly decreases the affinity for both substrate 
and product, increasing the turnover of the enzyme (Hardeland et al., 2002; 
Steinacher and Schar, 2005). Moreover, TDG can become acetylated by CBP/p300 
as well as phosphorylated through the protein kinase C (PKCα). These modifications 
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influence enzyme turnover, interaction with other proteins or localization in the cell 
(Hardeland et al., 2002; Madabushi et al., 2013; Mohan et al., 2010), indicating that 
PTMs contribute critically to the coordination of TDG-initiated BER. 
Substrates for TDG 
Initially discovered as an enzyme removing T from G•T mismatches believed to arise 
from deamination of 5-mC, it later turned out, that TDG possesses a much larger 
substrate spectrum (Table 1; (Neddermann et al., 1996)). Besides processing T and 
U resulting from hydrolytic deamination of 5-mC and C, respectively, TDG was also 
shown to excise larger uracil-derivatives like 5-hydroxymethyluracil (5-hmU), 5-
fluorouracil (5-FU) or 5-bromouracil (5-BrU) as well as bases with etheno-adducts 
(e.g. 3,N4-ethenocytosine) or oxidized pyrimidines (e.g. thymine glycol; (Hardeland et 
al., 2003)). Interestingly, a 5-mC processing activity has been described for chicken 
TDG (Jost, 1993; Zhu et al., 2000). This activity, however, is questionable, since it 
could never be reproduced.  
Table 1: Substrate* spectrum of human recombinant full length TDG 
 
  Base release efficiencies   
 
high intermediate low insignificant 
 
G•U A•FU A•U ss U 
 
G•FU ss FU A•BrU ss BrU 
 
G•BrU G•Tg G•Hx ss εC 
 
G•hmU A•εC 
 
T•Hx 
 
G•hU ss caC   ss Hx 
 
G•T     G•εA 
 
G•εC     ss εA 
 
G•fC     G•hmC 
 
G•caC     G•heC 
 
      G•hpC 
 
      G•G 
 
      G•mC 
 
* The putative substrate base is marked in bold letters.  
 
ss, single strand; F, fluoro-; Br, bromo-; h, hydroxy-; hm, hydroxymethyl-; Tg, thymine glycol; ε, 
etheno-; Hx, hypoxanthine; f, formyl-; ca, carboxyl-; he, hydroxyethano-; hp, hydroxypropano-.  
Information collected  from (Cortazar et al., 2007; Hardeland et al., 2003; Hardeland et al., 2001; He et 
al., 2011; Maiti and Drohat, 2011) and Alain Weber, unpublished data. 
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Notably, TDG was recently shown to excise 5-formylcytosine (5-fC) and 5-
carboxylcytosine (5-caC), intermediates of active DNA demethylation (He et al., 
2011; Maiti and Drohat, 2011). Importantly, TDG was shown to also process two 
single-stranded (ss) substrates, namely ss-5-caC and ss-5-FU ((Hardeland et al., 
2000) and Alain Weber; unpublished data), establishing that it is not strictly 
mismatch-dependent. Interestingly, TDG shows redundancy with other DNA 
glycosylases for certain substrates, as for example U, which may also be excised by 
SMUG1, UNG and MBD4 (Visnes et al., 2009). However, there are at least two 
characteristics rendering TDG unique when comparing it to other DNA glycosylases: 
(i) TDG is the only glycosylase whose knockout causes embryonic lethality (Cortazar 
et al., 2011; Cortellino et al., 2011) and (ii) TDG is thus far the only glycosylase 
cabable to excise 5-fC and 5-caC (He et al., 2011; Maiti and Drohat, 2011). Thus, 
albeit TDG was initially discovered as a DNA repair enzyme, it appears that its role in 
control of DNA methylation represents its primary task (Zheng et al., 2014).  
 
Biological functions of TDG 
The embryonic lethality of Tdg knockout mice was an unexpected and unique 
phenotype for a DNA glycosylase defect. Given that no other DNA glycosylase 
knockout shows such a severe phenotype and that there are other DNA glycosylases 
with redundant substrate spectra, pointed towards additional roles for TDG apart from 
classical DNA repair. Consequently, TDG has been implicated in several biological 
processes not immediately related to DNA repair, such as immunity, regulation of 
gene transcription, control of DNA methylation as well as epigenetic maintenance 
(reviewed in (Jacobs and Schar, 2012)).  
TDG was shown to interact with the nuclear receptors retinoic acid receptor (RAR) 
and retinoid X receptor (RXR) and to enhance their binding to their respective 
response elements, thereby influencing the transcriptional outcome (Um et al., 1998). 
Another nuclear receptor, the estrogen receptor α (ERα), was also found to interact 
with TDG, where TDG is acting as a co-activator of transcription for ERα-regulated 
genes (Chen et al., 2003). Next, TDG was demonstrated to act as a transcriptional 
repressor at thyroid transcription factor 1 (TTF-1) targeted genes (Missero et al., 
2001). Furthermore, TDG was shown to interact with the histone acetyltransferases 
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CREB-binding protein (CBP)/p300 and the resulting CBP-TDG complex is capable of 
binding DNA, repairing G•T/U mismatches and acetylating histones (Tini et al., 2002). 
TDG enhances the transcriptional co-activator function of CBP and serves itself as a 
substrate for acetylation by CBP. It was proposed that TDG acetylation abolishes the 
recruitment of APE1 (Tini et al., 2002). Furthermore, TDG was shown to act as a co-
activator of transcription for SRC1 family members (Lucey et al., 2005) and p53 
family proteins (Kim and Um, 2008). 
 
DNA methylation control and epigenetic maintenance 
We and others showed before, that loss of TDG leads to aberrant DNA methylation at 
promoters of developmental genes (Cortazar et al., 2011; Cortellino et al., 2011), as 
well as changes in histone modifications (Appendix III). The recent finding that TDG 
processes 5-fC and 5-caC clearly positions TDG as a key player in active DNA 
demethylation (Chapter 2.5; (He et al., 2011; Ito et al., 2011; Kohli and Zhang, 2013; 
Maiti and Drohat, 2011)). It emerges that TDG-mediated targeted DNA demethylation 
serves the maintenance of cellular plasticity during development through DNA 
methylation control at gene regulatory regions, further linking control of DNA 
methylation and regulation of transcription through TDG (Appendix II). I contributed 
to these discoveries during my PhD thesis; they are discussed in more detail in the 
results section.    
 
2.3 Chromatin  
In order to fit roughly 2 meters of DNA into a cell nucleus with an average diameter in 
the range of a few micrometers μm, organized compaction of the DNA is 
indispensable (Figure 4). The DNA primary structure is arranged into nucleosomes, 
with approximately 147 bp of DNA wrapped around a histone octamer. A nucleosome 
consists of two dimers of each of the canonical histones H2A, H2B, H3 and H4 
(reviewed in (Horn and Peterson, 2002)). Additionally, canonical histone proteins can 
be exchanged for histone variants as e.g. H2A.Z or H3.3, and ATP-dependent 
nucleosome remodeling allows the control of nucleosomal dynamics (see Chapter 
2.3.1). The highly basic N-terminal tails of these histone proteins protrude out of the 
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nucleosome and can be chemically modified by e.g. methylation or acetylation 
(reviewed in (Bannister and Kouzarides, 2011)). At the moment, at least eight distinct 
types of histone modifications are known and they can be placed on more than 60 
different residues on the different histone tails. Histone modifications are capable to 
dictate the higher-order structure of chromatin (reviewed in (Kouzarides, 2007)). 
 
Fig 4: Condensation of the DNA into nucleosomes and higher-order chromatin (From: 
Annunziato, A. (2008), DNA packaging: Nucleosomes and chromatin. Nature Education 1(1):26).  
Of all histone modifications identified so far, acetylation has the highest potential to 
impact the chromatin structure because it neutralizes the basic charge of the lysine, 
which leads to a less compacted chromatin state (Shogren-Knaak et al., 2006). The 
most important modifications and their preferential localization are summarized in 
Chapter 2.3.2. The primary chromatin structure is then further compacted with the 
help of linker histones (H1), which cover between 20 and 90 bp of DNA and induce 
zigzagging, resulting in a roughly 30 nm thick chromatin fiber. Additional looping and 
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tight coiling finally gives rise to one chromatid of a chromosome (Sajan and Hawkins, 
2012). A certain consistency in the combination of these variable modifications 
provoked the creation of the term “histone code” (Jenuwein and Allis, 2001). 
Modifications are deposited by “writers” such as histone methyltransferases (HMTs), 
recognized by “readers” such as the CBX subunit of the polycomb repressive 
complex 1 (PRC1) and eliminated by “erasers” such as histone deacetylases 
(HDACs; (Jakovcevski and Akbarian, 2012)). The most important chromatin 
modifying complexes and their regulation are discussed in Chapter 2.3.3. 
If chromatin is further compacted into a (constitutively) repressed heterochromatic 
state, it is often associated with the nuclear lamina and does not allow binding of 
DNA-associated proteins. Contrarily to that, transcription can occur at euchromatic 
regions where DNA-binding proteins still have access to the DNA due to the low level 
of its compaction (reviewed in (Zhou et al., 2011)). Histone modifications can thus 
either serve to establish global chromatin environments or to orchestrate DNA-based 
biological tasks, thereby influencing many key metabolic processes (reviewed in 
(Kouzarides, 2007)). 
 
2.3.1 Chromatin Remodeling and Histone Variants 
Chromatin remodeling complexes regulate the higher order chromatin structure and 
thereby the access to DNA and histone proteins. These complexes consist of 
numerous subunits and function in an ATP-dependent manner. Histone–DNA 
interactions must be loosened to facilitate access of protein complexes involved in 
DNA metabolic processes, such as transcription, replication, recombination and 
repair. This is achieved through the hydrolysis of ATP by chromatin remodeling 
complexes, which operate similar to DNA translocases to disrupt electrostatic 
interactions between DNA and histone proteins to facilitate nucleosome sliding, DNA 
exposure and nucleosome exchange (reviewed in (Hargreaves and Crabtree, 2011)). 
In mammals, there exist four different families of ATP-dependent chromatin 
remodeling complexes: SWI/SNF, INO80/SWR1, ISWI and CHD (reviewed in 
(Hargreaves and Crabtree, 2011)).  
Contrarily to canonical histones which are deposited behind the replication fork 
during S phase, histone variants are incorporated independently of DNA replication 
21 
 
(reviewed in (Jin et al., 2005)). It emerges that most histone variants are deposited at 
preferential genomic locations and that they have relevant biological functions, for 
instance in DNA damage signaling or transcription. An example for the latter is H3.3, 
a variant of canonical H3: H3.3 is associated with actively transcribed regions and 
relatively enriched in PTMs characteristic for transcribed genes (H3K4me2, 
H3K4me3, H3K9ac, H3K14ac, H3K18ac, H3K23ac; (McKittrick et al., 2004; 
Wirbelauer et al., 2005)). The canonical histone H3, in contrast, is rather enriched in 
silenced chromatin domains that are positive for H3K9 methylation (McKittrick et al., 
2004). Furthermore, H3.3 functions as an insulator against heterochromatin 
spreading in Drosophila melanogaster (Nakayama et al., 2007). H2A.X, a variant of 
H2A, is an ubiquitously incorporated histone variant and in its phosphorylated state 
(γH2A.X), it is a marker for DNA lesions and initiates DNA damage response 
(Rogakou et al., 1998). Another variant of H2A, H2A.Z, is preferentially incorporated 
into promoter-proximal regions and plays a positive role in transcription. Whereas 
H3.3 is distinguished from H3 in only four amino acid residues, H2A.Z only shows 
60% sequence identity with canonical H2A (reviewed in (Jin et al., 2005)). Still, the 
above mentioned histone variants are highly conserved in eukaryotes, further 
consolidating their fundamental biological roles (reviewed in (Jin et al., 2005)). Of 
course, also the regulation of the deposition of canonical histones plays a vital role, 
for instance in transcription: RNA polymerase II was shown to preferentially bind to 
nucleosomes that are depleted of one H2A-H2B dimer (Baer and Rhodes, 1983). 
Furthermore, elongation by RNA polymerase II contributes to histone dimer release 
(Levchenko et al., 2005; Levchenko and Jackson, 2004). This is in accordance with 
gene activation usually being accompanied by disassembly of nucleosomes in 
promoter regions (reviewed in (Henikoff and Ahmad, 2005; Jin et al., 2005)). The 
assembly of nucleosomes is assisted by specific histone chaperones, the histone 
regulatory homolog A (HIRA) e.g. deposits H2A variants and H3.3. Depending on the 
specific genomic location, H3.3 is deposited by different histone chaperones: HIRA 
deposits H3.3 at both active and repressed genes but not at telomeres and many TF 
binding sites; in contrast, ATRX (a member of SNF2 chromatin remodelers) is 
responsible for H3.3 deposition at telomeres and the death-domain associated 
protein (DAXX) incorporates H3.3 at pericentromeres (Drane et al., 2010; Goldberg 
et al., 2010; Lewis et al., 2010; Morozov et al., 2012). Contrarily, the canonical 
histone H3 is mainly deposited by the histone chaperone chromatin assembly factor 
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1 (CAF1; (Jin et al., 2005)). Interestingly, the chromatin remodeling complex INO80, 
which regulates the cell cycle checkpoint at G2/M for instance after a DSB, shows a 
preference for the incorporation of H2A.X and H2A.Z (Morrison and Shen, 2005; 
Papamichos-Chronakis et al., 2006; van Attikum and Gasser, 2005a; Watanabe and 
Peterson, 2010). Importantly, it was reported recently that conserved variation 
between amino acid residues on H3 may confer specificity to histone modifying 
enzymes. Specifically, it was shown in plants that the H3K27 methyltransferase 
ATXR5 methylates alanine 31 in H3.1 but not threonine 31 in H3.3. This can provide 
a way to assure accuracy in the mitotic inheritance of histone modifications (Jacob et 
al., 2014). 
It was suggested that due to its independency of replication, H3.3 is incorporated to 
replace the nucleosomes that were evicted during the transcription of highly active 
genes (Wirbelauer et al., 2005). Yet, H3.3 may also serve to mark sites of continuous 
histone turnover to maintain accessibility to gene regulatory elements (reviewed in 
(Szenker et al., 2011)). H3.3 impairs higher-order chromatin folding, although it does 
not significantly alter the stability of mononucleosomes (Chen et al., 2013a). This is in 
line with the role of H3.3 in transcription: H3.3 is actively deposited into enhancers in 
mouse ESCs prior to gene induction by retinoic acid (RA; (Chen et al., 2013a)). Upon 
RA-dependent gene activation, H3.3 is then depleted from enhancers and deposited 
into the promoter region (Chen et al., 2013a). This suggests that H3.3 plays a critical 
role in the activation of inducible genes (Chen et al., 2013a). Furthermore, in mouse 
ESCs, H3.3 is highly enriched at the promoters of developmental genes 
characterized by a bivalent chromatin state (Goldberg et al., 2010). Here, the 
deposition of H3.3 by HIRA facilitates the binding and activity of PRC2 to establish 
bivalency in mouse ESCs (Banaszynski et al., 2013). A summary of H3.3 “deposition 
dynamics” and turnover is shown in Figure 5. In my thesis, I addressed a possible 
role of the regulation of DNA methylation in H3.3 deposition; these data are 
presented in more detail in Appendix II. 
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Figure 5: Preferential deposition of H3.3 at distinct genomic regions and the respective turnover 
profiles are depicted schematically (Huang and Zhu, 2014). 
 
2.3.2 Genomic Region- and Context-Specific Histone Modifications  
Active promoters 
Gene promoter regions are characterized by an enrichment of histone 3 lysine 4 
trimethylation (H3K4me3), independently of the expression status of the respective 
gene (Guenther et al., 2007). Methylated H3K4 is selectively recognized by the PHD 
finger domain of TAF3, which is part of the general transcription factor TFIID. This 
interaction can generate a docking site for further proteins and finally activate 
transcription (Vermeulen et al., 2007). H3K4me3-positive sites are often 
accompanied by histone acetylation: There exist positive correlations both for H3K4 
methylation with H3 acetylation at lysines 9 and 18 as well as for the valency of the 
two modifications (Nightingale et al., 2007; Wang et al., 2001). Additionally, 
H3K4me3-positive sites are often occupied by the H3.3 histone variant (Goldberg et 
al., 2010; Guenther et al., 2007; Kim et al., 2005; Mikkelsen et al., 2007; Wang et al., 
2008). Chromatin in an open, accessible conformation is devoid of DNA methylation, 
an explanation for this might be that methylation of H3K4 does not allow a physical 
interaction between the histone tail and Dnmt3L (Meissner et al., 2008; Mohn et al., 
2008; Ooi et al., 2007). Many of these H3K4me3-positive promoter regions are also 
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bound by RNA Pol II and transcription is initiated there, although not all of these 
promoters produce detectable terminated transcripts (Guenther et al., 2007).  
Repressed promoters 
The typical chromatin mark for repressed promoters is the trimethylation of histone 3 
at lysine 27 (H3K27me3). Often, repressed chromatin also contains histone 3 which 
is trimethylated at lysine 9 (H3K9me3) and the respective DNA is methylated (Zhou 
et al., 2011). Importantly, it appears that deacetylation of histones precedes the 
silencing of genes by H3K9 methylation, as the H3K9-specific histone 
methyltransferase SUV39h1 was found to interact with several histone deacetylases, 
explaining both the physical and functional interaction (Vaute et al., 2002).  
Bivalent promoters, which are strongly associated with developmental genes and 
CpG islands (CGIs), are positive for H3K4me3 and H3K27me3 (Bernstein et al., 
2006). These bivalent genes are poised for transcription; they can either be rapidly 
induced or shut down, depending on the developmental requirement (reviewed in 
(Aloia et al., 2013)).  
Gene bodies   
The gene bodies of transcribed genes are predominantly trimethylated on histone 3 
at lysine 36 (H3K36me3) and dimethylated on histone 3 at lysine 79 (H3K79me2; 
(Mikkelsen et al., 2007; Schubeler et al., 2004)). Compared to introns, H3K36me3 is 
particularly strongly enriched in expressed exons (Kolasinska-Zwierz et al., 2009). 
This might be due to the interaction of RNA Pol II with SET2, the histone 
methyltransferase for H3K36 (Li et al., 2003). 
Enhancers 
The typical histone mark at enhancers is monomethylation of histone 3 at lysine 4 
(H3K4me1) while H3K4me3 is absent (Heintzman et al., 2007). In contrast to poised 
enhancers, which are marked by H3K4me1 alone, active enhancers are 
characterized by additional acetylation of histone 3 at lysine 27 (H3K27ac; 
(Creyghton et al., 2010)). H3K27ac, together with the deposition of the histone 
variant H2A.Z, correlates with gene expression levels of the downstream target gene 
(Ernst and Kellis, 2010). 
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Heterochromatic Regions 
Heterochromatin is very condensed and can be divided into two different types, 
constitutive and facultative heterochromatin. Constitutive heterochromatin is 
considered to remain compacted throughout an organism’s life span, such as the 
pericentric satellite repeats and telomeres (reviewed in (Craig, 2005)), whereas 
facultative heterochromatin is established during development, for instance at the 
inactive X chromosome in females or at silenced genes (Brockdorff, 2002; Trojer and 
Reinberg, 2007). Constitutive heterochromatin is marked by hypoacetylation and 
trimethylation of both H3K9 (H3K9me3) and histone 4 at lysine 20 (H4K20me3). The 
situation is less clear for facultative heterochromatin: for the process of local gene 
silencing it appears that general histone hypoacetylation, dimethylation of H3K9 
(H3K9me2), monomethylation of H4K20 (H4K20me1) as well as monoubiquitination 
of histone H2A on lysine 119 (H2AK119ub) are prevalent, whereas general histone 
hypoacetylation, H3K27me2/3, H2AK119ub and H4K20me3 are characteristic for 
long range gene silencing of e.g. Hox gene clusters (reviewed in (Trojer and 
Reinberg, 2007)). Frequently, the constitutive heterochromatin at centromeres is 
bound by the heterochromatin binding protein 1 (HP1; (Maison and Almouzni, 2004)). 
 
2.3.3 Chromatin Modifying Complexes and Their Regulation  
Histone Methyltransferases (HMTs) 
The current understanding is that at least three lysine residues on histone tails are 
associated with the activation of transcription when methylated (H3K4, H3K36, 
H3K79) and three lysine residues in the repression of transcription when methylated 
(H3K9, H3K27, H4K20; reviewed in (Kouzarides, 2007)). In the following paragraphs, 
the regulation of the most relevant lysine methylation residues for my thesis are 
presented in more detail (H3K4, H3K27 and H3K9). 
H3K4: The Trithorax complex (Trx) contains the mixed-lineage leukemia (MLL) HMT 
which catalyzes methylation of H3K4 through its SET domain (Dou et al., 2006). Trx 
proteins are found in different complexes with diverse functions, such as in cell cycle 
regulation, in DNA damage signaling and in stem cell maintenance. They are clearly 
associated with transcriptional activation and generally have opposing roles to the 
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polycomb repressive complexes (see below). Beside H3K4 methylation, Trx may also 
mediate H3K27 acetylation and H3K36 methylation (Schuettengruber et al., 2007). 
There are several H3K4 HMTs, among them five different MLL enzymes 
(MLL1/2/3/4/5) as well as SET1A, SET1B and ASH1 (reviewed in (Kouzarides, 
2007)). 
 
H3K27: H3K27me2/3 is deposited by EZH2 which is part of the polycomb repressive 
complex 2. In mammals, the polycomb group proteins exist in two major complexes: 
polycomb repressive complex 1 (PRC1) and 2 (PRC2). PRC2 consists of SUZ12, 
EED and EZH1/2. After the deposition of H3K27me2/3 by PRC2, this mark is then 
specifically recognized by the chromodomain of Polycomb (Pc), a subunit of PRC1, 
which is subsequently recruited to these sites thereby preventing the access of 
nucleosome remodeling factors and leading to the formation of a repressive 
chromatin state (Cao et al., 2002; Wang et al., 2004). Additionally, EZH2 interacts 
with all three DNMTs, although this interaction seems to be transient, leading to 
increased DNA methylation and thereby the connection of two epigenetic repression 
systems (Vire et al., 2006). Interestingly, genes that are bound by PRC2 and positive 
for H3K27me3 in ESCs become significantly more often aberrantly methylated in 
cancer. Developmental genes that are normally repressed during differentiation 
become somehow additionally and erroneously pre-marked to permanently stay 
repressed. Presumably, this is triggered by the additional deposition of H3K9me2 and 
H3K9me3 at these sites in embryonic cells. This specific chromatin pattern and the 
silencing of these developmental genes in stem cells prime these genes for DNA 
hypermethylation and the heritability of the silencing can provoke tumor initiation and 
progression (Lee et al., 2006; Mikkelsen et al., 2007; Ohm et al., 2007; Schlesinger et 
al., 2007; Widschwendter et al., 2007). This may reflect a PRC2-DNMT-mediated 
interruption of the cyclic DNA methylation-demethylation observed at developmental 
genes during differentiation (Appendices I, II and III). Further, PRC2 recruits the 
H3K4me2/3 demethylase (JARID1a) to target genes, further generating a repressive 
chromatin state and highlighting the importance of the coordinated recruitment of 
histone modifying enzymes  (Pasini et al., 2008). 
H3K9: In mammals, there are several H3K9 methyltransferases; SETDB1, G9a, 
SUV39h1, SUV39h2 and EHMT1 (Peters et al., 2001). H3K9 trimethylation by the 
SUV39 proteins is required for the DNA methylation of major satellite repeats in 
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pericentromeric heterochromatin by DNMT3b (Lehnertz et al., 2003). G9a interacts 
with DNMT1 and PCNC in a ternary complex directly at the replication fork, in order 
to coordinate the correct duplication of both DNA methylation and H3K9 methylation 
during replication (Esteve et al., 2006). Furthermore, some H3K9 methyltransferases 
interact with HDACs and with the heterochromatin binding protein 1 (HP1). This led 
to a model where deacetylation of H3K9 facilitates H3K9 methylation, this stimulates 
HP1 binding and recruitment of further HDACs and HMTs in order to orchestrate 
gene silencing (Czermin et al., 2001; Vaute et al., 2002). 
Lysine Demethylases (KDMs) 
Depending on its interaction partners, the lysine-specific demethylase 1 (LSD1) acts 
on different lysines: in association with the CoREST repressor complex, it 
demethylates H3K4me2/me1, leading to the repression of target genes (Shi et al., 
2005). Contrarily, in association with the androgen receptor (AR) it acts as a 
H3K9me2/me1 demethylase which induces the expression of AR-targeted genes 
(Metzger et al., 2005). The H3K27me3 demethylases JMJD3 and UTX, in conjunction 
with the H3K4me3 HMT MLL2, are able to resolve bivalent chromatin domains during 
ESC differentiation. This is accompanied by the displacement of PRC2 and 
transcriptional activation of certain gene clusters, such as the HoxB locus (Agger et 
al., 2007). 
Histone Acetyltransferases (HATs) 
Generally, the specificity of HATs is rather conferred to the histone type than to 
specific lysine residues. HAT1 for instance prefers both lysine 5 (K5) and lysine 12 
(K12) on H4. The p300/CBP-associated factor (PCAF) or lysine-acetyl transferase 2 
(KAT2) acetylate K9, K14 and K18 on H3. CBP/p300 targets all canonical core 
histones (H2A, H2B, H3 and H4) on several lysine residues (Kouzarides, 2007). 
CBP/p300 is an important transcriptional co-activator and associates with a number 
of chromatin-modifying proteins; like the histone chaperone DAXX, HATs, HMTs but 
interestingly also with the DNA repair enzyme TDG (Ernst et al., 2001; Kuo et al., 
2005; Tini et al., 2002).   
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Histone Deacetylases (HDACs) 
In mammals, one can distinguish between the classical HDACs, whose enzymatic 
activity requires Zn2+, and sirtuins, which are NAD+-dependent enzymes (reviewed in 
(Reichert et al., 2012)). The classical HDAC family contains 11 members which are 
further assigned to four different classes according to phylogenetic analysis and 
sequence homologies. For instance, class I is comprised of HDAC1/2/3 and 8 
(reviewed in (Walkinshaw et al., 2008)). HDACs are ubiquitously expressed and 
interact with numerous tissue-specific TFs, pointing to their important role in 
transcriptional regulation. Besides deacetylation of different histones (H3, H4), 
thereby generating a repressive chromatin environment; HDACs also deacetylate 
non-histone proteins such as TFs which is a further means to regulate transcription 
(reviewed in (Reichert et al., 2012)). Furthermore they constitute core components of 
several complexes: HDAC1 and 2 form the catalytic core of the (i) SIN3a co-
repressor complex, they are part of the (ii) nucleosome remodeling and deacetylase 
(NuRD) complex and (iii) the transcriptional co-repressor complex CoREST 
(reviewed in (Reichert et al., 2012)). HDACs lack a DNA binding domain; they thus 
have to interact with e.g. TFs to establish contact with their substrates. Thereby, they 
can be recruited to cell cycle regulator genes (such as p21 and p53) by different TFs 
where they directly repress transcription of these genes (reviewed in (Reichert et al., 
2012)).  
Non-coding RNAs (ncRNAs) 
Interestingly, long non-coding RNAs (lncRNAs) have been found to constitute 
scaffolds for histone modifying complexes, and act both in trans (e.g. HOTAIR) and in 
cis (e.g. Air, Kcnq1ot1). The human lncRNA HOTAIR (HOX Antisense Intergenic 
RNA), which is expressed from the HOXC locus, bridges the PRC2 and 
LSD1/REST/CoREST protein complexes, to perform H3K27 methylation and H3K4 
demethylation at the HOXD locus and select genes on other chromosomes in trans 
(Rinn et al., 2007; Tsai et al., 2010). Another lncRNA called Air was shown to 
regulate genomic imprinting in cis in the embryo proper as well as in the placenta. Air 
itself is imprinted and monoallelically expressed from the paternal allele, transcribed 
from a locus overlapping the Igf2r gene (Nagano et al., 2008; Sleutels et al., 2002). It 
mediates silencing of the imprinted, maternally expressed, genes Igf2r, Slc22a2 and 
Slc22a3 (Sleutels et al., 2002). The underlying mechanism is not entirely clear, but 
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silencing of Igf2r does not include G9a (Nagano et al., 2008). In contrast, the 
imprinting of Slc22a2 and Slc22a3 in the placenta requires Air-mediated targeting of 
G9a to these loci, leading to H3K9 methylation and allelic silencing (Nagano et al., 
2008). Similarly, Kcnq1ot1, another lncRNA, was shown to be involved in the 
epigenetic silencing of imprinted genes. Target genes include Kcnq1, Cdkn1c, 
Slc22a18 and Phlda1, which are ubiquitously imprinted, as well as Cd81, Osbpl5, 
Tssc4, Tspan32 and Ascl2, which are only imprinted in placenta ((Kanduri, 2011); 
see also Chapter 2.4.2). Kcnq1ot1 was shown to target several chromatin modifying 
complexes involved in epigenetic repression to these loci, among them are the G9a, 
PRC1 and PRC2 complexes as well as DNMT1 (Mohammad et al., 2010; Pandey et 
al., 2008; Terranova et al., 2008; Umlauf et al., 2004). Again, this promotes the 
epigenetic silencing of the target genes and strikingly, the silencing is observed in a 
lineage-specific manner (Pandey et al., 2008). Furthermore, miRNA and RNAi 
pathway components may also contribute to the methylation of H3K27 by recruitment 
of the PRC2 complex (Kim et al., 2008). 
 
2.3.4 Epigenetic Modifications and Cell Plasticity  
The different tissues and cell types in an organism all contain the same genetic 
information. Cellular identity is thus not solely determined by DNA sequence, but also 
by tissue-specific transcription factors that cooperate with epigenetic modifiers to 
establish and maintain distinct chromatin states that instruct cell-type-specific gene 
expression patterns and hence cell identity. Initially, the term “epigenotype” was used 
to describe the development and inheritance of phenotypic traits (Waddington, 2012). 
Already in 1950, the occurrence of 5-mC in nucleic acids was described for the first 
time (Wyatt, 1950), although at that time, this was not seen as an epigenetic 
modification. The term “epigenetic modification” became custom only in the 1990s 
and today, it comprises modifications of DNA bases and histone protein tails. These 
modifications are tightly regulated and also inherited during DNA replication in order 
to propagate a stable cellular identity. The underlying mechanisms are not exactly 
clear; except that epigenetic modifications can be reset and that they do not impact 
the primary sequence of the DNA molecule (reviewed in (Alabert and Groth, 2012; 
Cedar and Bergman, 2009; Cheedipudi et al., 2014; Jenuwein and Allis, 2001; 
Kouzarides, 2007)). 
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The correct setting, reading and restoration of epigenetic marks is especially critical 
during periods of high cellular plasticity, such as embryonic development and 
meiosis. But also for cellular metabolism or proliferation, epigenetic marks need to be 
strictly regulated. During embryogenesis, the developmental potential of embryonic 
cells becomes restricted by differentiation programs, channeling the cell fate to finally 
establish a terminal cell identity. Accompanying the differentiation of embryonic cells 
to somatic lineages, there is thus a progressive decrease of cell plasticity, which 
results in a restricted cell fate, where cellular memory is retained and cellular 
specialization is conferred (reviewed in (Shah and Allegrucci, 2013)). A core network 
of transcription factors (TFs), including POU domain, class 5, transcription factor 1 
(OCT4/POU5f1), SRY (sex determining region Y)-box 2 (SOX2) and Nanog 
homeobox (NANOG), define the ground state of pluripotent embryonic stem cells 
(ESCs). These factors are both transcription activators and repressors: cell 
proliferation and self-renewal genes become activated and the expression of lineage-
specific genes becomes repressed (reviewed in (Young, 2011)). Interestingly, it is 
sufficient to bring the key pluripotency factors OCT4, SOX2, Kruppel-like factor4 
(KLF4) and myelocytomatosis oncogene (MYC; OSKM) into a somatic cell to induce 
epigenetic reprogramming and give rise to an induced pluripotent stem cell (iPSC; 
(Takahashi and Yamanaka, 2006)). It was found later, that even two factors (OCT4 
and SOX2) are sufficient to induce pluripotency, however, a higher number of TFs 
increases the reprogramming efficiency as well as the differentiation potential of the 
iPSCs (Lohle et al., 2012). Recently, it was shown that the methyl-CpG binding 
domain protein 3 (MBD3) together with the NuRD complex is responsible for blocking 
the efficient induction of pluripotency genes (Rais et al., 2013). The reduction of 
MBD3 protein levels in the presence of OSKM allows a nearly complete reversion to 
naïve pluripotency, as evidenced by characteristic changes in DNA methylation, thus 
clearly linking epigenetic reprogramming to DNA methylation. The absence of 
MBD3’s inhibitory effects allows interactions of OSKM with pluripotency-promoting 
epigenetic regulators and channels the cell fate progressively towards pluripotency 
(Dos Santos et al., 2014; Rais et al., 2013). Hence, epigenetic landscapes are plastic 
and reversible and this allows the reset of the epigenetic make-up of one generation 
to another. The drawback is that this also allows aberrant reprogramming as 
observed for instance in cancer stem cells (reviewed in (Berdasco and Esteller, 2010; 
Munoz et al., 2012)). 
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2.4 DNA Methylation 
DNA methylation is found in many organisms, both in prokaryotes and eukaryotes. In 
prokaryotes, DNA methylation can occur both on C and A and is involved in diverse 
biological processes, like replication initiation, strand discrimination during MMR or 
defense against invading foreign DNA, i.e. bacteriophages (reviewed in (Kumar and 
Rao, 2013)). In eukaryotes, DNA methylation is predominantly found at the C5 
position of the Cytosine (C) and is generally associated with transcriptional 
repression. Examples include the inactivation of the second X chromosome in female 
mammals, silencing of retroviral DNA and transposons as well as the parent-of-
origin-specific silencing of imprinted loci (reviewed in (Basu and Zhang, 2011; 
Plasschaert and Bartolomei, 2014; Reiss and Mager, 2007)). Non-CpG methylation is 
also found in eukaryotes, although to a much lesser extent, and its role is not clear 
yet (Baubec and Schubeler, 2014; Patil et al., 2014). Methylation is performed by 
DNA methyltransferases (DNMTs) which use S-adenosyl-L-methionine (SAM) as a 
methyl donor (Jurkowska et al., 2011). DNMTs can be classified into maintenance 
and de novo DNMTs; the disruption of which in mice is lethal (Klose and Bird, 2006).  
 
De novo DNA Methylation                 
There are two active de novo DNMTs (DNMT3a and DNMT3b) in mammals. A third 
member (DNMT3L) is present but catalytically inactive and unable to bind the co-
factor SAM. DNMT3L binds DNA very poorly but stimulates the activity of both 
DNMT3a and DNMT3b in vivo and in vitro, probably by induction of a conformational 
change in the active site of the enzyme, which facilitates SAM and DNA binding and 
thus catalysis (Chedin et al., 2002; Gowher et al., 2005; Kareta et al., 2006). 
DNMT3L can hence be considered a positive regulator of de novo DNMTs. The 
preferential substrate for DNMTa and DNMT3b is the CpG dinucleotide, however, 
they can also methylate Cytosine in a non-CpG context (Gowher and Jeltsch, 2001; 
Jurkowska et al., 2011). Yet, it is unclear, how de novo DNMTs are recruited to their 
site of action. Several mechanisms have been proposed: (i) de novo DNMTs 
recognize chromatin directly via specific domains, such as the Proline-Tryptophane-
Tryptophane-Proline motif (PWWP domain) which is essential for the chromatin 
targeting of enzymes (Ge et al., 2004)); or (ii) de novo DNMTs are recruited to 
chromatin through protein-protein interactions with transcriptional repressors, such as 
32 
 
MYC (Brenner et al., 2005). Interestingly, DNMTs were shown to preferentially 
methylate DNA which is in a chromatin environment characterized by unmethylated 
H3K4 (Hashimoto et al., 2010; Zhang et al., 2010).  
 
Maintenance DNA Methylation         
The current understanding is that the maintenance DNMT (DNMT1) uses hemi-
methylated DNA molecules as a substrate and copies the pre-existing methylation 
pattern onto the new DNA strand during DNA replication (Jurkowska et al., 2011), 
thereby ensuring the maintenance of cell type-specific methylation states. DNMT1 
recruitment to replicating regions is dependent on ubiquitin-like containing PHD and 
RING finger domains 1 (UHRF1; or nuclear protein 95, NP95). UHRF1 possesses a 
SET and RING finger-associated (SRA) domain, by which it specifically binds to 
methylated or hemi-methylated CpG sites (Sharif et al., 2007). DNMT1 is then 
positioned right at the replication fork, where it catalyzes the transfer of the 
methylgroup with high processivity. It is able to maintain this velocity on long 
stretches of DNA without dissociating from the template and without swapping the 
target strand (Goyal et al., 2006; Hermann et al., 2004). Interestingly, the SRA-
domain of UHRF1 was recently shown to also bind to 5-hmC (Frauer et al., 2011), 
which implies that the contribution of UHRF1 to maintenance (or change) of DNA 
methylation patterns may indeed be more complex than anticipated before.  
 
DNA Methylation and Gene Activity 
DNA methylation can repress gene transcription in two ways. It can directly inhibit TF 
binding if a binding site requires unmethylated C (Blattler and Farnham, 2013). Also, 
DNA methylation triggers chromatin changes that affect the accessibility of DNA 
more generally, leading for instance to the recruitment of co-repressors of 
transcription by methyl-CpG binding domain proteins ((MBDs; (Nan et al., 1998; Watt 
and Molloy, 1988)). Moreover, DNA methylation can influence co-transcriptional 
processes, such as mRNA splicing. Intragenic DNA methylation was shown to 
modulate alternative splicing genome-wide. Compared to the excluded exons, 
alternatively spliced exons which become included in the transcript, show significantly 
more DNA methylation. This is mediated by the methyl CpG binding protein 2 
(MeCP2), which is recruited to the methylated exons and functions primarily in 
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promoting their recognition for inclusion. Further, MeCP2-mediated recruitment of 
histone deacetylases (HDACs) facilitates the inclusion of the exon probably through 
modulation of acetylation states of histones or other proteins (Maunakea et al., 2013).   
 
2.4.1 CpG Islands (CGIs) 
In mammals, DNA methylation occurs mainly at the C5 position of Cytosine and in 
the context of CpG dinucleotides. 5-mC has a higher deamination rate than C, thus 
generating at a steady rate TpG dinucleotides and hence, in mammals the CpG 
dinucleotide is strongly underrepresentated (Lander et al., 2001). The majority of 
CpG dinucleotides is methylated at the C5 position of the Cytosine (reviewed in 
(Illingworth and Bird, 2009)). Nevertheless, mammalian genomes contain clusters of 
CpG dinucleotides, the so called CpG islands (CGIs). The original definition of CGIs 
considers length (>200 bp), GC content (>50%) and the observed/expected CpG 
density (>0.6; (Gardiner-Garden and Frommer, 1987)). However, these regions are 
variable in length, with an average of approximately 1 kilo base (kb), furthermore, 
they are characterized by low levels of Cytosine methylation (Gardiner-Garden and 
Frommer, 1987; Zhao and Han, 2009). Mammalian genomes contain nearly 30’000 
CGIs which frequently span gene regulatory regions (e.g. promoters), and thus seem 
to play a role in gene regulation (Illingworth and Bird, 2009; Lander et al., 2001). To 
date it is unclear, how CGIs have evolved at all. There are two plausible scenarios: (i) 
actively transcribed CGIs are usually bound by TFs, transcriptional co-regulators and 
the transcription machinery; this could sterically hinder DNMT association and thus 
prevent DNA methylation (Brandeis et al., 1994); (ii) there is a targeted DNA 
demethylation and repair mechanism, which specifically maintains CGIs in an 
unmethylated state (Frank et al., 1991). In both scenarios, the absence of DNA 
methylation might keep the CT mutation rate low. In support of the latter, we show 
that TDG and TET1/2 act together to regulate DNA methylation at CGIs, relevant for 
lineage commitment. This indicates that cell-type-specific CGIs are kept in an 
unmethylated state by a precisely targeted mechanism, involving TET and TDG, 
which at the same time can repair deamination of Cs or 5-mCs (Appendices I and 
II). Indeed, it becomes evident that Cytosine methylation and demethylation at CGIs 
(as well as of the associated histone proteins) is regulated in a cell-type- and 
developmental-stage-specific manner (Li et al., 2014). This goes together with the 
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transcriptional repression caused by CGI methylation, which can prevent expression 
of non-tissue-specific genes and also of tumorsupressor genes during carcinogenesis 
(Baylin et al., 2001; Futscher et al., 2002; You and Jones, 2012). About 50% of all 
CGIs contain transcriptional start sites (TSSs) as evident from their overlap with 
promoters of annotated genes (promoter CGI; Figure 6). But also of the remaining 
50% inter- and intragenic CGIs, many represent not yet annotated promoters and 
indeed produce transcripts, often in a tissue-specific manner (orphan CGIs; 
(Illingworth et al., 2010)). Promoter CGIs are relatively free of nucleosomes 
(Ramirez-Carrozzi et al., 2009; Schwarzbauer et al., 2012). Nevertheless, 
characteristic histone modifications can be found at CGIs; among them elevated 
levels of H3 and H4 acetylation and H3K4me3 as well as loss of H1 and H3K36me2 
(Blackledge et al., 2010; Fan et al., 2008; Mikkelsen et al., 2007; Tazi and Bird, 
1990). Also, a unique composition of proteins, such as i.e. the CXXC finger protein 1 
(CFP1) which specifically binds to non-methylated CpGs as well as the H3K36-
specific lysine demethylase KDM2a, can be found at CGIs (Blackledge et al., 2010; 
Thomson et al., 2010). 
 
Figure 6: The promoter CpG island and both intra- and intergenic “orphan” CpG islands are 
characterized by a high density of CpG dinucleotides in an unmethylated state (Deaton and Bird, 
2011). 
 
2.4.2 Regulation of DNA Methylation During Development 
The timing and placement of DNA methylation needs to be tightly regulated and is 
essential for cellular function and finally normal development. In the first place, 
targeting of DNMTs is achieved by the sequence context of the CpG dinucleotide. 
Since this is not a highly specific recognition sequence, it can be speculated that 
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there are additional means to target DNMTs. These could include specific histone 
modifications or nucleosome positioning (reviewed in (Rose and Klose, 2014)). Also, 
since DNMTs are SAM-dependent enzymes, SAM metabolism could play a role as 
well. Furthermore, DNMT3L was shown to affect overall DNA methylation levels, by 
selectively modulating DNMT3a activity at imprinted loci in germ cells (Aapola et al., 
2000; Kaneda et al., 2004).  
The successful and healthy development of organisms is highly dependent on the 
accurate timing of DNA methylation as well as DNA demethylation (see also Chapter 
2.5). During embryonic development, when cells undergo lineage commitment, there 
are specific gene programs that are shut down by DNA methylation or activated by 
DNA demethylation. For instance, pluripotency genes become silenced very early 
upon differentiation, already within 24 hours (Rigbolt et al., 2011). Contrarily, 
developmental genes will rapidly become activated upon specific developmental 
clues (reviewed in (Kraushaar and Zhao, 2013)). 
An additional aspect of DNA methylation in development is genomic imprinting. For 
the majority of genes, the maternal and the paternal allele are expressed or 
repressed likewise. A number of genes, however, is expressed monoallelically, in a 
parent-of-origin-specific manner (reviewed in (Plasschaert and Bartolomei, 2014)). 
These are designated imprinted genes and they include probably up to 1000 genes 
in humans (Kelsey and Bartolomei, 2012). Usually, imprinted genes are located in 
clusters of 3-12 genes and the clusters are characterized by allele-specific epigenetic 
marks, including DNA methylation and histone modifications. Imprinting is well 
conserved in mammals; however, it is not exactly known how the specific recognition 
of these genes is achieved. Nevertheless, it is clear that in both germlines, DNA 
methylation is established by DNMT3a and DNMT3L, albeit there may be several 
mechanisms involved. An example for paternal-specific methylation is the H19/Igf2 
locus. DNA methylation is deposited there already prior to the onset of meiosis, in the 
germline which generates the gametes. Contrarily, maternal-specific imprinting 
occurs postnatally in growing oocytes. Interestingly, imprinted genes include many 
with functions in placental growth, and is therefore assumed to have evolved from the 
fundamental maternal-fetal conflict on nutrient allocation (Fowden and Moore, 2012; 
Girardot et al., 2013; Plasschaert and Bartolomei, 2014).  
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2.4.3 The Role of DNA Methylation in Disease 
DNA methylation is playing an important role in a variety of diseases. Of these, some 
types of cancer represent archetypes for misregulation of DNA methylation: They 
often exhibit hypomethylation at repetitive sequences, which may cause 
chromosomal instability (Cheung et al., 2009); whereas important genes are 
inactivated by aberrant hypermethylation of their CpG island promoters. This is in line 
with an aberrant silencing of tumor suppressor genes present in numerous cancers 
(Choi and Lee, 2013; Jones, 2002; Jones and Baylin, 2002). Since recently the TET 
proteins were identified as dioxygenases of 5-mC, aberrant DNA methylation in 
cancer was reconsidered. The question arose, whether malfunctioning Tet genes 
could be responsible for cancer-associated DNA methylation changes, including DNA 
hydroxymethylation. Indeed, in many different human cancer types, the levels of 5-
hmC were found to be significantly reduced (Haffner et al., 2011; Jin et al., 2011; 
Kudo et al., 2012; Lian et al., 2012; Yang et al., 2013). Corroborating this finding, 
TET proteins were reported to be mutated or dysfunctional due to chromosomal 
translocations in many hematopoietic malignancies (Solary et al., 2014). In our lab, 
we recently found that the Tet1 promoter is hypermethylated in a subtype of 
colorectal cancers (CRCs) characterized by the simultaneous hypermethylation of 
CpG islands (CpG Island Hypermethylator Phenotype, CIMP; Stefan Weis, 
unpublished data). The comparison between CIMP positive and CIMP negative CRC 
cell lines revealed elevated 5-hmC levels in CIMP positive cell lines (Annika Wirz, 
unpublished data). Similarly, mutations in Idh1 and Idh2 were reported to be sufficient 
to generate a CIMP phenotype in gliomas, possibly by depriving the TET proteins of 
its co-factor 2-oxoglutarate (2-OG; (Turcan et al., 2012)). 
Trinucleotide repeat disorders are characterized by well-defined, unstable 
trinucleotide regions located within different genes, which undergo expansion for 
unknown reasons. The expanded state is then frequently linked to neurodegenerative 
disorders (reviewed in (McMurray, 2010)). Examples herefore are the myotonic 
dystrophy (DM1) or the fragile X syndrome (FXS) – both disorders, in which DNA 
methylation plays an important role (Evans-Galea et al., 2013). In FXS, the DNA 
methylation following and presumably triggered by repeat expansion, is responsible 
for the manifestation of the syndrome as evident from the rare cases showing an 
expanded but unmethylated repeat and an absence of disease (Loesch et al., 2012). 
37 
 
The silencing of the Fmr1 gene, which was initiated by repeat expansion and 
followed by DNA methylation thus causes the loss of the gene product (FMRP1), 
which is responsible for the development of FXS. 
The misregulation of imprinting during development can lead to a number of 
disorders, including the Beckwith-Wiedemann (BW) and the Silver-Russell (SR) 
growth syndromes. In SR patients, the imprinting control region (ICR) of the Igf2/H19 
locus, which is the element regulating the imprinting of the whole cluster, is 
characterized by hypomethylation of the paternal allele in SR individuals. This is 
associated with a loss of Igf2 expression, thereby leading to the manifestation of the 
syndrome, which is characterized by intrauterine growth restriction, postnatal growth 
retardation, facial dysmorphism and body asymmetry (reviewed in (Girardot et al., 
2013)). Contrarily, the BW syndrome is characterized by fetal and postnatal 
overgrowth as well as an increased risk of childhood cancers. A variety of underlying 
causes has been described to cause BW syndrome, among them is the defective 
imprinting observed at the Kcnq1 imprinted domain, which leads to a strong reduction 
in Cdkn1c expression. CDKN1c is a negative regulator of the cell cycle and probably 
also a tumor suppressor gene (reviewed in (Girardot et al., 2013)). 
 
2.5 DNA Demethylation 
There are certain biological conditions (described in more detail below), where active 
DNA demethylation seems to occur. While the biochemistry of the methylation of 
Cytosine is relatively well-studied, knowledge about the reverse process, the DNA 
demethylation, has been lagging behind. At a first thought, direct removal of the 
methyl group from cytosine would represent an elegant and simple way to restore an 
unmethylated C. Plants like Arabidopsis thaliana possess the DEMETER (DME) and 
REPRESSOR OF SILENCING 1 (ROS1) enzymes, two DNA glycosylases able to 
excise 5-mC, thus allowing restoration of an unmethylated C by BER (Ikeda and 
Kinoshita, 2009). Although there have been reports about the direct excision of 5-mC 
in mammals as well (Bhattacharya et al., 1999; Fremont et al., 1997; Jost et al., 
1995; Zhu et al., 2000), the situation seems to be less clear here. Over the years, 
these activities could not be reproduced by others, thus potential DNA demethylation 
mechanisms remained under strong debate up to date. Recent evidence points to 
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mammalian DNA demethylation being a multi-step process, which might vary 
depending on, for instance, developmental stage and genomic location. The possible 
pathways that remove 5-mC are discussed below.  
 
2.5.1 Mechanisms of DNA Demethylation 
Passive DNA Demethylation 
In the absence of maintenance methylation, i.e. DNMT1 / UHRF1, and upon 
successive rounds of DNA replication, 5-mC will be lost due to passive dilution. This 
is the scenario envisioned for the global erasure of 5-mC in the maternal pronucleus 
in mouse preimplantation embryos (Monk et al., 1987; Wu and Zhang, 2014). Along 
these lines, recruitment of DNMT1 to replication foci is strongly reduced upon the 
loss of UHRF1 in PGCs (Ohno et al., 2013). A further possibility of “passive” DNA 
demethylation includes the action of the TET proteins: Since DNMT1 is not able to 
recognize 5-hmC, oxidation of 5-mC by the TET enzymes will render these sites 
“invisible” for DNMT1. This will eventually lead to dilution of 5-hmC and thus 
demethylation of the DNA after several cycles of DNA replication (Inoue et al., 2011; 
Inoue and Zhang, 2011; Otani et al., 2013).  
Suggested Pathways for Active DNA Demethylation 
Since plants have ways to directly excise 5-mC by DNA glycosylases, an analogous 
mechanism was initially anticipated to exist in mammals. However, the reports about 
such a direct activity remained scarce: MBD2 was reported to directly remove the 
methyl-group from the 5-mC and restore the unmodified C (Bhattacharya et al., 1999) 
and a chicken homolog of TDG was reported to act on 5-mC together with an RNA 
(Fremont et al., 1997; Jost et al., 1995; Zhu et al., 2000). Furthermore, several 
notions implicated a deaminase activity, such as AID (activation-induced cytidine 
deaminase) or other members of the APOBEC family (apolipoprotein B mRNA editing 
enzyme, catalytic polypeptide), that would deaminate 5-mC or 5-hmC to T or 5-hmU, 
respectively (Guo et al., 2011; Morgan et al., 2004). The thereby generated 
mismatches would be suitable substrates for the TDG, MBD4 or SMUG1 DNA 
glycosylases (reviewed in (Jacobs and Schar, 2012) and subsequent BER would 
restore the original unmethylated C. However, there are some caveats to a prevalent 
deamination-based DNA demethylation pathway: First, the generation of 
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premutagenic lesions (G:T or G:hmU mismatches) would inevitably increase the risk 
of mutation. Yet, we could not find an elevated CT mutation rate in a Tdg-knockout 
background, supporting the notion that a deamination-based pathway is rather 
unlikely to occur on a regular basis (Appendix I). Second, hmC was shown to be an 
unfavorable substrate for deamination by AID or APOBECs, due to steric constraints 
of the catalytic pocket (Nabel et al., 2012; Rangam et al., 2012).  
Fascinatingly, it turned out, that the predominant DNA demethylation pathway works 
through the iterative oxidation of 5-mC by the Ten-Eleven Translocation family of 
proteins (TET1-3; (He et al., 2011; Hu et al., 2014; Maiti and Drohat, 2011; Raiber et 
al., 2012; Shen et al., 2013)). All three TET proteins were shown to have the ability to 
catalyze these oxidation reactions in a Fe2+- and 2-OG-dependent manner applying a 
base-flipping mechansims (Chapter 2.5.2; (Hu et al., 2013; Ito et al., 2010; Ito et al., 
2011; Tahiliani et al., 2009)). Another milestone result was the finding that TDG very 
efficiently excises 5-fC and 5-caC (He et al., 2011; Maiti et al., 2013). Apart from 
TDG, no other DNA glycosylase has been shown to process these substrates. Direct 
removal of the carboxyl-group has been discussed as well, but so far, no direct 
decarboxylase activity could be identified (Figure 7). 
 
Figure 7: Implicated pathways for DNA demethylation include a deamination-repair based model [top], 
an oxidation-deamination-repair based model [middle] and an iterative oxidation-repair based model 
[bottom] (Maiti and Drohat, 2011). 
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There has been an intriguing report lately, that the de novo DNA methyltransferases 
DNMT3a and DNMT3b are able to dehydroxymethylate 5-hmC thereby restoring the 
unmethylated state. However, this is dependent on the redox-state of the protein: in 
an oxidized form, the dehydroxymethylase activity is enhanced and in a reduced 
form, the DNA methyltransferase activity is enhanced (Chen et al., 2012). 
Unfortunately, this has not been reproduced by others so far.  
 
Global and Targeted DNA Demethylation 
A global erasure of nearly all DNA methylation occurs twice in the development of 
mammals. The first event takes place in the paternal pronucleus in preimplantation 
embryos: Within 6-8 hours of fertilization and before the onset of DNA replication, the 
whole paternal genome is demethylated (Inoue and Zhang, 2011; Iqbal et al., 2011; 
Mayer et al., 2000; Oswald et al., 2000). This is achieved by TET3-mediated global 
oxidation of 5-mC to 5-hmC, which is subsequently diluted upon DNA replication 
(Inoue and Zhang, 2011). It is likely that different pathways cooperate in the erasure 
of both global and locus-specific DNA methylation, i.e. oxidation by the TET proteins 
followed by replication-dependent dilution or oxidation by the TET proteins followed 
by repair-mediated base excision (reviewed in (Wu and Zhang, 2014)). Interestingly, 
DNA in the maternal pronucleus as well as a few paternally imprinted loci are 
protected from TET3-mediated oxidation. These loci are characterized by the 
heterochromatic histone mark H3K9me2 to which the maternal factor DPPA3 (Stella / 
PGC7) exhibits strong affinity. This leads to the exclusion of TET3 binding and 
thereby prevention of DNA demethylation (Nakamura et al., 2012). The second global 
DNA demethylation event occurs during the development and migration of primordial 
germ cells (PGCs) and can be mechanistically divided into two distinct phases. The 
first phase occurs before embryonic day E9.5 and involves global depletion of 5-mC 
with the retention of locus-specific methylation at imprinted genes and repetitive 
elements (Hackett et al., 2013; Vincent et al., 2013). Although TET-mediated global 
DNA demethylation through the generation of 5-hmC can be excluded for the first 
phase (Vincent et al., 2013), the exact mechanism of methylation erasure is still not 
clear. Contrarily, the second phase of DNA demethylation in PGCs is initiated around 
E13.5 and involves DNA demethylation at maternally imprinted loci (Seisenberger et 
al., 2012). In contrast to the first phase, the second phase is initiated by targeted 
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TET1- and TET2-mediated oxidation (Vincent et al., 2013). DNA demethylation 
appears to be unidirectional in both phases, since de novo methylation is not 
observed (Seisenberger et al., 2012). However, to date, the mechanism that re-
establishes DNA methylation patterns in late PGCs is not clear. It involves DNMT3a, 
DNMT3b and DNMT3L, but seems to vary between distinct genomic locations, such 
as imprinted regions or transposable elements. Interestingly, the result of global DNA 
methylation re-establishment differs between female and male germ cells: sperm 
cells are heavily methylated, whereas oocytes are moderately methylated (reviewed 
in (Seisenberger et al., 2013)).  
The mechanism of targeted erasure of DNA methylation is more difficult to decipher. 
To this end, work from different laboratories including ours, suggests a TET-TDG-
mediated oxidation-excision repair pathway at gene regulatory elements, such as 
CGIs and enhancers of developmentally important genes ((Raiber et al., 2012; Shen 
et al., 2013; Song et al., 2013) and Appendices I and II). It is neither established, 
how the TET proteins or TDG are recruited to these specific sites, nor whether they 
are recruited in a sequential order or together in a protein complex. If and how the 
recruitment to DNA and/or putative protein interactions affect or even regulate the 
catalytic activity of the TET proteins or TDG is not known. There are several possible 
scenarios which could explain the precise recruitment of the TETs and TDG. The first 
possibility includes a tissue-specific or developmental-stage-specific TF, such as 
EBF1 or NANOG for targeting the TET proteins or RAR for targeting TDG (Costa et 
al., 2013; Guilhamon et al., 2013; Um et al., 1998). A second possibility for the 
targeting of TET and/or TDG can be envisioned by the recruitment through RNA 
Polymerase II to sites of active or stalled transcription. It was shown, for instance, 
that 5-fC is mainly enriched in promoter CGIs and exons and that high levels of 5-fC 
coincided with active transcription and hence presence of RNA Pol II (Raiber et al., 
2012). Additionally, both TETs and TDG have been shown to interact with several 
TFs, further strengthening the link to the transcription machinery (Chen et al., 2003; 
Tini et al., 2002; Williams et al., 2011).  
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2.5.2  Ten-Eleven-Translocation (TET) Protein Family 
The recent discovery of the catalytic activity of the TET proteins evoked a lot of 
interest. TET proteins are named after the ten-eleven chromosomal translocation, 
fusing the Mll1 gene on chromosome 10 to the Tet1 gene on chromosome 11, which 
is found in certain forms of leukemia (Lorsbach et al., 2003). It turned out later that 
the TET proteins are key enzymes in DNA methylation control and have roles in 
embryonic development as well as regulation of gene transcription (reviewed in 
(Pastor et al., 2013)). TET proteins represent a subfamily of Base J-binding proteins 
(JBP), and belong to a large family of Fe2+- and 2-oxoglutarate-dependent (2-OG) 
dioxygenases (Iyer et al., 2008; Iyer et al., 2009). Based on the analysis of JBPs in 
Trypanosoma brucei, the TET proteins were predicted to have DNA modifying activity 
(Iyer et al., 2008). JBPs generate base J, which is a modified thymine. This is 
achieved by the oxidation of the 5-methyl group of T and the subsequent 
glucosylation of the resulting hydroxyl group by an unknown glucosyltransferase 
(Gommers-Ampt et al., 1993; Yu et al., 2007).  
To date, three different TET proteins (TET1-3) have been described and all of them 
were shown to oxidize 5-mC to 5-hmC. Moreover, it was found that all three TET 
proteins are able to iteratively oxidize 5-hmC to 5-fC and 5-caC (He et al., 2011; Ito et 
al., 2011; Tahiliani et al., 2009). Metazoan TET proteins contain an N-terminal CXXC 
domain, enabling them to recognize and bind CpG dinucleotides in DNA; as well as a 
C-terminal catalytic domain, where the oxidation reaction occurs (Figure 8). The core 
of the catalytic domain is folded into a double-stranded β-helix (DSBH) which harbors 
a Cys-rich region that stabilizes the DNA above the catalytic core (Hu et al., 2013; 
Iyer et al., 2009; Tahiliani et al., 2009). In jawed vertebrates, the Tet gene underwent 
triplication giving rise to Tet1, Tet2 and Tet3. A subsequent chromosomal inversion 
event at the Tet2 locus resulted in the separation of its CXXC domain, which became 
a separate gene called Idax (Iyer et al., 2009; Ko et al., 2013). Interestingly, TET2 
does physically and functionally interact with IDAX (Ko et al., 2013). 
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Figure 8: Gene maps of the Tet genes, depicting the CXXC domain (which is located in Idax for Tet2) 
and the core catalytic regions (Pastor et al., 2013). 
 
The catalytic mechanism of the TET proteins was revealed recently and the applied 
base-flipping mechanism is reminiscent of both DNMTs as well as DNA glycosylases 
(Hu et al., 2013; Lloyd and Cheng, 1997). The crystal structure of TET2 bound to 
methylated DNA revealed that 5-mC is flipped into the catalytic cavity of the enzyme 
(Hu et al., 2013). This allows close contact to the catalytic Fe2+ iron, which is 
coordinated by a conserved Histidine residue in the C-terminal of the DSBH fold 
(Loenarz and Schofield, 2008, 2011). In addition to the aforementioned co-factors 
iron and 2-OG, ascorbic acid (vitamin C) was recently demonstrated to also act as a 
co-factor for TET proteins (Yin et al., 2013). Vitamin C enhances TET activity which 
leads to a global and fast increase in 5-hmC as well as 5-fC and 5-caC, resulting in a 
net loss of DNA methylation at promoters and thus a subsequent increase of gene 
expression (Blaschke et al., 2013; Minor et al., 2013; Yin et al., 2013). 
Interestingly, the catalytic activity of the TET proteins can be inhibited by mutations in 
the Idh1 or Idh2 genes, which encode isocitrate dehydrogenases that produce 2-OG. 
These mutations lead to an accumulation of 2-hydroxyglutarate (2-HG) at the 
expense of 2-OG, thus depriving TET of its co-factor (Xu et al., 2011a). Idh1 and Idh2 
mutations are often found in gliomas and acute myeloid leukemias, and Idh1 
mutations may account for a CpG island methylator phenotype in gliomas (G-CIMP), 
possibly by inhibition of TET activity (Turcan et al., 2012).  
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Expression of TET proteins 
Although TET1 and TET2 are highly expressed in ESCs and play important roles in 
regulating mouse development, ESC survival and pluripotency, their expression is 
dispensable for development (reviewed in (Pastor et al., 2013)). With exception of 
distinct hematological abnormalities and enhanced self-renewal of hematopoietic 
stem cells in the case of Tet2, the single gene knockouts of Tet1 and Tet2 have 
surprisingly little effect on the health of mice (Dawlaty et al., 2011; Ko et al., 2011; Li 
et al., 2011; Moran-Crusio et al., 2011; Quivoron et al., 2011). Double Tet1-Tet2 
knockout animals, however, show a lethal phenotype with incomplete penetrance: 
half of the animals die perinatally, with visible defects in head development. The 
remaining animals survive and have fully developed organs but exhibit lower body 
weight and reduced fertility (Dawlaty et al., 2013; Pastor et al., 2013). In case of Tet3-
knockout, about half of the embryos stop growing and die around E11.5 and the 
remaining ones die perinatally for unknown reasons (Gu et al., 2011). 
 
Figure 9: Expression profiles of TET3 during early events after fertilization (a) and expression profiles 
of TET1 and TET2 in primordial germ cells (PGCs; b), correlated in both panels with 5-mC and 5-hmC 
profiles (Kohli and Zhang, 2013). 
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TET3 is mainly expressed in the zygote where it oxidizes 5-mC in the male 
pronucleus. The concomitant increase in 5-hmC is not observed in TET3-deficient 
oocytes (Gu et al., 2011; Wossidlo et al., 2011). Contrarily, Tet1 and Tet2 genes are 
mainly expressed in the blastula stage of the embryo as well as in embryonic stem 
cells, but become quickly downregulated during differentiation ((Tahiliani et al., 2009) 
and reviewed in (Pastor et al., 2013); Figure 9).  
 
Genome-wide binding patterns of the TET proteins and their products             
TET1 binding sites are mainly found within gene bodies (exons and introns), with the 
highest density at the TSS (Williams et al., 2011). Similarly, TET2 binding sites show 
the highest density around the TSS (Chen et al., 2013b). These are genomic 
locations with high CpG density and interestingly, besides the TET proteins, also 
IDAX is strongly enriched at CpG-rich regions, often coinciding with promoter regions 
in close proximity to the TSS (Ko et al., 2013; Xu et al., 2011c). The oxidation 
products of TET1 and TET2 are also mostly found in regions of high CpG density, 
often located at gene regulatory elements (Booth et al., 2012; Shen et al., 2013). For 
instance, a strong enrichment of 5-hmC was found at enhancer regions and the 
levels of 5-hmC increased particularly at those enhancers, which become activated 
during differentiation of ESCs (Serandour et al., 2012; Stadler et al., 2011; Stroud et 
al., 2011; Szulwach et al., 2011; Yu et al., 2012).  
Interaction partners of the TET proteins             
All three TET proteins were shown to interact with the O-linked N-acetylglucosamine 
transferase (OGT) and to enhance and stabilize the association of OGT to chromatin 
(Chen et al., 2013b; Deplus et al., 2013; Ito et al., 2014; Shi et al., 2013; Vella et al., 
2013). The binding of TET2/3 and OGT to chromatin was found to enhance the 
activity of the H3K4 methyltransferase SETD1a, thereby helping to activate gene 
expression (Deplus et al., 2013). Furthermore, TET1 and TET2 were shown to 
interact physically and functionally with NANOG to facilitate reprogramming of 
somatic cells to iPSCs. The reprogramming synergy between NANOG and the TET 
proteins was dependent on the catalytic activity of the latter (Costa et al., 2013). 
Additionally, the early B cell factor 1 (EBF1) was found to physically interact with 
TET2. In cell lines with impaired TET function due to increased levels of 2-HG, the 
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interaction with the DNA-binding protein EBF1 was suggested to serve the tissue-
specific targeting of DNA demethylation (Guilhamon et al., 2013). Recently, TET1 
was shown to form a protein complex with SUZ12, a member of the Polycomb 
Repressive Complex 2 (PRC2), in ESCs. It is believed that PRC2 tethers TET1 to 
bivalent promoters in order to generate 5-hmC there, which provides the epigenetic 
plasticity necessary for normal differentiation (Neri et al., 2013). This is further 
supported by a reported interaction of TET1 with Enhancer of zeste homolog 2 
(EZH2), another component of PRC2 (Cartron et al., 2013). This report included the 
identification of additional interaction partners for TET1, belonging to the family of 
chromatin modifying enzymes, such as the histone deacetylases 1, 6 and 7 
(HDAC1/6/7) and lysine-specific demethylase 1a (LSD1). In addition, they found an 
interaction of TET1 with PCNA, the sliding clamp crucial in DNA replication and other 
DNA metabolic processes; as well as with the methyl-CpG binding protein 2 (MeCP2; 
(Cartron et al., 2013)). Moreover, TET1 interacts with SIN3a, a transcriptional co-
repressor complex (Cartron et al., 2013; Williams et al., 2011). The PR domain-
containing transcriptional regulator (PRDM14) physically interacts with TET1 and 
TET2 and enhances the targeting of the TET proteins to chromatin, thereby 
promoting DNA demethylation of PRDM14 target genes (Okashita et al., 2014). The 
examination of TET interaction partners indicates that the TET proteins are involved 
in a variety of biological processes. These include the regulation of transcription, 
maintenance of epigenetic plasticity, as well as the coordination of histone 
modifications and DNA demethylation. 
 
2.6 Linking DNA Repair to Epigenetics 
It is evident that DNA repair processes play a crucial role in prevention from 
mutations and thereby the preservation of the primary genetic information, which is 
important to ensure cellular identity and viability. However, many DNA repair proteins 
have also been linked to epigenetic mechanisms, either by processing epigenetic 
modifications in DNA and/or by physically or functionally interacting with chromatin 
modifying enzymes. As an example for the former, the DNA glycosylase TDG has 
been shown to process epigenetic DNA modifications, namely oxidative DNA 
demethylation intermediates: TDG excises 5-fC and 5-caC and by the recruitment of 
downstream BER proteins is able to restore unmethylated C (He et al., 2011; Maiti 
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and Drohat, 2011). Vice versa, it is assumed that chromatin remodeling is necessary 
to allow access for DNA repair proteins, thus several chromatin modifying enzymes 
were shown to associate with and participate in various DNA repair events (reviewed 
in (Verger and Crossley, 2004)). Some of the interconnections between DNA repair 
enzymes and chromatin modifying enzymes are discussed below.  
The histone chaperone CAF1 was shown to facilitate chromatin assembly after NER-
mediated DNA repair (Gaillard et al., 1996). The recruitment of CAF1 is restricted to 
damaged sites and depends on NER and may involve PCNA (Green and Almouzni, 
2003; Moggs et al., 2000), suggesting that CAF1 is involved in local chromatin 
rearrangements following DNA damage and repair (Verger and Crossley, 2004). 
Furthermore, the TC-NER-specific repair protein Cockayne Syndrome B protein 
(CSB) was the first DNA repair enzyme shown to possess nucleosome remodeling 
activity (Citterio et al., 2000; Scharer, 2013). CSB is a DNA-dependent ATPase and 
belongs to the SWI/SNF family of chromatin remodelers. Thus, CSB not only 
interacts with ds DNA but also with core histones and it is assumed that its 
nucleosome remodeling is important to generate space for the numerous other NER 
proteins (Citterio et al., 2000; Thoma, 1999; Verger and Crossley, 2004).       
Moreover, the HAT TIP60 was shown to be involved in DSB repair. The absence of 
TIP60 HAT activity appears to deprive the cell of its ability to signal the occurrence of 
DNA damage to the apoptotic machinery, resulting in the loss of apoptotic 
competence (Ikura et al., 2000). The yeast homologue of TIP60 was found to 
acetylate H4, a modification which was demonstrated to be essential for DSB repair 
(Bird et al., 2002). These results indicate that TIP60 participates in the signal 
transduction between DNA damage recognition and recruitment of DNA repair 
proteins.                   
Another example is the interaction between the HATs CBP/p300, which are 
transcriptional co-activators, with several DNA repair proteins, among them TDG and 
XPE which initiate BER and NER, respectively (Datta et al., 2001; Tini et al., 2002). 
TDG was shown to recruit CBP/p300 to DNA and, importantly, the resulting ternary 
complex consisting of CBP-TDG-DNA was competent for both the excision step of 
DNA repair as well as histone acetylation. TDG stimulated CBP’s transcriptional 
activity and was itself a substrate for CBP/p300-mediated acetylation (Tini et al., 
2002). The acetylation of TDG triggered the release of CBP from DNA and, 
furthermore, it prevented the recruitment of APE1, the downstream repair enzyme 
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(Tini et al., 2002). These results implicate CBP/p300 as a possible chromatin 
remodeling co-factor in TDG-mediated DNA repair.            
As a last example, an effect of EZH2, the catalytic subunit of PRC2, on DNA damage 
signaling has been reported: EZH2-mediated gene silencing in cancer cells was 
found to determine the cellular response to DNA damage. The inhibition of EZH2 
activity abrogated both G1 and G2/M cell cycle checkpoints and promoted apoptosis 
after treatment with DNA damaging agents in cancer, but not in healthy cells (Wu et 
al., 2011). In addition, it was shown that EZH2 controls the intracellular localization of 
Breast Cancer 1 (BRCA1), a protein involved in the repair of DNA DSBs. Upon 
upregulation of EZH2, BRCA1 is exported from the nucleus, causing aberrant mitosis 
and thus genomic instability; presumably due to the absence of BRCA1-dependent 
DSB repair (Gonzalez et al., 2011).  
Due to the manifold connections between chromatin modifying enzymes and DNA 
repair factors, it is tempting to speculate about a certain epigenetic “code” for 
coordination of DNA repair. One example is the well-studied, rapid phosphorylation of 
the histone variant H2A.X (γH2A.X), particularly at sites of DNA DSBs. γH2A.X is 
itself a product of early DNA damage response and stabilizes DNA damage 
signaling, facilitating recruitment of DNA repair proteins (Svetlova et al., 2010; van 
Attikum and Gasser, 2005b). Furthermore, it can be envisioned that PTMs on both 
DNA repair as well as histone proteins could regulate repair activity. Examples 
include the acetylation of FEN1 by p300, which is significantly increased after DNA 
damage induction by UV, limiting its nuclease activity (Hasan et al., 2001) as well as 
the increased ADP ribosylation of histone proteins after DNA damage (Bouchard et 
al., 2003; Verger and Crossley, 2004).   
A consistent functional endpoint of the co-operation between DNA repair proteins 
and chromatin modifiers appears to be the generation of a chromatin environment, 
facilitating DNA-templated processes like repair or transcription. In general, 
chromatin is still considered as a barrier for the repair of DNA damage (Lukas et al., 
2011).  
 
 
 
49 
 
Genetics and Epigenetics in Cancer  
The connection between genetics and epigenetics is exemplified in different cancers, 
where the interplay between the two is often misregulated. On one hand, changes in 
epigenetic mechanisms can lead to genetic mutations and on the other hand, genetic 
mutations in epigenetic regulators can have various effects on the epigenome 
(reviewed in (You and Jones, 2012)). For instance, many cancers were found to 
harbor distinct mutations in EZH2, the catalytic subunit of the PRC2 complex; if the 
mutation is inactivating, it is associated with poor prognosis (Chase and Cross, 
2011). There were two main mechanisms described, which can lead to the loss of a 
functional gene product and are often observed during tumorigenesis: (i) mutations in 
genes controlling the cell cycle progression or DNA repair and (ii) promoter 
hypermethylation of e.g. tumor-suppressor or DNA repair genes (reviewed in (You 
and Jones, 2012)). An example for the latter is hypermethylation of the Mlh1 
promoter (Menigatti et al., 2001). MLH1 is a DNA repair protein involved in MMR, and 
its epigenetic silencing leads to defective MMR. This in turn negatively impacts 
genomic stability due to absent repair of base-base mismatches and 
insertion/deletion mispairs that are generated during DNA replication (Sameer et al., 
2014). Such defects in MMR cause genetic hypermutability and instability mainly at 
short repeat sequences (micro-satellite instability; (MSI)), which is a hallmark of many 
tumors (Esteller et al., 1998). Bioinformatical clustering of the genome-wide 
occurrence of DNA methylation reveals certain recurrent patterns in tumors that allow 
the identification of tumor subgroups, like for instance the CpG Island Methylator 
Phenotype (CIMP) in CRCs or gliomas. This subtype is characterized by both specific 
epigenetic and genetic traits, namely simultaneous DNA hypermethylation of CGIs 
and genetic mutation of the BRAF gene, respectively (Hinoue et al., 2009; 
Noushmehr et al., 2010; Toyota et al., 1999; Xu et al., 2011b).  
 
2.7 Transcription by RNA Polymerase II 
A major interest during my PhD thesis was the investigation of how TDG affects 
transcription, both directly and indirectly (Supplementary Results 4.4 and 
Appendix II). In order to provide the essential background, the relevant processes 
during transcription are described here in detail.  
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DNA-dependent RNA polymerases (RNA Pol) transcribe the genetic information in 
the DNA into a corresponding RNA, the transcript. In mammalian nuclei, transcription 
is done by three distinct RNA Polymerases, RNA Pol I-III, each of them being 
responsible for the synthesis of a discrete subset of RNAs. While RNA Pol I and III 
are responsible for the synthesis of ribosomal RNA and tRNAs, respectively, it is 
RNA Pol II which transcribes protein encoding genes as well as small non-coding 
RNAs (e.g. small nuclear RNAs, small nucleolar RNAs, microRNAS) and lncRNAs 
(Jacobs et al., 2004). RNA Pol II consists of 12 subunits (Bushnell and Kornberg, 
2003), whereof the largest subunit (Rbp1) developed a unique, highly conserved 
carboxy-terminal domain (CTD; (Barron-Casella and Corden, 1992)). In mammals, 
this CTD is composed of 52 tandem heptapeptides with the evolutionary conserved 
consensus motif YSPTSPS (Allison et al., 1985; Corden et al., 1985; Liu et al., 2010). 
The CTD can interact with many different proteins at different stages of the 
transcription cycle. This is achieved by the dynamic structural plasticity of the CTD 
together with the variety of specific binding surfaces generated by extensive PTMs on 
the heptapeptide repeats ((Komarnitsky et al., 2000) and reviewed in (Phatnani and 
Greenleaf, 2006)). For instance, the phosphorylation pattern on each heptapeptide 
repeat was shown to be involved in the recruitment of more than 100 different 
proteins with diverse roles (Phatnani et al., 2004). The manifold possibilities for PTMs 
on the heptapeptide repeats of the CTD – all seven amino acids having the potential 
of being modified – provoked the creation of the term “CTD code”. A great number of 
combinatorial variations can be achieved by exclusive or simultaneous 
phosphorylation of tyrosine, threonine and serine and/or glycosylation of threonine 
and serine and/or isomerization of proline (Kelly et al., 1993).  
 
2.7.1 Transcription Initiation 
Initiation of transcription by RNA Pol II is a highly regulated process. Regulation is 
accomplished by gene-specific activators and repressors as well as PTMs of  the 
RNA Pol II itself (reviewed in (Grunberg and Hahn, 2013)). General transcription 
factors (GTFs) function in gene promoter as well as TSS recognition and RNA Pol II 
recruitment. Additionally, they interact with regulatory factors, like TFs or co-
regulators of transcription (reviewed in (Grunberg and Hahn, 2013)). 
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The assembly of the preinitiation complex (PIC) is the earliest event during gene 
expression. The PIC contains the RNA Polymerase II, the TATA binding protein 
(TBP), the GTFs (TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH) and, in most cases, 
the Mediator complex. The latter can be considered as a general co-activator for 
RNA Pol II-mediated transcription, although it is not per se needed for transcription 
(reviewed in (Poss et al., 2013)). Interactions between DNA and the GTFs anchor the 
RNA Pol II to double-stranded promoter DNA (Figure 10). In a next step, TFIIH 
unwinds approximately 10 bp of promoter DNA in an ATP-dependent manner, 
generating the open complex state. The correct assembly of the PIC is thus crucial to 
position the RNA Pol II at the TSS and to prepare the DNA for subsequent 
transcription (reviewed in (Grunberg and Hahn, 2013)). TFIIH is the most complex 
GTF, comprised of ten subunits, whereof three contain ATP-dependent enzymatic 
activities, one of these being CDK7, a CTD-Serine 5 kinase (reviewed in (Grunberg 
and Hahn, 2013)). In addition to transcription initiation, TFIIH plays important roles in 
both GG- and TC-NER, where it unwinds DNA, thus allowing excision of the damage-
containing single strand (Compe and Egly, 2012). The Mediator complex is even 
more complex and consists of 25-30 protein subunits. These are grouped into head, 
middle and tail domains as well as the CDK8 kinase module, which was shown to 
phosphorylate serine 5 of the CTD (Davis et al., 2002; Ramanathan et al., 2001). 
Different Mediator subunits make contact with various TFs, including activators, co-
activators, GTFs and subunits of RNA Pol II (Ansari and Morse, 2013). For instance, 
Mediator was shown to functionally interact with CBP/p300, thereby enhancing ERα-
dependent transcription (Acevedo and Kraus, 2003). H4 tails are also targeted by 
interactions with Mediator subunits (Liu and Myers, 2012). Interestingly, Mediator was 
recently shown to interact with Cohesin, which forms ring structures capable to 
embrace two double-stranded DNA segments, apparently to physically and 
functionally connect enhancers and core promoters of active genes in ESCs. This 
results in cell-type-specific DNA looping, ensuring the initiation of cell-type-specific 
gene expression (Kagey et al., 2010). Furthermore, lncRNAs can associate with 
Mediator and thereby modulate chromatin architecture and transcription (Lai et al., 
2013). 
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Figure 10: Recruitment to and anchoring of the RNA Polymerase II (the 12 subunits are displayed in 
numbers) at the promoter and subsequent conformation change upon stable binding to the TSS. The 
subunits (α, β) of several GTFs are also depicted (IIB: TFIIB; IIF: TFIIF; IIE: TFIIE; (Hirose and 
Ohkuma, 2007)).  
  
2.7.2 Transcription Elongation 
The establishment of the PIC is followed by transcription initiation and elongation. 
Two different modes of elongation by RNA Pol II can be distinguished: early and 
productive elongation. Early elongation is unproductive and the RNA Pol II is 
frequently stalling and pausing (reviewed in (Li and Gilmour, 2011; Nechaev and 
Adelman, 2011)). Upon transition to productive elongation, which is triggered by 
several RNA Pol II-interacting factors including the Positive Transcription Elongation 
Factor b (P-TEFb), the resulting mature RNA Pol II complex is remarkably stable 
(reviewed in (Nechaev and Adelman, 2011)). During productive elongation, RNA Pol 
II incorporates nucleotides into nascent RNA at a rate of 10-70 s-1 (Darzacq et al., 
2007; Neuman et al., 2003) with a fidelity of about 1 error per 100‘000 inserted bases 
(Ninio, 1991).  
The productivity of the RNA Polymerase II is largely dependent on the temporal and 
spatial distribution of PTMs on its CTD (see also Supplementary Results 4.4). The 
levels of serine 5 phosphorylation (S5p) are highest at promoters and decrease 
successively towards the 3’ end of a gene, whereas serine 2 phosphorylation (S2p) 
increases throughout the gene (Figure 11; reviewed in (Heidemann et al., 2013)). 
Kinases responsible for CTD phosphorylation are CDK7 (subunit of TFIIH) for S5 and 
S7, ERK2 for S5, CDK9 (subunit of P-TEFb) and BRD4 for S2 ((Devaiah et al., 2012; 
Tee et al., 2014) and reviewed in (Heidemann et al., 2013)). There is extensive 
cross-talk among the CDK7, CDK9 and BRD4 kinases. BRD4 and CDK9 
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phosphorylate each other at multiple sites. Phosphorylation by CDK9 enhances the 
CTD kinase activity of BRD4, while phosphorylation of BRD4 by CDK7 inhibits its 
CTD kinase activity. In addition to these direct interactions, the GTF TAF7 (subunit of 
TFIID) regulates the CTD kinase activities of CDK7, CDK9 and BRD4 indirectly. 
However, the sequential order of these interactions is still unclear. It can be 
speculated that once the CTD is phosphorylated at S5 (by CDK7 or ERK2), the 
BRD4 kinase is activated and thus the CTD can be phosphorylated at S2. This is in 
line with the finding that BRD4 preferentially phosphorylates S2 of CTD when it is 
pre-phosphorylated at S5 by CDK7 (Devaiah et al., 2012; Devaiah and Singer, 2012). 
In vitro assays with purified mammalian RNA Pol II revealed that 5-mC and 5-hmC do 
not deteriorate nucleotide incorporation efficiency much. Yet, both 5-fC and 5-caC 
reduced the incorporation rate significantly, indicating that the occurrence of 5-fC 
and/or 5-caC may perturb efficient elongation by RNA Pol II, possibly due to its 
stalling (Kellinger et al., 2012). 
 
Figure 11: Typical phosphorylation pattern across a transcribed gene, from TSS to poly(A) tail 
(Heidemann et al., 2013). 
 
2.7.3 Transcription Termination 
After successful elongation, transcription is terminated, which implicates 
disengagement of both RNA Pol II and the transcript from the DNA template 
(reviewed in (Nechaev and Adelman, 2011)). After RNA Pol II transcribes past the 
poly(A) site located in the 3’ end of the gene, the RNA is cleaved by the 
polyadenylation machinery and the RNA downstream of the cleavage site is 
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degraded (Kim et al., 2004). Polyadenylation of the transcript is tightly linked to the 
termination of transcription; polyadenylation factors are even required for 
transcription termination ((Kim et al., 2004) and reviewed in (Buratowski, 2009)). S2p 
of the CTD triggers the co-transcriptional recruitment of the cleavage and 
polyadenylation specificity factor (CPSF or PCF11). Subsequently, CPSF tethers 
further polyadenylation factors, such as the poly(A) polymerase (PAP), the cleavage 
stimulation factor (CstF) and cleavage factors I and II (CFI/IIm). The assembly of 
these proteins ensures mRNA maturation (reviewed in (Buratowski, 2009)). In yeast, 
the 5’-3’ exonuclease Rat1 is recruited to the 3’ ends of protein coding genes, 
indicating that poly(A) site cleavage by Rat1 triggers transcription termination ((Kim et 
al., 2004) and reviewed in (Buratowski, 2009)). However, termination of RNA Pol II 
transcription can also function through a non-canonical, poly(A)-independent 
pathway, especially for shorter transcripts, including those of the small nucleolar RNA 
genes (reviewed in (Nechaev and Adelman, 2011)). This appears to require the 
activity of the negative elongation factor (NELF), whose recruitment is promoted by 
TFIIH kinase activity (reviewed in (Buratowski, 2009)). Surprisingly, components of 
the RNA end processing as well as yeast transcriptional termination complexes have 
been detected at 5’ ends of genes, interacting with RNA Pol II marked by S5p 
((Vasiljeva et al., 2008) and reviewed in (Nechaev and Adelman, 2011)). At least half 
of the tandem heptadpeptide repeats are required for transcription termination (Ryan 
et al., 2002), providing evidence for the involvement of the versatile CTD domain of 
RNA Pol II in mRNA processing (McCracken et al., 1997; Proudfoot, 2004). It has 
been suggested that the released RNA Pol II may be “recycled” back to the promoter 
at genes, where multiple rounds of transcription take place in rapid succession, thus 
facilitating productive transcription (Yao et al., 2007). 
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3. Aims of My PhD Thesis 
Recent research has shown that TDG, a bona fide DNA repair enzyme, has a role 
beyond classical repair of damaged DNA. It has emerged as a key player in active 
DNA demethylation initiated by the TET proteins, and thus as a master epigenetic 
regulator (Cortazar et al., 2011; He et al., 2011; Maiti et al., 2013; Shen et al., 2013; 
Song et al., 2013). Genome-wide studies have associated TET proteins and products 
of their 5-mC oxidation predominantly in gene bodies and at gene regulatory 
elements (Shen et al., 2013; Song et al., 2013; Song et al., 2011; Stadler et al., 2011) 
and both TET proteins and TDG were implicated in regulation of gene expression 
((Williams et al., 2011) and reviewed in (Cortazar et al., 2007)). We showed before 
that TDG is essential for embryonic development and contributes to the maintenance 
of an active chromatin environment, i.e. counteracts aberrant DNA methylation and 
histone modifications and, thus, gene silencing in cells undergoing differentiation-
associated epigenetic transitions ((Cortazar et al., 2011); Appendix III).  
The molecular mechanism by which TDG prevents DNA from hypermethylation was 
not clear. Furthermore, the effect of TDG on both the regulation of gene expression 
and the productivity of the transcription machinery were not known. In my PhD thesis, 
I thus wanted to further investigate the exact role of TDG in epigenetic control of DNA 
methylation in the context of stem cell differentiation, the mechanism of its action, 
including its functional interactions and coordination with TET proteins and the 
resulting impact on gene regulation.  
The first goal of my PhD thesis was to investigate the function and consequence of 
TDG-dependent DNA methylation control during early embryonic stem cell 
differentiation (Appendix I). The second goal was to explore genome-wide 
interactions and possible coordination of TDG and TET proteins in the control of 
epigenetic states at gene regulatory elements as well as in a putative direct 
association with the RNA polymerase II transcription machinery (Appendix II, 
Supplementary Results 4.4).              
To these ends, I thoroughly characterized DNA methylation and demethylation 
dynamics during stem cell differentiation and I generated and functionally 
investigated genome-wide data sets for TDG, TET1 and TET2 chromatin association. 
Additionally, I explored the performance of transcription initiation and elongation 
events in dependence of the presence and functionality of TDG.  
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4. Results 
In the following section, I will summarize the results presented in the manuscripts 
attached in the appendix, as well as a selection of additional results that are not 
contained in the manuscripts. 
 
4.1 TDG balances DNA methylation and oxidative demethylation in 
differentiating cells (Appendix I) 
Our work summarized in Cortázar et al. ((Cortazar et al., 2011); Appendix III) 
established a role for TDG in the protection of CpG island promoters of 
developmental genes from aberrant DNA methylation during cell differentiation. 
Meanwhile, work by others had clearly implicated TDG in active DNA demethylation 
by excising the 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC) products 
generated by oxidation of 5-methylcytosine (5-mC) by the Ten Eleven Translocation 
(TET) family of proteins (He et al., 2011; Maiti and Drohat, 2011; Tahiliani et al., 
2009). Thus, we wanted to investigate how the TET-TDG system of active DNA 
demethylation contributes to the epigenetic programming of cells during 
differentiation. We observed a failure of TDG-deficient mESCs to differentiate into 
late neuronal progenitor cells (NPs) and neurons, whereas no morphological 
difference could be observed in undifferentiated cells (Appendix I, Supplementary 
Figure 1a). To determine whether this observation is caused by defective DNA 
demethylation, we performed MeDIP-seq of mESCs, in vitro-differentiated NPs and 
MEFs in TDG-proficient and TDG-deficient cells, respectively. We could confirm that 
differentially methylated regions (DMRs) arose upon differentiation only: more than 
900 DMRs were identified in NPs and more than 32’000 in MEFs, while none were 
detected in mESCs (Appendix I, Figure 1a). Interestingly, DMRs with a high CpG 
density, predominantly representing CGIs, were almost exclusively hypomethylated 
in TDG-deficient NPs, while CpG-poor DMRs were predominantly hypermethylated 
(Appendix I, Figure 1b). Most of the hypomethylated NP-specific DMRs turned out to 
be CGIs that become de novo methylated upon lineage commitment (Appendix I, 
Figure 1c). Importantly, these CGI DMRs are significantly more often bound by TET1 
and marked by H3K27me3 and H3K4me1, and often they represent low-methylated 
regions (LMRs; Appendix I, Figure 1d). LMRs are CpG-poor distal regulatory regions 
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and they are occupied by cell-type-specific DNA-binding factors, which locally 
influence DNA methylation. This showed that the loss of TDG causes a misregulation 
of DNA methylation at regions important for gene regulation including CGIs and 
enhancers. Since the methylation analysis was done by MeDIP-seq with a 5-mC-
specific antibody, the observed loss of DNA methylation can result from either of 
these different events; (i) the exchange of 5-mC with a C, (ii) the oxidation of 5-mC to 
5-hydroxymethylcytosine (5-hmC), (iii) mutation of 5-mC to T. All these events would 
invariably lead to the loss of the 5-mC epitope for the antibody. 5-mC could be 
replaced by a C, either after replication when DNA maintenance methylation is 
deficient, or upon active DNA demethylation. The oxidation of 5-mC can be achieved 
catalytically by one of the TET proteins, or theoretically likewise through oxidative 
DNA damaging agents. CT transition mutations can arise from deamination of 5-
mC or 5-hmC to T or 5-hmU opposite G, respectively. This could occur if a 
deaminase, for instance AID, would be engaged on a regular basis. By hairpin Na-
bisulphite sequencing (BS-seq), which allowed us to evaluate a putative elevation of 
the mutation frequency besides measuring the levels of DNA methylation, we could 
validate the presence of the above identified DMRs. However, we were not able to 
detect an elevated mutation frequency in TDG-deficient NPs: the frequency of CT 
transition mutations did not rise above the error rate of the method and since the 
methylation changes we measured were in the higher percentage range, mutations 
cannot explain the methylation changes we observed. These results argued strongly 
against a deamination-based pathway for DNA demethylation at the DMRs tested 
(Appendix I, Figure 2).  
Being interested in the levels of DNA demethylation intermediates in response to 
TDG (5-hmC, 5-fC and 5-caC), we established a 24h differentiation of mESCs with 
retinoic acid (RA), to minimize the effects of replication-dependent dilution of the 
above mentioned intermediates (Appendix I, Figure 3a, Supplementary Figure 2). 
The analysis of genomic DNA from time points 0h, 8h and 24h by LC-MSMS 
revealed a significant increase of 5-fC and 5-caC in cells without TDG or with 
catalytically inactive TDG (Appendix I, Figure 3b); the global levels of 5-mC, 5-fC and 
5-caC increased with differentiation and this effect was more pronounced in cells 
lacking TDG activity (Appendix I, Supplementary Figure 3). In agreement with 
previous work (He et al., 2011), 5-caC levels were 9 fold higher, already in 
undifferentiated mESCs lacking TDG activity. Although catalytically inactive TDG is 
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unable to remove substrate bases, it binds to 5-caC with very high affinity (Appendix 
I, Figure 4b, Supplementary Figure 4b). Hence, the processing of DNA demethylation 
intermediates which accumulate upon cell differentiation is dependent on TDG’s 
catalytic activity. To clarify whether these global changes also reflect changes at the 
CGI DMRs, we investigated 5-mC, 5-hmC and 5-caC levels at these loci. Compared 
to TDG-deficient mESCs, we found increasing 5-mC, 5-hmC and 5-caC levels at 
selected CGI DMRs in mESCs expressing wildtype or catalytically inactive TDG upon 
cell differentiation (Appendix I, Figure 4a, Supplementary Figure S4a). To investigate 
whether TET and TDG associate with the CGI DMRs, we performed ChIP-qPCR 
experiments, which revealed an enrichment of both at these loci. Interestingly, 
catalytically inactive TDG showed a particularly high enrichment, presumably due to 
its inability to process the substrates and continued re-association with 5-fC and 5-
caC. TET1 enrichment was particularly high in a TDG wildtype background, indicating 
that TDG facilitates TET1 association, presumably by eliminating the oxidized 5-mC 
and, thus, giving way to a new round of methylation (Appendix I, Figures 5a and 5c, 
Supplementary Figures 5 and 6). 
Differentiation towards NPs requires non-NP-specific genes to be repressed by de 
novo methylation. We propose that TET and TDG constitute an active DNA 
methylation – demethylation system that operates to maintain epigenetic plasticity at 
genomic loci that undergo programming in the context of cell lineage commitment. 
During differentiation, 5-mC is oxidized by TET, finally generating 5-caC which is 
excised by TDG. Re-methylation is catalyzed by DNMT3a or DNMT3b. This cycle will 
be exited eventually, once lineage commitment is accomplished and the point of exit 
determines the final CpG methylation state of the gene regulatory regions. 
Importantly, CGI DMRs in a TDG-deficient background did not show any changes in 
the levels of DNA demethylation intermediates, indicating a structural role of TDG in 
coordinating the DNA methylation – demethylation cycle, besides its crucial catalytic 
role in excising DNA demethylation intermediates (Appendix I, Figure 4a). 
Taken together, we found that TDG safeguards the equilibrium between 5-mC and 
DNA demethylation intermediates during lineage restriction, which is a state of high 
epigenetic plasticity. We describe a “DNA methylation – oxidative demethylation 
cycle” which occurs during cell differentiation at CGIs that are preferentially 
associated with the polycomb-mediated mark H3K27me3 and poised enhancers, and 
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are prone to be methylated in the process of lineage commitment. Hence, TDG might 
be selectively targeted to cell-fate-specific regulatory sequences where it actively 
contributes to DNA demethylation by excising TET-mediated 5-mC oxidation 
products and coordinates the initiation and/or maintenance of the cycle in a structural 
manner (Appendix I, Figure 6). 
 
Contribution: I conducted MeDIP, GLIB and caC-DIP experiments, performed quantitative PCRs for 
the targets shown and further positive and negative controls (data not shown) as well as extensive 
quantitative analysis and quality controls of the DIP and GLIB data sets. Further, I prepared chromatin 
extracts of the timecourse samples prepared by Angelika Jacobs and conducted TET1 and TDG ChIP 
experiments as well as subsequent qPCRs. I quantitatively analysed and conducted quality controls of 
these ChIP data sets. I further did fC-DIP including qPCR analysis, expression analysis of the DMRs 
and surrounding genes (RT-qPCR), TET1 and TDG ChIPs including qPCR from TET1-knockout 
mESCs, and I established and performed TET2 ChIP (data not shown). Additionally, I prepared 
samples for oxBis and MAB-seq analysis by Pascal Giehr and coordinated the collaboration with him.  
 
4.2 TET1, TET2 and TDG cooperate locus-specifically to promote chromatin 
plasticity by oxidative DNA demethylation (Appendix II) 
TET1 and TET2 have been shown to associate genome-wide with gene bodies, 
TSSs and enhancers, fundamental features for productive transcription (Chen et al., 
2013b; Stadler et al., 2011; Williams et al., 2011). Furthermore, the products of TET-
mediated 5-mC oxidation (5-hmC, 5-fC and 5-caC) have been shown to arise 
predominantly at gene regulatory elements of developmental genes (Raiber et al., 
2012; Serandour et al., 2012; Shen et al., 2013; Song et al., 2013; Stadler et al., 
2011). This hints at a mechanism where DNA methylation of gene regulatory 
elements is controlled by the TET proteins in the context of gene regulation. To 
elucidate a putative involvement of and a functional interaction with TDG, we wanted 
to determine the genome-wide association of TDG and further clarify a possible 
dependency of TET chromatin-interactions on the presence or activity of TDG. We 
thus performed ChIP followed by deep sequencing (ChIP-seq) for TDG, TET1 and 
TET2. ChIP-seq was performed in isogenic mouse embryonic stem cells (mESCs) 
deficient for TDG and complemented with minigenes encoding either a wildtype TDG 
(Tdg[wt]), a catalytically inactive but structurally intact TDG (Tdg[cat]) or the empty 
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vector (Tdg[null]). Since TDG function becomes apparent in differentiating rather than 
in pluripotent mESCs (Appendix I), the cells were differentiated for 24 hours in the 
presence of all-trans retinoic acid (RA). Datasets were obtained for TDG-ChIP-seq in 
Tdg[wt] and Tdg[cat] backgrounds at 24h RA and TET1- and TET2-ChIP-seq in 
Tdg[wt], Tdg[cat] and Tdg[null] backgrounds at 0h RA and 24h RA. After aligning the 
reads and peak calling, we were able to identify 14’144 TDG peaks in Tdg[wt] and 
28’164 in Tdg[cat]. Notably, we found only a minor overlap (3’058), which can be 
explained with the different enzymatic properties of wildtype and catalytically inactive 
TDG (Appendix II, Figure 1a). We explain this divergence by the fact that the 
catalytically inactive TDG exhibits reduced turnover and is thus potentially more 
efficiently detected by ChIP than the wildtype TDG. Catalytically active TDG may well 
be associated with the same sites as the inactive TDG, but due to its rapid turnover 
not as well detectable by ChIP. When we mapped the average distance of the TDG 
peaks to the nearest TSS, we found a narrow peak around the TSS and a broader 
peak ranging from 1 to 1000 kb away from the TSS (Appendix II, Figure 1b). 
Interestingly, there was no difference between Tdg[wt] and Tdg[cat]. Next, we 
characterized the preferential genomic features that TDG associates with: we found 
an increased association of both active and inactive TDG to regions of intermediate 
to high CpG density, including a significant enrichment of CGIs. Functional 
characterization then revealed a preference for introns and intergenic regions 
(Appendix II, Figures 1c and 1d). Furthermore, a significant portion of TDG peaks in 
both Tdg[wt] and Tdg[cat] coincides with histone marks associated with transcription 
(H3K36me3, H3K4me3, H3K9ac), the latter two characteristic for active promoters 
(Appendix II, Figure 2c). Additionally, there was a striking enrichment of the 
polycomb-mediated histone mark H3K27me3 in TDG peaks, which occurs 
predominantly at CGI promoters of developmental genes. Contrarily, the 
heterochromatin mark H3K9me3 did not show a comparable enrichment (Appendix II, 
Figure 2b), indicating that TDG is not targeted randomly to chromatin. Excitingly, 
TDG peaks (in Tdg[wt] and Tdg[cat]) are strongly enriched for sites of DNase 
hypersensitivity, dynamic histone variants (H3.3 and H2A.Z) as well as histone marks 
characteristic for active enhancers (H3K4me1, H3K27ac), implicating a possible 
function for TDG at gene regulatory elements which are characterized by high 
nucleosome dynamics and depletion (Appendix II, Figures 2a, 2d and 2e). Generally, 
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TDG peaks in Tdg[wt] and Tdg[cat] showed very similar properties, suggesting that 
they represent subfractions of the same functional entity. 
Next, we were interested in the proportion of TDG peaks that are also bound by 
TET1 or TET2, respectively. We found 38% and 31% of TDG peaks (in Tdg[wt] and 
Tdg[cat], respectively) co-bound by TET1 in Tdg[wt] mESCs and only 10% and 4% of 
TDG peaks (in Tdg[wt] and Tdg[cat], respectively) co-bound by TET2 (Appendix II, 
Figure 3a). Compared to the TET1/2 occupancy in the whole genome, the increase of 
TET1/2 peaks within the TDG peaks was highly significant. Interestingly, the co-
localization of both TET1 and TET2 with TDG was higher in Tdg[wt] compared to 
Tdg[cat], indicating that blocking of the removal of 5-fC and 5-caC will interfere with 
de novo TET binding and the subsequent cyclic DNA methylation and oxidative 
demethylation. This suggests that TET and TDG are not engaged as a complex but 
individually. The triple overlap between active TDG and inactive TDG as well as 
TET1 and TET2 revealed 633 and 825 targeted loci, respectively (Appendix II, Figure 
3b). Interestingly, only a minor fraction of TDG-TET1 peaks is additionally associated 
with TET2, whereas the major fraction of TDG-TET2 peaks is additionally bound by 
TET1, indicating a close functional relationship between TDG and TET2. Gene 
ontology analysis of the triple-positive peaks identified mainly pathways involved in 
gene expression and cellular development (Appendix II, Figure 3e). Especially CGIs 
are significantly enriched within these triple-positive peaks, compared to the peaks 
that are only bound by TDG (Appendix II, Figures 3c), indicating that the triple-
positive peaks could indeed account for the peaks located in CpG-dense regions 
(Appendix II, Figure 1d). We conclude from these data, that the triple-positive TET1-
TET2-TDG sites are predominantly targeted to promoter CGIs, whereas the unique 
TDG peaks show an enrichment for active enhancers. This is consistent with the 
histone modifications that were found to be enriched in TDG peaks, however, it 
indicates that there is a functional separation between TDG only and triple-positive 
fractions. 
We could not determine a dependency of TET1 or TET2 association to chromatin on 
TDG presence at 24 hours of differentiation; the majority of TET1 peaks in Tdg[wt] 
were also bound in Tdg[cat] (64.6%) and in Tdg[null] (64.1%), indicating that 
presence and functionality of TDG have no influence on the major portion of TET1 
binding events. This was not unexpected, since TET1 is implicated upstream of TDG 
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(Appendix II, Figure 4a). Interestingly, the overlap between TET2 binding sites in the 
different TDG backgrounds at 24h RA exposure was lower than that observed for 
TET1; only 42% of total TET2 peaks in Tdg[wt] were also bound by TET2 in Tdg[cat] 
and 48% were in the Tdg[null] background (Appendix II, Figure 4b). Fascinatingly, 
whereas the number of TET2 peaks in a background without or with inactive TDG 
stayed roughly the same throughout the 24 hours of differentiation, it decreased 
dramatically in a Tdg[wt] background, which is unlike the situation for TET1. This 
dependency seems to arise only upon differentiation, indicating that the turnover of 
TET2 in particular might be regulated by wildtype TDG during differentiation 
(Appendix II, Supplementary Figure 6).  
To determine whether the combined targeting of the TET proteins and TDG to CGIs 
might involve active DNA demethylation, we next investigated the correlation 
between the triple-positive binding sites and the occurrence of DNA demethylation 
intermediates (5-hmC and 5-fC). Indeed, we found a significant overlap between the 
triple-positive peaks and 5-hmC as well as 5-fC. The correlation was higher than that 
obtained for unique TDG peaks, indicating that it is the joint action of both TET 
proteins and TDG that is necessary for DNA demethylation (Appendix II, Figure 5a). 
The same observation was made for the bivalent histone marks (H3K4me3 and 
H3K27me3); they were strongly increased in triple-positive peaks, both in Tdg[wt] 
and Tdg[cat] (Appendix II, Figure 5b). This may indicate, that the joint action of both 
TET proteins and TDG induces DNA demethylation-mediated gene activation at 
developmental genes during cell differentiation. Since the deposition of the dynamic 
histone variants H3.3 and H2A.Z was reported to mark gene regulatory elements and 
regulate the transcriptional outcome of inducible genes (Chen et al., 2013a), we were 
interested in clarifying whether occurrence of dynamic histone variants is correlated 
with TDG occupancy. Indeed, we found a significant fraction of both triple-positive as 
well as unique TDG peaks to be co-occupied by H3.3 (Appendix II, Figure 5c). 
Moreover, H2A.Z was also highly enriched, particularly in the triple-positive peaks 
(Appendix II, Figure 5d). Notably, in the unique TDG peaks, the occurrence of H2A.Z 
was lower in a Tdg[wt] compared to Tdg[cat] background, indicating that TDG’s 
catalytic activity plays a role in nucleosome turnover. This led us to propose a model, 
where TET-TDG-mediated DNA demethylation facilitates histone exchange and 
nucleosome turnover in order to promote a state of chromatin plasticity at regulatory 
elements of developmental genes in differentiating mESCs. 
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In summary, we propose a model where TET proteins together with TDG are 
targeted to gene regulatory regions, particularly CpG islands, where they coordinately 
engage in active DNA demethylation (Appendix II, Figure 6). The tight spatio-
temporal control ensures high plasticity of chromatin and gene expression, a 
necessity during differentiation. Additionally, the strong correlation with the highly 
dynamic histone variants H3.3 and H2A.Z suggests a putative involvement of TET 
and TDG in the mediation of nucleosomal dynamics. 
 
Contribution: I extracted chromatin from short-differentiation timecourses (prepared by Angelika 
Jacobs and Zeinab Barekati), established ChIP procedures and performed all ChIPs for TDG, TET1 
and TET2. I analyzed the samples by qPCR and conducted thorough quantitative and qualitative 
analyses of the data. I prepared the samples for next generation sequencing and sent them to the 
Genome Technology Access Center (GTAC) at the Washington University in St. Louis, USA. I 
coordinated the processing and the analysis of our samples there, and I participated in the 
coordination of the subsequent bioinformatical analysis. Finally, I wrote the manuscript in Appendix II. 
 
4.3 Embryonic lethal phenotype reveals a function of TDG in maintaining 
epigenetic stability (Appendix III) 
Besides being a DNA repair protein, TDG was also shown to be a co-regulator of 
transcription. To further clarify the biological role of TDG, we generated Tdg knockout 
mice and, quite unexpectedly, found TDG to be essential for embryonic development; 
TDG knockout embryos died at E11.5 (Appendix III, Figure 1a, Supplementary Figure 
1). TDG-deficient embryos revealed signs of internal hemorrhage and hemorrhagic 
necrosis, but apart from that no informative pathology. The severity of the phenotype 
was surprising, since other DNA glycosylases have a substrate spectrum partially 
redundant with TDG, and additionally, no other knockout of a DNA glycosylase 
displays embryonic lethality. We thus aimed to investigate the reason for 
developmental failure of TDG knockout mice. To address a potential DNA repair 
defect, we subjected TDG-proficient and –deficient MEFs to ionizing radiation and 
H2O2 treatment, but could not find an effect on cell survival dependent on TDG. Also, 
using different mutation assays, we were not able to measure increased mutation 
upon loss of TDG (Appendix III, Supplementary Figure 2). This argued strongly 
against a function of TDG in canonical DNA repair to account for its developmentally 
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essential role. Next, we assessed the effect of TDG on gene expression in MEFs and 
this revealed 461 genes differentially regulated in a TDG knockout background. 
Interestingly, the catalytic activity of TDG was necessary to restore gene expression 
upon re-introduction of TDG into TDG-deficient MEFs (Appendix III, Figure 2a). 
These 461 genes comprised many transcription factors (TF) and therefore, the loss 
of TDG probably has direct and indirect, TF-mediated effects. Gene ontology analysis 
of these differentially expressed genes identified mostly pathways in embryogenesis 
and development (Appendix III, Figure 1b, Supplementary Figure 3) and since TDG 
had been implicated in one way or another in active DNA demethylation and because 
many of the differentially expressed genes are known to be epigenetically regulated 
during development, we next analyzed the DNA methylation state of promoter CpG 
islands (pCGIs) of genes down-regulated upon TDG knockout. Bisulfite sequencing 
data then revealed aberrant de novo DNA methylation in TDG-deficient MEFs 
(Appendix III, Figure 1c, Supplementary Figure 4). By TDG-ChIP we could also 
confirm an association of TDG to these developmental gene promoters (Appendix III, 
Figure 1d). Together with DNA methylation changes, we found a loss of the activating 
histone mark H3K4me2 and a gain of the repressive histone marks H3K27me3 and 
H3K9me3 in TDG-deficient MEFs at affected loci. More specifically, active promoters 
(positive for H3K4me2 in TDG-proficient cells: Sfrp2 and Twist2) acquired 
H3K27me3; whereas bivalent promoters (positive for H3K4me2 and H3K27me3 in 
TDG-proficient cells: HoxD13 and HoxA10) acquired H3K9me3 (Appendix III, Figure 
1e). This indicated that TDG is recruited to specific gene promoters to protect them 
from aberrant epigenetic silencing. In case of Sfrp2 and Twist2, we found that the 
chromatin state as well as gene expression was rescued by the stable 
complementation of TDG-deficient MEFs with wildtype TDG. In case of HoxD13 and 
HoxA10, which completely lost H3K4me2 and additionally gained H3K9me3, 
however, re-introduction of TDG could not restore the bivalent chromatin state. This 
indicated that, in the latter case, the epigenetic silencing has progressed extensively 
and thus became irreversible (Appendix III, Figure 2). To investigate the origin of the 
epigenetic aberrations observed in TDG-deficient MEFs, we performed gene 
expression analysis in TDG-proficient and TDG-deficient mESCs and NPs derived 
from these mESCs (Appendix III, Supplementary Figure 6). Interestingly, gene 
expression differences were minor in the undifferentiated mESCs (16 genes), but 
increased upon differentiation (297 genes in NPs; Appendix III, Figure 3a). Again, 
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gene ontology analysis identified a predominant misregulation of developmental 
genes in TDG-deficient cells (Appendix III, Supplementary Figure 7) and TDG was 
associated with these gene promoters both in mESCs and in NPs. In line with this, 
we found aberrant DNA methylation to arise only in the differentiated state and not in 
mESCs. Interestingly, ectopic expression of TDG during differentiation prevented 
from the gain of de novo DNA methylation at these specific gene promoters 
(Appendix III, Figures 3b and 3c). Similarly, altered histone methylation patterns were 
only observed in TDG-deficient differentiated NPs but no in TDG-deficient 
undifferentiated mESCs (Appendix III, Supplementary Figure 8). To elucidate 
whether the epigenetic function of TDG involves active DNA repair, as implicated by 
the necessity of TDG’s catalytic activity to restore gene expression, we assessed the 
association of downstream BER proteins with the above indicated developmental 
genes by ChIP. Indeed, we found XRCC1 and APE1 to be enriched at these sites in 
TDG-proficient MEFs, but not in TDG-proficient mESCs (Appendix III, Figure 4a). 
Thus, TDG induces DNA BER at loci where chromatin state and DNA methylation 
patterns are altered upon the loss of TDG. Similarly, we found an increase of 
chromatin-associated XRCC1 foci after treatment of mESCs with all-trans retinoic 
acid (RA) for 8 hours in the presence but not in the absence of TDG. This was further 
supported by a higher sensitivity of TDG-proficient cells to PARP inhibition following 
RA treatment compared to TDG-deficient cells (Appendix III, Supplementary Figures 
9 and 10). This strongly indicated that cell-differentiation-induced TDG activity 
initiates PARP and XRCC1-dependent DNA single strand break repair. We further 
found association of histone modifying proteins to the promoter CGIs of 
developmental genes; specifically, we found a significant enrichment of the H3K4-
specific methyltransferase MLL1 and the histone acetyltransferases CBP/p300 only 
in TDG-proficient MEFs. In undifferentiated mESCs, however, we did not detect 
MLL1 or CBP/p300 enrichment, independent of the TDG background (Appendix III, 
Figure 4b). The thereby induced changes in histone modifications were only 
observed in a TDG-proficient background.  
In summary, this study established a novel role of TDG and DNA repair in the 
epigenetic maintenance of CpG island promoters during cell differentiation (Appendix 
III, Figure 4c). In that context, TDG apparently has structural as well as catalytic 
functions; structurally, TDG complexes with activating histone modifiers to maintain 
the chromatin state in an active or bivalent conformation during cell differentiation. 
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Upon loss of TDG, chromatin modifications are imbalanced towards a more 
repressive state. Catalytically, TDG activity contributes to erasure of aberrant DNA 
methylation and recruitment of downstream BER proteins (XRCC1 and APE1). This 
suggests that TDG is part of a repair-mediated control system which contributes to 
epigenome stability at critical DNA sequences during cell differentiation. 
 
Contribution: I contributed to the preparation of chromatin extracts from MEFs and mESCs and to 
ChIP experiments for H3K4me2, H3K9me3 and H3K27me3 in MEFs (Appendix III, Figure 1e; together 
with Daniel Cortázar). I performed ChIP experiments in wildtype-complemented MEFs for all histone 
marks shown (Appendix III, Figure 2b); as well as for XRCC1 and CBP in MEFs (Appendix III, Figures 
4a and 4b). Additionally, I performed ChIP experiments for H3K4me2 and H3K27me3 in mESCs 
(Appendix III, Supplementary Figure 8). Moreover, I performed ChIP experiments for H3K4me2, 
H3K9me3 and H3K27me3 in MEFs carrying a catalytic-dead TDG (data not shown). Finally, I 
performed qPCR analysis of TDG ChIPs in MEFs and XRCC1 ChIPs in NPs (together with Daniel 
Cortázar). 
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An attractive hypothesis is that the DNA repair function of TDG and its role in cyclic 
DNA methylation and demethylation at gene regulatory elements reflects different 
aspects of one and the same function in the context of transcriptional activity. 
Thymine DNA glycosylase (TDG) has been linked to transcription through its 
manifold interactions with transcription factors (TF). TDG was shown to have both co-
activator and co-repressor functions (Chen et al., 2003; Kim and Um, 2008; Missero 
et al., 2001; Tini et al., 2002). For example, TDG was reported to stimulate 
transcription by interaction with the nuclear TFs retinoic acid receptor (RAR) and 
retinoid X receptor (RXR), resulting in enhanced binding of these factors to their 
cognate response elements and increased transcriptional activity (Leger et al., 2014; 
Um et al., 1998). Our laboratory recently discovered an interaction of TDG with BRD4 
in an yeast two-hybrid screen (Roland Steinacher and Primo Schär, unpublished 
data); BRD4 is a bromodomain protein, interacting with acetylated histones (e.g. 
H3K9ac) and a number of chromatin modifiers and it is also an atypical kinase for 
serine 2 on the C-terminal domain (CTD) of the RNA Polymerase II (RNA Pol II; 
(Devaiah et al., 2012; Liu et al., 2008; Rahman et al., 2011)). This latter discovery is 
very interesting as it may link TDG’s role in chromatin dynamics directly to the 
regulation of RNA Polymerase II. 
Therefore, I performed pilot experiments to test this possibility. I analyzed the effect 
of catalytically inactive and wildtype TDG on transcriptional outcome of the RARβ 
locus. RARβ was chosen because its expression is induced by RA and because our 
ChIP data confirmed that TDG is strongly associated with this locus. Furthermore, I 
characterized the phosphorylation pattern of RNA Pol II’s C-terminal domain (CTD) – 
which is highly indicative of transcriptional progression (Bataille et al., 2012; Gebara 
et al., 1997) – as a function of TDG, to be able to distinguish between effects on 
transcriptional initiation and productive elongation. Inhibition of BRD4 with the small-
molecule inhibitor JQ1 was shown to abrogate its binding to acetylated histones, 
which coincides with the inhibition of BRD4-dependent RNA Pol II phosphorylation 
(Devaiah et al., 2012). I thus wanted to additionally investigate the effect of BRD4 
inhibition on the phosphorylation pattern of the CTD in the presence or absence of 
TDG or its catalytic activity.  
First, I confirmed the inducibility of RARβ expression upon the treatment of mouse 
embryonic fibroblasts (MEFs) with all-trans retinoic acid (RA). Induction was 
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observed independent of the Tdg background (Tdg-/- MEFs complemented with 
minigenes encoding either wildtype TDG (Tdg[wt]), catalytically inactive TDG 
(Tdg[cat]) or the empty vector (Tdg[null])). Interestingly, compared to mock-treated 
MEFs (DMSO), the induction of RARβ expression was lowest in Tdg[wt] (20-fold, p = 
0.013) compared to Tdg[cat] (53-fold, p = 0.001) and Tdg[null] (65-fold, p = 0.0.015); 
Figure 1a). Treatment of these MEFs with JQ1 showed an inverse effect on RARβ 
gene expression in Tdg[wt] and Tdg[null]: expression was decreased in Tdg[wt] but 
was significantly increased in Tdg[null] upon JQ1 treatment compared to control 
treatment (DMSO; p = 0.015; Figure 1b), although expression levels were generally 
low. These results indicate a synergistic effect of the combined absence of TDG and 
BRD4 on induction of RARβ expression.   
A             B 
    
 
 
 
 
Figure 1: Expression analysis of the RARβ gene in MEFs in different Tdg backgrounds. A: RT-
qPCR of mRNA extracted from MEFs, treated with all-trans retinoic acid (RA; 1 μM for 24h) or with 
DMSO as a mock control. B: RT-qPCR of mRNA extracted from MEFs, treated with the BRD4 inhibitor 
JQ(+)1 (250 nM for 24h) or with DMSO as a mock control. Normalization was conducted against β-
Actin and B2m (in 1a and 1b). n=2 or 3; error bars are standard deviations or standard errors, 
respectively. two-tailed t-tests; p < 0.05: *; p < 0.01: ***. 
 
To investigate a possible role of TDG in transcription initiation, I then checked the 
influence of RA-treatment on the formation of the preinitiation complex (PIC), which is 
characterized by an unphosphorylated state of the RNA Pol II CTD (Lolli, 2009), in 
MEFs expressing wildtype, catalytically inactive or no TDG. This was achieved by 
chromatin immunoprecipitation (ChIP) with an antibody directed against the CTD of 
RNA Pol II followed by quantitative PCR (qPCR). Indeed, I found RA-treatment 
promoting an elevated association of the RNA Pol II to the promoter region of RARβ 
(Figures 2a and 2b). This was most pronounced when TDG was catalytically 
inactive (Tdg[cat]) or absent (Tdg[null]), suggesting that loss of TDG activity is 
beneficial for PIC formation. To see how the Tdg background further affects 
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downstream steps of transcription, I performed ChIP-qPCR experiments for CTD 
phosphorylated at serine 5 (S5p; the mark for promoter escape and abortive 
transcription) and serine 2 (S2p; the mark for productive transcription elongation) 
(Devaiah and Singer, 2012; Heidemann et al., 2013; Phatnani and Greenleaf, 2006). 
To facilitate investigation of the phosphorylation pattern and the association of RNA 
Pol II along the entire RARβ gene, I defined regions of interest along the gene 
(primer pairs 1 through 7; Table 2 and Supplementary Figure 1). Upon treatment 
with RA, I detected a significantly increased S5 phosphorylation in Tdg[cat], however, 
the distribution of S5p RNA Pol II did not differ significantly between Tdg[wt] and 
Tdg[null] throughout the RARβ locus (Figures 2c and 2d). S5 phosphorylation of the 
CTD in Tdg[cat] was most pronounced in the promoter region (Map 1), but was 
additionally also enriched towards the 3’ end of the gene (Map 6 and Map 7). The 
genuinely higher levels of S5p in the Tdg[cat] background for RA-treated MEFs 
(Figure 2c) could be explained by an effect on co-transcriptional alternative splicing. 
It is along these lines, that the CTD is rather phosphorylated at S5 than S2 upon 
slowing down of the RNA Pol II due to an alternative splicing event at an exon variant 
(Batsche et al., 2006). The fact that this is more pronounced in Tdg[cat] compared to 
Tdg[wt] and Tdg[null] might be explained by the delay of RNA Pol II progression due 
to a prolonged association to or constant association and dissociation from chromatin 
by catalytically inactive TDG (compare to (Hardeland et al., 2000; Hardeland et al., 
2002)). This could implicate that TDG activity contributes to alternative splicing or 
spliceosome assembly at particular intron-exon configurations. Interestingly, DNA 
methylation has been reported to regulate alternative splicing events (Maunakea et 
al., 2013); this constitutes yet another possibility for TDG to participate in the 
regulation of transcription, namely by actively demethylating alternatively spliced 
exons, resulting in aberrant splicing. 
As expected, levels of S2 phosphorylation increased towards the 3’ end of the RARβ 
locus (Figures 2e and 2f), which is in accordance with a previous report (Mahony et 
al., 2011). Interestingly however, the increase was strongest, though not significant, 
in the absence of TDG (Tdg[null]) at Map 6 and Map 7. This could indicate two 
things; on one hand the structure of TDG may be inhibitory for productive 
transcriptional elongation, on the other hand, absence of TDG (Tdg[null]) could cause 
the transcription machinery to slow down, thus facilitating detection by ChIP-qPCR 
due to more efficient cross-linking. 
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Figure 2: Association of the RNA Polymerase II to the RARβ gene upon RA-treatment. A: RNA 
Pol II CTD ChIP and mapping along the RARβ gene by qPCR in RA-treated MEFs. B: RNA Pol II CTD 
ChIP and mapping along the RARβ gene by qPCR in DMSO-treated MEFs. C: RNA Pol II S5p ChIP 
and mapping along the RARβ gene by qPCR in RA-treated MEFs. D: RNA Pol II S5p ChIP and 
mapping along the RARβ gene by qPCR in DMSO-treated MEFs. E: RNA Pol II S2p ChIP and 
mapping along the RARβ gene by qPCR in RA-treated MEFs. F: RNA Pol II S2p ChIP and mapping 
along the RARβ gene by qPCR in DMSO-treated MEFs. % input is normalized against an external 
control (chr2:75’408’932-75’409’164); n=2, error bars are standard deviations. Mapping positions: 1: 
promoter CGI in exon 1; 2: intron 1, 15 kb downstream of TSS; 3: exon 2, 25 kb downstream of TSS, 
3’UTR of one isoform; 4: intron 3, high CpG content (45%), 70 kb downstream of TSS; 5: exon 4, 120 
kb downstream of TSS; 6: exon 6, 5 kb upstream of 3’UTR of main isoform; 7: just after exon 8, 
3’UTR.       
BRD4 was shown to bind to acetylated histone proteins, function as a regulator of cell 
cycle progression and serve as a scaffold for the recruitment of the positive 
transcription elongation factor b (P-TEFb). Further, BRD4 was shown to be an 
atypical kinase that phosphorylates S2 on the CTD of RNA Pol II (Devaiah et al., 
2012). S2 phosphorylation of RNA Pol II’s CTD can be inhibited by JQ1, which 
functions by competitively binding to BRD4’s BET-bromo-domain, thereby preventing 
its binding to chromatin (Delmore et al., 2011). I was thus interested if and how the 
loss of BRD4 binding affects the progression of the RNA Pol II depending on the 
TDG status. For this purpose, I treated MEFs with JQ1 and investigated the 
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association of RNA Pol II to the RARβ locus as well as the phosphorylation pattern 
RNA Pol II’s CTD. In TDG-deficient cells (Tdg[cat] and Tdg[null]) I measured a trend 
to more CTD association upon BRD4 inhibition (Figures 3a and 3b). However, the 
levels of CTD association were generally low, consistent with the low levels of RARβ 
expression observed (Figure 1). 
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Figure 3: Association of the RNA Polymerase II to the RARβ gene upon JQ1-treatment. A: RNA 
Pol II CTD ChIP and mapping along the RARβ gene by qPCR in JQ1-treated MEFs. B: RNA Pol II 
CTD ChIP and mapping along the RARβ gene by qPCR in DMSO-treated MEFs. C: RNA Pol II S5p 
ChIP and mapping along the RARβ gene by qPCR in JQ1-treated MEFs. D: RNA Pol II S5p ChIP and 
mapping along the RARβ gene by qPCR in DMSO-treated MEFs. E: RNA Pol II S2p ChIP and 
mapping along the RARβ gene by qPCR in JQ1-treated MEFs. F: RNA Pol II S2p ChIP and mapping 
along the RARβ gene by qPCR in DMSO-treated MEFs. % input is normalized against an external 
control (chr2:75’408’932-75’409’164); n=2; t-tests corrected for multiple comparisons with the Holm-
Sidak method; error bars are standard deviations. Mapping positions: 1: promoter CGI in exon 1; 2: 
intron 1, 15 kb downstream of TSS; 3: exon 2, 25 kb downstream of TSS, 3’UTR of one isoform; 4: 
intron 3, high CpG content (45%), 70 kb downstream of TSS; 5: exon 4, 120 kb downstream of TSS; 6: 
exon 6, 5 kb upstream of 3’UTR of main isoform; 7: just after exon 8, 3’UTR.       
 
Similarly, the level of S5p was also quite low overall and the treatment with BRD4-
inhibitor (JQ1) did not lead to different phosphorylation levels in Tdg[cat] and 
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Tdg[null] backgrounds (Figures 3c and 3d). Surprisingly, the enrichment was most 
pronounced towards the 3’ end of the gene (Map 6) and not in the promoter region as 
expected. Analysis of S2 phosphorylation levels of CTD along the RARβ locus 
showed a clear effect of BRD4 inhibition (Figures 3e and 3f): the enrichment of S2p 
was relatively small along the gene body (Supplementary Figure 1), but again 
especially increased at positions 6 and 7. The effect of JQ1 treatment was beneficial 
for S2 phosphorylation of the RNA Pol II CTD in Tdg[wt] but inhibitory in Tdg[cat] and 
Tdg[null]. This was significant for Tdg[wt] (p = 0.0.004) and Tdg[cat] (p = 0.002) and 
interestingly, the trends observed for S2p are perfectly contrary to the trends 
observed for CTD enrichment and gene expression (Figures 3a and 3b, Figure 1). It 
is interesting that I observed more S2p, which is the mark for productive 
transcriptional elongation, but less CTD and gene expression in Tdg[wt] compared to 
Tdg[cat]. This might indicate that the RNA Pol II requires both functional TDG as well 
as RA to facilitate gene expression.  
Next, I wanted to assess the effect of BRD4 inhibition by JQ1 on the association of 
TDG to the RARβ locus by TDG-ChIP-qPCR. Little enrichment was found in Tdg[wt] 
and Tdg[null] independent of the treatment (JQ1 or DMSO). However, BRD4 
inhibition increased TDG association in Tdg[cat] markedly (Figure 4a). This may be 
explained by the lack of turn-over of catalytically inactive TDG and hence more 
efficient cross-linking and detection by ChIP (Wirz et al, manuscript in preparation, 
2014). I further checked for CDK9 enrichment at the RARβ locus, because CDK9 is 
another S2 kinase and part of P-TEFb, which is recruited by BRD4. In untreated 
MEFs, I observed little enrichment, possibly because CDK9 levels are generally low 
in MEFs (Devaiah et al., 2012). There may be a trend for more CDK9 enrichment in a 
TDG-deficient background (Tdg[null]), especially towards the 3’ end of the RARβ 
locus (Figure 4b). An explanation for this could be that in the absence of TDG, BRD4 
is not recruited to the chromatin and thus cannot act as a S2 kinase. Thus, CDK9 
may take over, especially at the 3’ end of the gene, where S5 of the CTD is markedly 
decreased, which is the favorite substrate for CDK9 (Devaiah et al., 2012; Tietjen et 
al., 2010).  
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Figure 4: Association of TDG to the RARβ gene upon JQ1-treatment and association of the 
CDK9 serine 2 kinase to the RARβ gene in untreated MEFs. A: TDG ChIP-qPCR in JQ1- or 
DMSO-treated MEFs, mapping along the RARβ locus. B: CDK9 ChIP-qPCR in untreated MEFs, 
mapping along the RARβ locus. The % input is normalized against an external control 
(chr2:75’408’932-75’409’164) in 4a and 4b. Single experiments are shown. Mapping positions: 1: 
promoter CGI in exon 1; 2: intron 1, 15 kb downstream of TSS; 3: exon 2, 25 kb downstream of TSS, 
3’UTR of one isoform; 4: intron 3, high CpG content (45%), 70 kb downstream of TSS; 5: exon 4, 120 
kb downstream of TSS; 6: exon 6, 5 kb upstream of 3’UTR of main isoform; 7: just after exon 8, 
3’UTR.   
 
Taken together, I could show that RA-treatment increases the association of 
unphosphorylated CTD to the promoter region of RARβ. In this context, functional 
TDG seems to play an inhibitory role. Additionally, I found significantly increased 
levels of S5p of the RNA Pol II CTD in MEFs expressing catalytically inactive TDG, 
not only in the promoter region (position 1), but towards the 3’ end of the gene 
(positions 6 and 7). This could indicate that alternative splicing takes place and is 
misregulated in the absence of TDG catalytic activity. TDG catalytic activity seems to 
be important for early elongation, where TDG might be in a complex with BRD4, 
which was suggested to be the initial S2 kinase (Devaiah et al., 2012). Upon 
productive transcriptional elongation, however, the absence of TDG is beneficial, 
which is also mirrored in the most significantly elevated gene expression induction 
upon RA-treatment. The loss of BRD4 chromatin association seems to effect the PIC 
formation mostly. Additionally, TDG association to the RARβ locus is increased, 
mainly at positions of particular interest; located in the promoter CGI, in the 3’UTR of 
a splice variant and near the 3’UTR of the main splice variant, again indicating that 
TDG might be involved in co-transcriptional processes like mRNA end processing or 
splicing.  
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I conclude that in the absence of TDG protein or activity, normal transcription at the 
RARβ locus is disturbed, depending to some extent on the functions of BRD4. This 
may provide an entry point towards investigation of the mechanistic links between 
DNA demethylation and the control of RNA Pol II-mediated transcription. 
 
Material and Methods 
Cell culture and treatment of cells 
SV40-immortalized MEF cell lines were previously described (Kunz et al., 2009a) and 
cultivated in growth medium (Dulbecco’s Modified Eagle’s Medium (DMEM), 
containing 10% Fetal Bovine Serum (FBS), 2 mM L-glutamine and 1x Penicillin / 
Streptomycin) at 37 °C in a humidified atmosphere containing 5% CO2. Before 
starting retinoic-acid or JQ(+)1 inhibitor (JQ1) treatment, MEFs were grown for two 
passages. Treatment with all-trans retinoic acid (RA) was conducted at 1μM for 24h. 
Treatment with JQ(+)1 inhibitor (BioVision) was conducted at 250nM for 24h. DMSO 
mock controls were included for both treatments. After 24h, cells were harvested to 
perform downstream experiments. All cell culture components were from Sigma if not 
denoted differently.  
Chromatin immuno-precipitation (ChIP) and qPCR analysis 
Chromatin was prepared and the immunoprecipitation was performed as described in 
Appendix I. The only adaptation was the addition of phophatase inhibitors (5mM 
NaF and 2mM Na3VO4) to all three lysis buffers and the dilution buffer for S5p and 
S2p ChIPs. Quantitative PCR (qPCR) analysis was performed on a Rotor-Gene 3000 
thermocycler (Qiagen) using 1x QuantiTect SYBR Green (Qiagen). Antibodies and 
primers used are shown in Table 1 and Table 2, respectively. Statistical analysis was 
performed with GraphPad Prism 6, by t-tests corrected for multiple comparisons by 
Holm-Sidak. 
RNA extraction, reverse transcription and expression analysis 
RNA was extracted with the TRI Reagent (Sigma) according to the manufacturer’s 
protocol and as described in Appendix I. RNA was then subjected to DNAse I 
digestion (Fermentas) and reverse transcribed with the High-Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems), as indicated by the manufacturers. qPCR 
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analysis was performed using 1x QuantiTect SYBR Green (Qiagen) with a Rotor-
Gene 3000 thermocycler (Qiagen), primers are shown in Table 2. Statistical analysis 
was performed on independent duplicate or triplicate experiments by non-paired, two-
tailed t-tests. 
Table 1: Antibodies used in this study 
Antibody Product 
number 
Manufacturer 
Anti-RNA polymerase II CTD repeat 
YSPTSPS [8WG16] antibody 
ab817 Abcam 
Anti-RNA polymerase II CTD repeat 
YSPTSPS (phospho S5) antibody 
ab5131 Abcam 
Anti-RNA polymerase II CTD repeat 
YSPTSPS (phospho S2) antibody 
ab5095 Abcam 
Anti-Cdk9 antibody (C-20) sc-484 Santa Cruz 
Biotechnology 
The anti-TDG antibody used for ChIP was produced and affinity purified in our lab, for further 
information see (Cortazar et al., 2011; Hardeland et al., 2002; Neddermann et al., 1996). 
 
Table 2: Primers used in this study 
Primer Forward (5’-3’ sequence) Reverse (5’-3’ sequence) 
RARβ-1 GAT CCC AAG TTC TCC CTT CC GGC AGG AGG GTC TAT TCT TTG 
RARβ-2 TTG CCA GGT AGT CAG GAA GG CCC ACT GCA ACA GCC TAG AG 
RARβ-3 CTG ACG CCA TAG TGG TAG CC TTG TAG CCA TCG AGA CAC AGA 
RARβ-4 GCC ACA TAA AGA GGA GGA GGA TTG ATG AAG GCT ACC CCT TG 
RARβ-5 CAG TGG CTC TTA CCG TGG TG 
GCT GTT AGG AAT GAC AGG AAC A 
 
RARβ-6 GGG TCT GGT GAC GGT TTC TA TGA TGG CCT TAC ACT AAA TCG 
RARβ-7 CTG GGC AAC ATA AGG GAA AG AAG ACA CCG AGG TTG TGG AG 
chr2neg AGCACAGCCTGAAGCCTCTA AGAGGGCATTTCCGTCTTTT 
RARβ (RT) TTAATCTGTGGAGACCGCCAG TTACACGTTCGGCACCTTTCG 
Actinβ (RT) CGT CGA CAA CGG CTC CGG CAT CCA CCA TCA CAC CCT GGT GCC TAG G 
B2m (RT) TCA CGC CAC CCA CCG GAG AA TCT CGA TCC CAG TAG ACG GTC TTG G 
All primers were from Microsynth, Switzerland. RT: reverse transcription. 
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Supplementary Information 
 
 
 
 
 
 
 
Supplementary Figure 1: Schematic summary of the RARβ gene from the Genome 
Browser (http://genome-euro.ucsc.edu/index.html). UCSC (top) and RefSeq (bottom) 
Genes are depicted, as well as CGIs (in green). Primer positions are indicated in red 
and numbered as shown in Figures 2, 3 and 4 (cf. Table 2). RT primer positions are 
indicated below (in green, RT).   
 
Contributions: I designed and performed all the experiments described in this section. 
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5. Concluding Discussion and Outlook 
 
Although the initial discovery of TDG as a mismatch-specific DNA glycosylase 
implicated a function in DNA repair, it emerged quickly that TDG contributes to more 
biological processes beyond canonical DNA repair. TDG has been linked physically 
and functionally to transcriptional activation and, although less frequently, to 
transcriptional repression, findings that are underlined by the manifold interactions of 
TDG with different transcription factors. In further support of a link to transcription is 
the fact that TDG was found to associate with RNA and an RNA helicase (p68), 
which was proposed to enhance its catalytic activity (Boland and Christman, 2008; 
Fremont et al., 1997; Gallais et al., 2007).  
Other lines of investigation established that TDG participates in the control of DNA 
methylation. TDG was demonstrated to interact physically and functionally with both 
de novo DNA methyltransferases DNMT3a and DNMT3b (Boland and Christman, 
2008; Li et al., 2007). Early evidence indicated that TDG plays a role in direct DNA 
demethylation, which was by virtue of its ability to excise 5-mC from DNA, a finding 
that was highly controversial (Jost, 1993; Jost et al., 1995). Instead, it turns out, that 
TDG accomplishes the last step in an enzymatic cascade for active DNA 
demethylation, which requires precedent catalytic activity of the TET proteins (He et 
al., 2011; Ito et al., 2011; Maiti and Drohat, 2011; Tahiliani et al., 2009). These 
findings, together with the fact that the loss of TDG leads to aberrations in DNA and 
histone modifications, clearly place TDG in the context of epigenome regulation and 
maintenance. 
The focus of my work lay on the characterization of the epigenetic functions of TDG. 
During my PhD thesis, the mechanistic involvement of TDG in DNA demethylation, 
downstream of the action of the TET or AID proteins, was clearly demonstrated. The 
main part of my work focused on the investigation of TDG’s role in DNA methylation 
control in the context of epigenetic programming in stem cell differentiation, its 
functional interactions and coordination with TET proteins and the resulting impact on 
gene regulation (Appendices I and II). 
In a mouse model, we were able to characterize the Tdg-knockout phenotype. 
Intriguingly, we found that loss of Tdg causes embryonic lethality which is unlike the 
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phenotype of any other DNA glycosylase knockout. We could rule out TDG’s DNA 
repair function to be causative for this severe phenotype and, instead, established 
aberrant epigenetic modulation as a reason: at promoter CGIs of developmental 
genes, we found a shift towards a more repressed state upon loss of TDG – both in 
terms of histone marks as well as DNA methylation. Since this was only found in 
differentiated but not in pluripotent cells, we concluded that TDG safeguards the 
epigenetic state of developmental genes upon cell lineage commitment. Importantly, 
we found a TDG-dependent association of both downstream BER proteins as well as 
histone modifying proteins with these developmental genes, indicating that TDG 
triggers the regulation of the epigenetic state of gene promoters. On the basis of 
these data, we proposed that TDG-dependent DNA repair has evolved to provide 
epigenetic stability during cell lineage commitment (Appendix III).  
We continued to investigate TDG’s role in DNA methylation control by genome-wide 
approaches and discovered that TDG-deficient mouse embryonic stem cells 
accumulated differentially methylated regions (DMRs) in the course of differentiation 
to neuronal progenitor cells. Again, we observed a peculiarity with respect to CGIs, 
namely, the DMRs located in CGIs were almost exclusively hypomethylated in TDG-
deficient cells. This implicated that CGIs are subject to DNA methylation and 
demethylation, challenging the prevailing view that CGIs are bona fide unmethylated. 
Upon further characterization of the methylation state of these CGI DMRs, we indeed 
found evidence for ongoing DNA methylation – oxidative demethylation cycles at 
these loci. Nota bene, this cycle was disturbed in the case of catalytically inactive 
TDG, as demonstrated by the aberrant accumulation of DNA demethylation 
intermediates (5-fC and 5-caC). As the CGIs affected were sequences that become 
de novo methylated during cell differentiation, this pointed at the necessity for TDG-
mediated DNA repair and/or demethylation activity for developmental programming of 
gene expression. Consistently, these CGI DMRs showed a significant enrichment of 
genomic features of distal gene regulatory regions. These results postulate a novel 
mechanism for the establishment and maintenance of gene expression patterns 
based on the epigenetic regulation of enhancer elements by a DNMT-TET-TDG-
mediated DNA methylation and oxidative demethylation. As there is an ongoing 
debate about a possible deamination-based DNA demethylation pathway, we 
analysed the occurrence of mutations at CGI DMRs in TDG-deficient and –proficient 
cells. Since the implicated AID- or APOBEC-mediated deamination of C or 5-mC 
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would give rise to premutagenic lesions (T•G or U•G, respectively), which are 
substrates for TDG, we predicted to find an elevated CT mutation frequency in a 
background without or with inactive TDG. Since this was not the case, as measured 
with hairpin Na-sulfite deep-sequencing, we concluded that a deamination-based 
DNA demethylation pathway plays no or only a minor role in the demethylation 
events observed at the CGI DMRs investigated. A highly dynamic alteration of DNA 
methylation at transcriptionally stimulated promoters as well as other gene regulatory 
elements has been described before and linked to the orchestrated action of DNMTs, 
TDG and BER (Kangaspeska et al., 2008; Metivier et al., 2008) as well as the TET 
proteins and TDG (Shen et al., 2013; Song et al., 2013). Our findings additionally link 
the aberrant DNA methylation patterns caused by the loss of TDG to a biological 
phenotype, namely the failure to undergo lineage commitment, as evidenced by 
increased cell death in Tdg knockout cells subjected to retinoic acid-induced 
neuronal differentiation (Appendix I). 
To further disentangle the mechanisms underlying the Tdg knockout phenotype, I 
analyzed the genome-wide association of TDG to chromatin in mESCs subjected to 
24 hours of RA-treatment. Catalytically inactive TDG, which binds but does not 
remove substrate bases from DNA and, hence, shows a severely reduced DNA 
dissociation, localized to the genome in roughly 28’000 peaks that showed a higher 
than 2 fold enrichment (log2>1). TDG peaks showed a bimodal distribution; a narrow 
peak was encompassing the TSS and a broader peak was located roughly 1 to 1000 
kb away from TSS. Further, TDG peaks were characterized by an intermediate to 
high CpG density, showing a clear enrichment of CGIs. Moreover, TDG peaks were 
mainly positive for activating histone marks (H3K36me3, H3K4me3, H3K9ac) as well 
as histone marks characteristic for active enhancers (H3K4me1, H3K27ac), 
supporting the notion that TDG is targeted to gene regulatory sites to regulate DNA 
methylation and thereby the epigenetic state. It will be interesting to clarify whether 
TDG facilitates transcription by the maintenance of epigenetic plasticity at gene 
regulatory elements only, or whether TDG is actively involved in facilitating and 
establishing enhancer-promoter loops and thereby the assembly of the transcription 
machinery. In support of the latter, we found a clear correlation of TDG association to 
genomic loci with occurrence of the dynamic histone variants H3.3 and H2A.Z. These 
histone variants have been linked to actively transcribed genes, promoters and 
enhancers and, particularly at the latter, were found to rapidly turn over (Kraushaar et 
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al., 2013). We further found a striking enrichment of both TET1 and TET2 occupancy 
in TDG peaks and, interestingly, the triple-positive TET1-TET2-TDG peaks showed a 
significant preference for CGIs, whereas the unique TDG peaks did not. Contrarily, 
unique TDG peaks were preferentially located in active enhancers, indicating a 
functional separation between the distinct TDG protein fractions. In line with this 
notion is the finding that triple-positive peaks showed a drastic increase in DNA 
demethylation intermediates as well as bivalent chromatin marks, in contrast to the 
unique TDG peaks. This suggests that the orchestrated, TET1-TET2-TDG-mediated 
DNA demethylation occurs mostly at developmental gene promoters, characterized 
by a high CpG density (CGIs). The increased co-occupancy with dynamic histone 
variants at triple-positive sites is in further support of this; enhanced nucleosome 
turnover might be promoted by TDG-mediated single-strand breaks generated in the 
context of excision repair-mediated active DNA demethylation. This is an attractive 
hypothesis, supported by an increased sensitivity to PARP inhibitors of differentiated 
TDG-proficient cells when compared to TDG-deficient cells (Cortazar et al., 2011). 
The hypersensitivity to PARP1 inhibitor suggests that single-strand breaks 
accumulate in a TDG-dependent manner whose further processing would require 
PARP-coordinated single-strand break repair. The above mentioned results are 
consistent with a mechanistic model where TDG is recruited to gene regulatory 
regions together with the TET proteins to perform DNA demethylation by 5-mC 
oxidation and excision. This will generate a DNA single-strand break, which facilitates 
nucleosome eviction or turnover and thus gene expression. The preferential co-
occupancy of TET1-TET2-TDG with bivalent CGIs indicates that this may occur 
predominantly in the context of developmental gene activation (Appendix II). 
TDG was shown to physically and functionally interact with the retinoic acid receptor 
(RAR/RXR; (Um et al., 1998)), in addition to several other nuclear receptors and 
transcription factors. I investigated the assembly and the progression of the 
transcription machinery as a function of TDG and BRD4, the latter having been 
identified as a TDG interacting protein in our laboratory and, thus, possibly providing 
a direct link between TDG and the RNA Polymerase II (data not shown). In a series 
of pilot experiments, I analyzed the phosphorylation state of RNA Pol II’s C-terminal 
domain (CTD) along the RARβ locus upon retinoic acid (RA)-induced transcription as 
well as upon BRD4 inhibition in cells expressing wildtype, catalytically inactive or no 
TDG. Interestingly, I observed elevated levels of pre-initiation complex (PIC) 
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formation upon RA-induced transcription in the absence of functional TDG. 
Additionally, phosphorylation of CTD’s Serine 5 (early elongation) and Serine 2 
(productive elongation) were increased in cells expressing catalytically inactive or no 
TDG, respectively. It is not clear at this point whether this somewhat unexpected 
finding reflects indeed an overall increase of productive transcriptional elongation in 
the absence of TDG, or whether it represents an increase of stalled or paused RNA 
Polymerase II, which is more readily cross-linked and detected by ChIP-qPCR. The 
inhibition of the putative bridging factor BRD4 generally reduced transcriptional 
activity, reflected by low mRNA expression levels, low amounts of PIC formation and 
low presence of early elongation states. However, inhibition of BRD4 increased 
productive transcriptional elongation in a TDG wildtype background, raising again the 
question whether this really reflects increased transcriptional levels or rather an 
increased stalling of the RNA Polymerase II. When investigating the association of 
TDG to the RARβ locus, I found an increase in TDG association upon BRD4 
inhibition; the highest enrichment of TDG was observed in the 3’ UTRs of different 
splice variants of RARβ (besides the promoter CGI), indicating a possible 
involvement of TDG in co-transcriptional processes, like mRNA end processing or 
splicing. These data strengthen a direct role of TDG in transcriptional regulation, 
possibly by means of modulating PIC assembly, productive transcriptional elongation 
and/or co-transcriptional processes (Supplementary Results 4.4). Further studies 
will be needed to dissect the effective role of TDG herein and to specify the 
engagement of TET-TDG in transcription initiation.  
Taken together, I was able to further specify and provide novel insight into TDG’s role 
in the epigenetic programming and maintenance of gene regulatory elements during 
cell lineage commitment. Together with the TET proteins, TDG participates in 
targeted DNA methylation and demethylation at gene promoters and enhancers, 
which is tightly associated with the maintenance of a dynamic chromatin structure, 
required for the setup of developmental stage-specific gene expression programs. 
Hopefully, this work constitutes a basis for answering many questions that still remain 
open. For instance, what is the mechanistic relationship between TET-TDG-mediated 
cyclic DNA demethylation, and how are the deposition of H3.3 and H2A.Z and the 
depletion of nucleosomes orchestrated at such sites? And how is TET-TDG-mediated 
5-mC oxidation and excision regulated such that an accumulation of DNA strand 
breaks and genomic instability can be avoided? Since the TET proteins and TDG co-
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localize at many genomic loci, further questions to be addressed are: what are the 
underlying targeting mechanisms and is TET-TDG co-occupancy simultaneous or 
successive? Moreover, TET proteins and TDG cooperate in cycles of DNA 
methylation and demethylation at sites determined by cell differentiation stage and 
cell type. How is the exit from cycling regulated such that one region can end up 
terminally methylated and another terminally unmethylated once a cell fate is 
determined? Finally, TET proteins have been assigned to different developmental 
stages but have catalytically redundant roles – so are there differences in the 
recruitment efficiency and activity of TDG, depending on the different TET proteins? 
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Abstract 
The Thymine DNA Glycosylase (TDG) initiates Base Excision Repair of G•T mismatches 
arising from deamination of 5-methylcytosine (5-mC). Due to this substrate specificity, TDG 
has been suggested to act in a deamination-coupled 5-mC demethylation process. More 
recently, TDG has been found to process 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-
caC), the final products of TET mediated 5-mC oxidation, implicating TDG in an oxidative 
DNA demethylation process. However, the significance of either of these proposed pathways 
in the context of epigenetic programming during cell differentiation is yet unclear. Here, we 
report that TDG is required to establish DNA methylation at CpG islands during differentiation 
by controlling a transitory cycle of DNA methylation and demethylation. We provide evidence 
that this cycle does not entail a deaminase but stepwise oxidation of 5-mC and that TDG 
structure and catalytic activity both contribute to controlling the epigenetic transitions from a 
pluripotent to a differentiated state. 
 
Introduction 
Cell type specific patterns of gene expression are shaped by chemical modifications of 
histone proteins and the DNA, termed “epigenetic”. The C5-position of cytosine is subject to 
methylation by DNA methyltransferases (DNMTs) (Goll and Bestor, 2005). 5-methylcytosine 
(5-mC) occurs predominantly in CpG dinucleotides, the vast majority of which is methylated 
throughout the genome, with the exception of CpG islands (CGIs) (Bird et al., 1985). These 
regions of high CpG density are maintained unmethylated and colocalize with the promoters 
of all ubiquitously expressed genes but also with about 40% of those with tissue-specific 
expression patterns. However, a small but significant proportion of CGIs, many of which are 
distal to promoters, is differentially methylated between cell types (Illingworth and Bird, 
2009). 
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In contrast to histone modifications that are highly dynamic (Bannister and Kouzarides, 
2011), cytosine methylation has long been regarded as a stable epigenetic mark that is 
established and maintained by DNMT3a or b and DNMT1, respectively (Goll and Bestor, 
2005). However, two global DNA demethylation events have been described to occur in the 
mammalian life cycle (Seisenberger et al., 2013) and both have recently been shown to 
involve the activity of the Ten Eleven Translocator (TET) family of proteins. These 5-mC 
hydroxylases convert 5-mC to 5-hydroxymethylcytosine (5-hmC) (Tahiliani et al., 2009), 
which is not maintained by DNMT1 and thus diluted through DNA replication (Hackett et al., 
2013; Hashimoto et al., 2012; Iqbal et al., 2011; Valinluck and Sowers, 2007; Wossidlo et al., 
2011). Whereas such passive removal presents a plausible pathway for global 
demethylation, it appears that specific loci are actively demethylated independent of DNA 
replication (Bruniquel and Schwartz, 2003; Kangaspeska et al., 2008; Metivier et al., 2008). 
Efforts to identify an enzyme that actively demethylates 5-mC have implicated the thymine 
DNA glycosylase (TDG) as a prime candidate. Its protein interactions have placed TDG in 
the context of DNA methylation control and regulation of gene expression (Cortazar et al., 
2007). In further support of such a function, we and others have found deletion of Tdg in 
mice to be embryonic lethal and cause epigenetic aberrations at CpG island promoters 
(Cortazar et al., 2011; Cortellino et al., 2011).  
As TDG recognizes and processes the deamination product of 5-mC, a G•T mismatch, it has 
been proposed to act downstream of a cytosine deaminase in a putative DNA demethylation 
pathway, e.g. the activation induced deaminase (AID) or the apolipoprotein B RNA-editing 
catalytic component (APOBEC) enzymes. Several lines of evidence support an involvement 
of these deaminases in both, global and targeted DNA demethylation (Bhutani et al., 2010; 
Popp et al., 2010; Rai et al., 2008). Another hypothetical DNA demethylation pathway entails 
oxidation, converting 5-mC to 5-hmC, and subsequent deamination of 5-hmC to 5-
hydroxymethyluracil (5-hmU), which can be excised by TDG (Cortellino et al., 2011; 
Hardeland et al., 2003). However, a recent study has cast doubt on such a pathway since 
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AID and the APOBEC deaminases appear to be mostly inactive on 5-hmC (Nabel et al., 
2012). 
G•T and G•5-hmU are processed also by the Methyl-CpG Binding Domain protein 4 (MBD4) 
and the Single-strand specific Monofunctional Uracil Glycosylase 1 (SMUG1), respectively. 
As neither MBD4 nor SMUG1 are essential for embryonic development (Kemmerich et al., 
2012; Wong et al., 2002) and neither can compensate for the loss of TDG, it appears that 
TDG acts in a non-redundant pathway essential for embryo development. Such a pathway 
has taken shape with the finding that the TET proteins can oxidize 5-hmC further to 5-
formylcytosine (5-fC) and 5-carboxylcytosine (5-caC), both of which are excellent substrates 
for TDG-mediated Base Excision Repair (BER) and appear not to be processed by any other 
DNA glycosylase (He et al., 2011; Ito et al., 2011; Maiti and Drohat, 2011). However, the 
significance of a putative DNA demethylation pathway coupling the activities of TET and 
TDG through processes of cell fate determination has not been studied. Here, we report that 
TDG is essential for establishing differentiation-induced methylation at CpG islands by 
structurally and enzymatically supporting an equilibrium of DNA methylation and oxidative 
demethylation during a transitory state of high epigenetic plasticity. 
 
Results  
Aberrant DNA methylation in Tdg-/- cells 
We reported previously that TDG is essential for embryonic development and that TDG 
deficient cells accumulate aberrant DNA methylation at CpG island (CGI) promoters 
(Cortazar et al., 2011). To investigate the role of TDG in the regulation of DNA methylation, 
we performed MeDIP combined with next generation sequencing on DNA from TDG 
proficient (Tdg+/-) and deficient (Tdg-/-) embryonic stem cells (ESCs), early (4h) neuronal 
progenitors (NPs) derived by in vitro differentiation (Fig. S1a) and MEFs isolated from Tdg+/+ 
and Tdg-/- embryos (Wilson, 2012). Whereas Tdg+/- and Tdg-/- ESCs showed no significant 
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differences in their DNA methylation patterns, in vitro neuronal differentiation gave rise to 942 
differentially methylated regions (DMRs), and comparison of the MEFs revealed 32976 
DMRs (Fig. 1a). This phenotype indicated a failing DNA methylation control in the TDG 
deficient cells that deteriorates with differentiation. This notion is supported by the 
observation that Tdg-/- ESCs fail to form terminal neurons in vitro and rapidly lose cell viability 
in neuronal differentiation medium (Fig. S1a).  
Of the 942 DMRs found in NPs, 609 are hypermethylated and 333 hypomethylated in Tdg-/- 
cells compared to Tdg+/-. As DNA methylation is not equally distributed throughout the 
genome (Meissner et al., 2008), we characterized the relationship between DMRs and CpG 
density. In the absence of TDG, CpG poor DMRs were preferentially hypermethylated while 
DMRs with a higher CpG density were associated with a loss of DNA methylation (Fig. S1b). 
We also analysed the average distance of the DMRs to the nearest transcriptional start site 
(TSS). Hypomethylated DMRs were on average located closer to a TSS (24.3 kb ± 45.0 kb) 
than the hypermethylated (47.7 kb ± 77.4 kb) (Fig. S1c). Accordingly, 57% of the 
hypomethylated DMRs but only 34% of the hypermethylated lie within 10 kb of a TSS. 
Intersection of the DMRs with promoter regions confirmed that only a minority of the DMRs 
overlap with promoters (1kb upstream and 0.5kb downstream of a TSS), but that 
hypomethylated DMRs are more often promoter-associated than hypermethylated ones (Fig. 
S1d). We thus conclude that the hypomethylated DMRs are more likely to affect gene 
expression, but aberrant methylation appears to affect mostly regions distal to promoters. 
 
De novo methylation of CGIs requires TDG 
We found 123 DMRs to overlap with CGIs (UCSC) (Gardiner-Garden and Frommer, 1987). 
Unexpectedly, 122 of these 123 differentially methylated CGIs, henceforth called CGI DMRs, 
were hypomethylated in Tdg-/- NPs, whereas DMRs not classified as CGIs were 
predominantly hypermethylated (hyper-:hypomethylated = 3:1) (Fig. 1b). Although a vast 
majority of CGIs is maintained in a hypomethylated state in ESCs, a subset was shown to 
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acquire de novo methylation during neuronal differentiation (Mohn et al., 2008). We therefore 
asked whether hypomethylation at CGIs in Tdg-/- NPs represents a loss of DNA methylation 
present in ESCs or a failure to establish methylation during NP differentiation. We thus 
intersected the CGI DMRs with all CGIs acquiring de novo methylation with differentiation 
(Wilson, 2012). 117 of the 122 CGI DMRs overlap with CGIs that acquire methylated in NP 
differentiation (Fig. 1c), revealing diminished differentiation-associated de novo methylation 
to be the cause of hypomethylation in absence of TDG. 
To further explore the genomic features of the CGI DMRs, we intersected them with 
published datasets of genome-wide protein-binding sites and histone modifications in ESCs. 
This revealed that the CGI DMRs were significantly depleted for gene promoters (Ensembl 
TSS -1kb and +0.5kb), sites of RNA-polymerase II (RNA-Pol II), histone acetyltransferase 
p300 and H3K27ac enrichment (Fig. S1e). On the other hand, we found the CGI DMRs to be 
enriched in sites of TET1 binding and H3K4me1 and H3K27me3 modification (Fig. 1d), 
suggesting that a large proportion of these CGIs represent enhancer elements and targets of 
the polycomb repressive complex 2 (PRC2) which trimethylates H3K27 (Kuzmichev et al., 
2002). Enhancer elements were shown to be marked by H3K4 monomethylation and bound 
by TET1 (Heintzman et al., 2007; Serandour et al., 2012) but the fact that the CGI DMRs are 
depleted for H3K27ac and p300 suggests that  these enhancer elements are inactive or 
poised in ES cells (Creyghton et al., 2010). Interestingly, we found a highly significant 
overlap of CGI DMRs with low methylated regions (LMRs) that represent transcription factor 
binding sites at distal regulatory regions (Stadler et al., 2011); 52% of the CGI DMRs 
coincided with NP-specific LMRs and 7% with ESC-specific LMRs (Fig. 1d), whereas 
constitutive LMRs showed no significant overlap (Fig. S1e). The CGI DMRs thus appear to 
be enriched for polycomb targets and poised enhancer elements. 
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Loss of 5-mC is not caused by mutation 
The diminished differentiation-triggered methylation of CGIs and, thus, the apparent 
hypomethylation of such regions in Tdg knockout NPs can be explained in two ways: 1) by 
failure to target the DNA methylation machinery to these regions or 2) by conversion of 5-mC 
to another base that would no longer be recognized by the 5-mC antibody used in MeDIP. 
Conversion of 5-mC could occur by deamination, i.e. by AID, which would generate a G•T 
mismatch that – unless repaired by TDG or MBD4 – will give rise to C→T mutations, or by 
oxidation of 5-mC to 5-hmC and further to 5-fC and 5-caC by the TET proteins. 
To test these hypotheses and to be able to distinguish between a structural and enzymatic 
role of TDG in this context, we performed in vitro differentiation in a complemented cell 
system, in which either wildtype TDG (wt), a catalytically dead mutant TDG N151A (TDG∆cat) 
or vector control (ko) were stably expressed in Tdg-/- ESCs. Genomic DNA from NPs derived 
from these ESCs was subjected to hairpin Na-bisulfite sequencing (BS-seq) to allow 
simultaneous analysis of strand-specific methylation status and mutation frequency (Arand et 
al., 2012). The analysis of 7 representative hypomethylated CGIs (Supplementary Table 1) 
sequenced with a coverage of ~10’000 reads confirmed the hypomethylation in 5 targets 
(Fig. 2). Furthermore, the frequency of C→T mutations we observed did not rise above the 
error rate of the method and cannot explain the loss of 5-mC, which is in the higher 
percentage range. We thus conclude that the hypomethylation appearing in NPs is not 
caused by deamination of 5-mC or 5-hmC, as both deamination products (T and 5-hmU) are 
pre-mutagenic and would give rise to appreciable amounts of C→T mutations in Tdg 
knockout cells. Compensation by other DNA glycosylases like MBD4 and SMUG1 is unlikely, 
as neither is capable of compensating the loss of 5-mC nor the developmental phenotype of 
the Tdg knockout. 
Notably, 2 of the 7 targets chosen for hairpin Na-bisulfite sequencing (DMR36 and 8) 
exhibited hypermethylation in TDG∆cat and (only in DMR8) knockout NPs but hypomethylation 
in MeDIP-seq in TDG deficient cells. 5-mC and 5-hmC are not distinguishable by BS-seq, 
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whereas MeDIP-seq relies on an antibody specific for 5-mC. The discrepancy between the 
results from BS-seq and MeDIP-seq thus suggests accumulation of 5-hmC at the respective 
targets. This notion is supported by the increased appearance of hemimethylated CpGs at 
the same targets; 5-hmC is not maintained by DNMT1 (Hashimoto et al., 2012; Valinluck and 
Sowers, 2007) and therefore is expected to occur more often opposite an unmethylated 
CpG. 
 
5-fC and 5-caC rise with differentiation 
TDG was proposed to be the only DNA glycosylase capable of excising 5-fC and 5-caC and, 
consistently, the levels of these C-modifications were shown to increase following a 
knockdown of TDG in ESCs (He et al., 2011). We wanted to investigate the generation of 
these derivatives in the context of ESC differentiation, i.e. when differential methylation in 
TDG proficient and deficient cells becomes apparent. Yet, as neither 5-hmC nor the higher 
oxidized C-modifications are maintained by DNMT1 (Inoue et al., 2011; Valinluck and 
Sowers, 2007), the quantitative analysis of these modifications is perturbed by dilution 
through DNA replication. To minimize this dilution effect, we performed a 24 h retinoic acid 
(RA) differentiation time course, allowing a maximum of two rounds of DNA replication to 
occur. To reduce epigenetic heterogeneity often observed in ESC culture, we conditioned our 
complemented ESC lines in 2i medium prior to RA-induced differentiation (Ying et al., 2008). 
We observed that culturing in 2i medium decreased the global 5-mC levels in comparison to 
cells cultured exclusively in ESC medium with LIF (Fig. S3b) by about 50%, irrespective of 
Tdg genotype. This suggested that active inhibition of differentiation in the 2i medium 
changes the epigenetic ground state of our ESCs in a TDG independent manner and 
consistent with previous observations ((Leitch et al., 2013) and Reik, W., personal 
communication). 
We harvested genomic DNA and chromatin after 0, 8 and 24 h of incubation with RA (Fig. 
3a). By testing the mRNA levels of Nanog, Oct4, Rex1 and Gata6 throughout the timecourse, 
  Appendix I 
8 
 
we verified the downregulation of pluripotency genes and induction of developmental genes 
within these 24 h of differentiation (Fig. S2a), and we confirmed at mRNA and protein level 
that TET1 and TET2 expression was equal in all three cell lines (Fig. S2a and b and Fig. 5b). 
The levels of AID mRNA were extremely low and protein levels were below the detection limit 
in Western blot analysis (Fig. S2c). 
We then measured levels of 5-mC, 5-hmC, 5-fC, 5-caC and 5-hmU in the genomic DNA of 
undifferentiated and differentiated cells by liquid chromatography-tandem mass spectrometry 
(LCMSMS). In agreement with previous findings in TDG knockdown experiments (He et al., 
2011), we found a significant enrichment of 5-fC and 5-caC (~2- and 9-fold, respectively) in 
Tdg knockout as well as catalytically inactive (TDG∆cat) cells (Fig. 3b). We also found the 
global levels of 5-mC, 5-fC and 5-caC to rise with differentiation. This effect was more 
pronounced in cells lacking TDG activity and specifically induced by RA (Fig. S3a and c). 
Accordingly, global 5-mC levels became significantly different between TDG proficient and 
deficient (ko, TDG∆cat) cells at 24 h of differentiation (Fig. 3b). Interestingly, global 5-fC levels 
in mutant cells increased significantly above wildtype levels already after 8 h of 
differentiation. By contrast, 5-caC levels were ~9 fold higher in undifferentiated mutant cells 
compared to wildtype and only the mutant cell lines showed a further significant increase in 
5-caC with differentiation (Fig. S3a). Global 5-hmC and 5-hmU levels were not significantly 
different neither between any of the genotypes nor within the differentiation timecourse. 
From these results, we conclude that the loss of pluripotency triggers a turnover of global 5-
mC, 5-hmC, 5-fC and 5-caC, a process which is disturbed in the absence of active TDG. 
Overall, cytosine modification levels are equally affected in Tdg knockout or Tdg∆cat cells, 
implicating a catalytic active role of TDG in controlling transitions in CpG methylation. 
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TDG activity balances 5-mC and 5-caC 
The absence of increased C→T mutations at CGI DMRs indicated that the hypomethylation 
observed in TDG deficient NPs is not a result of deamination-mediated loss of CpG sites but, 
instead, may originate from targeted 5-mC oxidation by the TET proteins. To address this 
hypothesis, we analyzed 5-mC (MeDIP), 5-hmC (GLIB) and 5-caC (caCDIP) levels at 4 CGI 
DMRs and compared their change in the 24 h interval of RA-induced ESC differentiation in 
the presence or absence of TDG protein and/or activity. 
While the effects we observed varied to some extent with the genomic context of the target, 
certain trends became apparent across targets. We observed a slight but consistent 
differentiation-induced increase of 5-mC in TDG wildtype and TDG∆cat set against no change 
or even a decrease in knockout cells (Fig. 4a). While the levels of 5-hmC showed a high 
variability between replicate experiments and, thus, no consistent difference between Tdg 
genotypes, 5-caC levels were clearly increased in TDG∆cat across the targets when compared 
to wildtype and knockout cells (Fig. 4a, aggregated p-value < 0.0001, Anova). Comparing the 
proportions of 5-mC and 5-caC modifications at 0 and 24 h revealed a shift in the equilibrium 
between these modifications in a time- and genotype-dependent manner (Fig. S4a). While in 
wildtype and in Tdg ko cells, both modifications remained equilibrated at the CGI DMRs 
during the 24 h interval of differentiation, this balance tipped towards an increase in 5-caC in 
differentiated TDG∆cat cells (Fig. S4a).  
The increase of 5-mC and 5-caC at CGI DMRs in RA-stimulated wildtype and TDG∆cat ESCs 
indicates that the transition to a higher methylated state of these CGIs in the course of cell 
differentiation is accompanied by the generation of higher oxidized 5-mC-modifications. 
Subsequent re-methylation by DNMT3a or DNMT3b requires 5-caC to be excised and 
replaced with an unmodified C. The fact that Tdg-/- cells did not show an increase in 5-mC but 
rather a reduction of 5-caC suggests that TDG is structurally involved in the initiation and/or 
maintenance of cyclic methylation and oxidative demethylation.  
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This cycle of methylation and demethylation appears to be disrupted in TDG∆cat, resulting in 
an increase of 5-caC over time that surpasses that observed in wildtype. To elucidate how 
this disruption occurs, we characterized TDG∆cat biochemically regarding its activity on and 
association with 5-caC. We tested the activity of recombinant wildtype TDG and TDG∆cat in a 
standard base release assay on double-stranded oligonucleotide substrates with one 
fluorescence-labeled strand containing a single thymine or modified cytosine opposite 
guanine. We found TDG∆cat to be virtually inactive on 5-caC (Fig. 4b), which is in agreement 
with the accumulation of 5-caC in TDG∆cat cells (Fig. 3b). We then tested the ability of the 
catalytic-dead TDG to bind the 5-caC substrate in electrophoretic mobility-shift assays with 
fluorescence-labelled substrate oligonucleotides (G•T, G•5-mC, G•5-hmC, G•5-caC) in the 
presence of a 10 or 20 fold excess of unlabelled competitor DNA containing either 
unmodified C or a 5-caC. These competition assays identified 5-caC as the substrate most 
efficiently bound by TDG (Fig. 4c); the binding specificity and efficiency of the catalytic-dead 
protein appeared to be comparable to that of the wildtype TDG (Fig. S4b) with the caveat 
that the assay with the latter most likely reflects binding of to the product abasic-sites  
(Hardeland et al., 2000). We thus conclude that TDG∆cat binds 5-caC with higher affinity than 
5-mC and 5-hmC. 
 
TDG facilitates TET1 occupancy at CGIs 
The differential effects of the Tdg disruption and the catalytic-dead mutant on the 
methylation-demethylation equilibrium at the CGI DMRs suggest a structural role of TDG in 
this context. To elucidate this role, we tested whether the presence or absence of TDG 
influences the association of TET1 – the most highly expressed of the TET proteins in ES 
cells (Fig. S2a) – with these regions. Chromatin immunoprecipitation (ChIP) revealed that 
TET1 enrichment increases at all selected CGI DMRs over time of RA stimulation in wildtype 
cells.  Whereas the association of TET1 to the CGI DMRs appears to be independent of TDG 
in pluripotent cells, differentiation induces a gradual loss of TET1 occupancy at the CGI 
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DMRs in both knockout and TDG∆cat cells (Fig. 5a and S4).  These findings corroborate that 
initiation of ESC differentiation activates a cycle of DNA methylation and demethylation 
involving 5-mC oxidation at specific CGIs. 
Notably, while TDG∆cat is sufficient to support the stepwise oxidation of 5-mC to 5-caC 
structurally (Fig. 4a), the absence of the catalytic activity in this mutant significantly 
destabilizes – or suppresses – TET1 association to the CGI DMRs (Fig. 5a). The high affinity 
of TDG∆cat to 5-caC combined with its inability to turn over (Fig. 4b and c) is likely to result in 
an accumulation of TDGΔcat at these CGIs, thus blocking the progression of the cycle. Indeed, 
by ChIP, we found TDG∆cat to be clearly enriched at the CGI DMRs, while association of 
wildtype TDG hardly rose above the background measured in Tdg knockout (Fig. 5c, for 
relative enrichment, controls and statistics see Fig. S6).  
It thus appears that both TDG structure and catalytic activity are essential for stabilizing 
TET1-occupancy at the CGI DMRs but that TDG structure can become an obstacle without 
the ability to turnover on 5-caC.  
 
Discussion 
 
We have found that in vitro differentiation of TDG deficient ESCs is accompanied by an 
increasing disturbance of DNA methylation patterns. Intersection of the DMRs with CGIs 
revealed that 99% of all differentially methylated CGIs are hypomethylated in cells lacking 
TDG. The vast majority of these regions are CGIs that undergo de novo methylation during in 
vitro differentiation of ESCs to NPs, suggesting that TDG is essential for establishing cell-
type specific methylation of CGIs in the course of cell differentiation. Interestingly, many of 
these CGI DMRs appear to be inactive or poised enhancers and overlap with NP-specific 
LMRs (Stadler et al., 2011). 
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We found that a catalytically-dead but structurally intact TDG variant (TDG∆cat) fails to rescue 
differentiation-triggered methylation at these CGI DMRs, showing that the establishment and 
maintenance of methylation patterns at these regions depends on the active excision of DNA 
bases. Furthermore, we exclude that loss of 5-mC at these CGIs arises through deamination 
of either 5-mC or 5-hmC, which was proposed to be catalysed by AID in direct interaction 
with TDG (Cortellino et al., 2011). By hairpin bisulfite-sequencing with high coverage of a 
representative set of hypomethylated CGIs, we did not detect increased mutation levels, 
which would be the consequence of unrepaired deaminated 5-mC, neither in Tdg knockout 
cells nor in cells expressing TDG∆cat. The results with the catalytic inactive but structurally 
intact TDG allow us to exclude that the lack of mutations may reflect a failure to recruit AID to 
these genomic loci. Our data strongly argue against a deamination-dependent process 
accounting for the loss of 5-mC at these CGIs.  
In contrast, our data support a model connecting the loss of 5-mC at CGIs in TDG deficient 
NPs with the conversion of 5-mC to 5-hmC and 5-fC/caC by TET proteins. In a 24 h 
timecourse of RA-induced ESC differentiation, we found the genomic levels of all 5-mC-
derivatives to increase in Tdg wildtype, knockout and TDG∆cat cells, but more extensively so 
in the mutant cell lines. This suggests that differentiation triggers the generation of 5-mC and 
of oxidative demethylation intermediates, the latter of which accumulate globally in absence 
of TDG.  
The analysis of local C-modification levels at representative CGI DMRs revealed an 
imbalance of 5-mC and 5-caC in TDG∆cat but no significant shift of C-modification levels in 
knockout cells, indicating a dual function of TDG in controlling these levels during 
differentiation: one as an enzymatic component and one as a structural scaffold. Indeed, we 
found that TET1 associates with the CGI DMRs independent of TDG in ESCs but is rapidly 
lost upon differentiation in Tdg knockout cells. 
Additionally, we found that the failure of turnover of TDG∆cat combined with its high affinity for 
5-caC disrupts the methylation-demethylation complex, i.e. TET1-occupancy at the CGI 
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DMRs. This may occur either through steric hindrance or by generation of unusual 
demethylation intermediates, i.e. hemi-5-caC sites that cannot be remethylated by DNMT1 
after DNA replication. Also, DNMT3a and DNMT3b cannot target 5-caC for methylation and 
may not be able to methylate a CpG opposite a 5-caCpG bound by TDG∆cat. Without BER 
resetting the methylation state, methylation cannot be established correctly at these CGIs, 
which eventually results in the hypomethylation observed in NPs. The passive removal of 5-
hmC/fC/caC by DNA replication does not appear to be sufficient to establish methylation at 
these loci as the process clearly depends on functional TDG. 
We propose that at these CGIs, RA-induced differentiation triggers a cycle of DNA 
methylation and demethylation involving the iterative oxidation of 5-mC and enzymatic 
removal of 5-fC/caC by TDG and BER (Fig. 6). This establishes a transient equilibrium of 
methylation and demethylation intermediates that, at later stages of differentiation (early 
NPs), is tipped towards methylation (Fig. 6), suggesting that this cycle represents a transitory 
state that accompanies the loss of pluripotency. Such a cycle induced by differentiation is in 
agreement with our previous observation that RA induces DNA repair processes involving 
TDG that increase the number of XRCC1 foci and the sensitivity to PARP inhibitors in 
differentiating wildtype compared to Tdg-/- cells (Cortazar et al., 2011). 
Previous reports of cyclical methylation and demethylation of the pS2 promoter in response 
to estrogen-induced transcriptional activation have implicated DNMT3a and DNMT3b as well 
as TDG in coordinating these epigenetic transitions between transcriptionally active and 
silent states (Kangaspeska et al., 2008; Metivier et al., 2008). Others have proposed such a 
cycle involving oxidation of 5-mC by the TET proteins. However, the biological function of this 
cycle has not been described. We provide the first phenotypic evidence for a biological 
function of this cycle in establishing methylation patterns during cell-fate determination as its 
disruption by deletion of Tdg causes epigenetic aberrations and compromises cell viability.  
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Methods 
 
Cell culture and ES cell differentiation 
For NP differentiation, ESCs were grown on Feeders at 37°C in ES cell medium (ECM: 
DMEM, 15% heat-inactivated FCS, 1x non-essential amino acids, 1 mM Na-pyruvate, 2 mM 
L-glutamine and 90 µM β-mercaptoethanol) with LIF (1’000Uml-1) in a humidified atmosphere 
containing 5% CO2. 
Prior to differentiation, ESCs were grown without Feeders for 2 passages. For embryoid body 
formation, 4x106 Tdg+/-, Tdg-/- or Tdg-/- pWt, pΔcat and pVec ESCs were plated onto non-
adherent bacterial dishes (Greiner Bio-one) in differentiation medium (ECM without LIF and 
with 10% FCS) and grown at 37°C with a medium exchange after 2 days. After 4 days, 5 µM 
all-trans retinoic acid (RA) was added and cells were further incubated for 4 days with a 
medium exchange after 2 days. Embryoid bodies were washed twice with 1x PBS and 
dissociated with freshly prepared trypsin solution (0.05% TPCK-treated trypsin in 0.05% 
EDTA/PBS) at 37°C for 3 min. Dissociated embryoid bodies were resuspended in 10 ml 
differentiation medium and collected by centrifugation at 700xg for 5 min at room 
temperature. The pellet was resuspended in N2 medium (DMEM-F12 nutrient mixture 1:1, 
1xN2 supplement) and the cell suspension filtered through a 40 mm nylon cell strainer (BD). 
Filtered cells were immediately plated onto poly-L-lysine and laminin-coated dishes at a 
density of 5x106 cells per 60 mm dish or 1.5x107 cells per 100 mm dish. The N2 medium was 
exchanged 2 and 24 h after plating. For MeDIP-sequencing and hairpin BS-sequencing, cells 
were collected after 4 h in N2 medium. 
Complemented ES cell lines were derived by transfection of Tdg-/- ES cells with the 
complementation vectors pTCO2 TDG wt, pTCO2 TDGΔcat and empty pTCO2 (Cortazar et 
al., 2011) using jetPEI® (Polyplus Transfections) according to the manufacturer’s 
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recommendations. Cells were cultivated in ECM supplemented with 1.5 µg ml-1 puromycin to 
select stable clones. 
For the 24 h RA differentiation, complemented ES cells were cultured on Feeders for 2 
passages, then conditioned for 4 passages without Feeders in 2i medium (Neurobasal 
medium and DMEM/F-12 1:1, 1x N2 supplement, 1x B27 supplement, LIF (1’000 Uml-1), 
2 mM L-glutamine, 90 µM β-mercaptoethanol, 3 µM CHIR99021 and 1 µM PD0325901 
(University of Dundee) and 1x penicillin/streptomycin). Prior to RA differentiation, ESCs were 
seeded at suitable cell numbers for each time point onto two 140 mm dishes (for Chromatin 
and genomic DNA extraction) or two 30 mm dishes (for Protein and RNA extraction) in ECM. 
For differentiation, the medium was exchanged for ECM without LIF but supplemented with 
5 µM RA (5 mM stock in DMSO). Chromatin, genomic DNA were harvested at 0, 8 and 24 h, 
Protein and RNA at -16 h (2i control),  0, 4, 8 and 24 h. For the DMSO control for LCMSMS, 
ES cells were treated accordingly but incubated with DMSO 1:1’000 in ECM. 
If not indicated otherwise, cell culture components were obtained from Gibco® Life 
Technologies, chemicals from Sigma and LIF from Merck Millipore. 
 
MeDIP-Sequencing 
5 µg of DNA was sonicated giving fragment sizes <500bp. Fragments were end repaired, 
phosphorylated, 3’ adenylated and ligated to Illumina adapters in accordance with the 
Illumina Multiplex Sample Preparation protocol (PE-930-1001). These samples were then 
subjected to MeDIP as described previously (Weber et al., 2005), with 3 µg 5-mC antibody 
(Euogentec) per 1 µg DNA. The immunoprecipitated (IP) sample was purified using the DNA 
Clean & Concentrator™-5 kit (Zymo Research) according to the manufacturer’s instructions. 
The sample isolated by MeDIP then underwent gel electrophoresis and library size selection 
(150-200 bp), prior to PCR amplification using Illumina paired-end primers for 18 cycles. 
During this step, the libraries were tagged with a unique identifier, or index, as per Multiplex 
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Sample Preparation Oligonucleotide protocol (PE-400-1001). Libraries were quantified using 
an Agilent Bioanalyzer 2100. 
 
MeDIP-seq Data Analysis  
The generated MeDIP-seq data were analyzed using the computational pipeline MeDUSA 
(v1.0.0)(Wilson, 2012) and the MEDIPS (v1.0.0) R bioconductor package (Chavez et al., 
2010). MeDUSA comprises several analysis steps. Firstly, BWA (v0.5.8) (Li and Durbin, 
2009) was used to align the paired end sequence data to the reference mouse genome 
(Build mm9) using default settings. Filtering was performed to remove reads that were 
unable to be aligned as a viable pair and also those pairs in which neither read scored an 
alignment score of ≥ 10. In cases of non-unique reads, possibly caused by PCR artifacts, all 
but one pair was removed. Quality control was performed using the tool FastQC (v0.9.4) 
(http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/) and MEDIPS. The USeq (v6.8) suite 
of tools (Nix et al., 2008), specifically MultipleReplicaScanSeqs (MRSS) and 
EnrichedRegionMaker, were used to identify DMRs between cohorts. MRSS processes Point 
data for use in the BioConductor package DESeq (Anders and Huber, 2010). Window size 
was set at 500. Only regions containing a minimum of 10 reads summed from the cohorts 
being compared were included for DMR analysis. The dataset was initially described in 
(Wilson, 2012), and is available in the GEO repository (GSE27468). 
To determine the overlap between DMRs and other genomic features, the “operate on 
genomic intervals” tool of the Galaxy project was used (http://usegalaxy.org/; (Blankenberg et 
al., 2010; Giardine et al., 2005; Goecks et al., 2010). DMRs were intersected with promoters, 
defined as Ensembl TSS plus 1kb upstream and 0.5kb downstream, RNA-Pol II 
(GSM918749), p300 (GSM918750), H3K4me1 (GSM1000121), H3K27ac (GSM1000126), 
H3K4me3 (GSM769008) and H3K27me3 (GSM1000089) peaks for ES cells, generated by 
ENCODE/LICR (Dunham et al., 2012), as well as with CGI coordinates (Gardiner-Garden 
and Frommer, 1987) and LMRs (Stadler et al., 2011). TET1 binding sites (GSM706672) were 
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converted from mm8 to mm9 using liftOver (Kent et al., 2002) prior to intersection with the 
DMRs.  
 
Hairpin bisulfite deep sequencing for selected genomic regions 
The analysis was performed according to (Arand et al., 2012). Briefly, genomic DNA was 
digested with a restriction enzyme cutting in the selected DMRs, specified in Supplementary 
Table 1, followed by a ligation of a hairpin linker to link the upper to the lower strand. After 
bisulfite treatment the selected regions were amplified. Restriction enzymes and primers 
used in this analysis are given in Supplementary Table 2. The amplified products were 
sequenced by 454 sequencing. The sequencing data was then analyzed by BiQAnalyzerHT 
(Lutsik et al., 2011) for accurate alignment and methylation evaluation, followed by merging 
of the methylation information of the upper and lower strand using python scripts.  Average 
methylation, hemimethylation and mutation rates were calculated in Microsoft Excel. 
 
LCMSMS analysis of global C-modification levels 
Genomic DNA was enzymatically hydrolyzed to nucleosides essentially as described (Crain, 
1990), followed by addition of 3 volumes of methanol and centrifugation (16’000xg, 30 min, 
4°C). The supernatants were dried and dissolved in 50 µl 5% methanol in water (v/v) for 
LCMSMS analysis of the deoxynucleosides 5-hm(dC), 5-f(dC), 5-ca(dC), and 5-hm(dU). A 
portion of each sample was diluted for the quantification of 5-m(dC) and unmodified 
deoxynucleosides (dA, dC, dG, and dT). Chromatographic separation was performed on a 
Shimadzu Prominence HPLC system with a Zorbax SB-C18 2.1x150 mm i.d. (3.5 µm) 
column equipped with an Eclipse XDB-C8 2.1x12.5 mm i.d. (5 µm) guard column (Agilent 
Technologies). The mobile phase consisted of water and methanol (both supplemented with 
0.1% formic acid), for 5-m(dC), 5-hm(dC), 5-f(dC), and 5-ca(dC) starting with a 5 min 
gradient of 5-60% methanol, followed by 6 min re-equilibration with 5% methanol, and for 
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unmodified nucleosides maintained isocratically with 85% methanol. hm(dU) was gradient 
chromatographed with a mobile phase of only water and methanol. Mass spectrometry 
detection was performed using an MDS Sciex API5000 triple quadrupole (Applied 
Biosystems) operating in positive electrospray ionization mode for the mass transitions 
258.1/ 142.1 (5-hm(dC)), 256.1/ 140.1 (5-f(dC)), 272.1/ 156.1 (5-ca(dC)), 242.1/ 126.1 (5-
m(dC)), 252.1/136.1 (dA), 228.1/112.1 (dC), 268.1/152.1 (dG), and 243.1/127.1 (T), or 
negative electrospray ionization mode for the mass transitions 257.1/ 124.1, 257.1/ 141.1, 
and 257.1/ 214.1 (5-hm(dU), quantifier and qualifier ions). 
 
Purification of recombinant TDG 
See (Kunz et al., 2009), briefly, TDG wt and TDGΔcat were expressed from vectors pET28c-
mTDGa.0 and pET28c-mTDGa.1 as described. Cell lysis was carried out in NiNTA lysis 
buffer (50 mM Na-phosphate [pH 7.5], 500 mM NaCl, 20% glycerol, 0.1% Tween-20, 20 mM 
imidazole, 20 mM β-mercaptoethanol, 0.1 mM phenylmethylsulfonyl fluoride) by sonication 
followed by extract clarification. The clear supernatant was loaded onto a 5 ml HisTrap FF 
crude column (GE Healthcare), bound protein was eluted with 400 mM imidazole and 
dialyzed against Heparin buffer (25 mM Na-phosphate [pH 7.0], 250 mM NaCl, 20% glycerol, 
20 mM β-mercaptoethanol, 0.1 mM phenylmethylsulfonyl fluoride). The dialyzed fractions 
were loaded onto a 5 ml HiTrap Heparin HP column (GE Healthcare) and bound protein was 
eluted with a linear gradient of 250 mM – 1.5 M NaCl. For ion exchange, relevant fractions 
were pooled, dialyzed against AIEX buffer (50mM Bicine [pH 8.8], 25 mM NaCl, 20% 
glycerol, 20 mM β-mercaptoethanol, 0.11 mM phenylmethylsulfonyl fluoride) and loaded onto 
a 1 ml Resource Q column (GE Healthcare). Bound protein was eluted with a linear salt 
gradient of 25 mM – 1 M NaCl and purest fractions finally dialyzed against storage buffer 
(50 mM Tris-HCl [pH 8.0], 50 mM NaCl, 10% glycerol, 1 mM dithiothreitol), frozen on dry-ice 
and stored at -80°C. 
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Base release assay 
60-mer double-stranded oligonucleotide substrates containing different modifications were 
prepared by annealing of an unlabeled upper strand oligonucleotide (5‘-
TAGACATTGCCCTC 
GAGGTACCATGGATCCGATGTCGACCTCAAACCTAGACGAATTCCG-3‘) to a (5‘-
fluorescein-labeled lower oligonucleotide strand 5‘-F-
CGGAATTCGTCTAGGTTTGAGGTXGACATCGGATCCATGGTACCTCGAGGG 
CAATGTCTA-3‘, where X = T, 5mC, 5hmC or 5caC. 
Base release assays were carried out in a total volume of 20 µl containing 0.5 pmol of 
recombinant protein and 0.5 pmol of the labeled DNA substrate in 1x reaction buffer (50 mM 
Tris-HCl [pH 8.0], 1 mM EDTA, 1 mM DTT, 1 mg/ml BSA) for 15 min at 37°C. Generated AP-
sites were cleaved by the addition of NaOH to a final concentration of 100 mM and heating to 
99°C for 10 min. Subsequently, DNA was ethanol precipitated overnight at -20°C in 0.3 M 
Na-acetate (pH 5.2) and in the presence of 0.4 mg/ml carrier tRNA. The DNA was collected 
by centrifugation (20 min, 20‘000g, 4°C) and washed in 80% ethanol. Air-dried pellets were 
resuspended in loading buffer (1x TBE, 90% formamide), heated at 99°C for 5 min, and then 
immediately chilled on ice. Reaction products were separated on 15% denaturing 
polyacrylamide gels in 1x TBE. The fluorescein-labeled DNA was visualized with a Typhoon 
9400 (GE Healthcare) and quantified using the ImageQuant TL software (GE Healthcare). 
 
Electrophoretic mobility shift assay 
EMSAs were performed to measure the DNA-binding ability of wild-type and mutant TDG 
protein, using the double-stranded oligonucleotide substrates described above. Standard 
EMSA were carried out in a total reaction volume of 10 µl containing 2 pmol of recombinant 
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protein and 1 pmol of labeled DNA substrate with varying amounts of unlabeled competitor 
DNA in 1x reaction buffer (50 mM Tris-HCl [pH 8.0], 1 mM DTT, 5% glycerol, and 1 mM 
EDTA). After 15 min incubation at 37°C the reactions were loaded immediately onto 6% 
native polyacrylamide gels and separated in 0.5x TBE for 50 min at 100 V at room 
temperature. The fluorescein-labeled DNA was also visualized with a Typhoon 9400 (GE 
Healthcare) and quantified using the ImageQuant TL software (GE Healthcare). 
 
DNA Immunoprecipitation and GLIB 
Genomic DNA was prepared from cells by incubation in lysis buffer (20 mM Tris-HCl pH 8.0, 
4 mM EDTA, 20 mM NaCl, 1% SDS and 1 mg ml−1 proteinase K) at 55°C for 8-12 h and 
subsequent phenol/chloroform extraction and Na-acetate/ethanol precipitation. DNA pellets 
were resuspended in 10 mM Tris-HCl pH 8 and concentration was measured by absorbance 
at 260 nm. RNA was removed by incubation with 2.5 µg RNaseA per µg DNA for 30 min at 
37°C, followed by Na-acetate/ethanol precipitation. Quality of the DNA tested by standard 
agarose gel electrophoresis. 
5-mC and 5-caC were detected by MeDIP and caCDIP, performed essentially as described 
in (Weber et al., 2005). DNA was sonicated to yield fragments of 100-500bp followed by 
NaCl (400 mM)/ethanol precipitation in the presence of glycogen-carrier. 1 µg fragmented 
DNA in TE was denatured and incubated with 0,3 µg of monoclonal anti-5-methylcytidine or 
2 µg polyclonal anti-5-carboxylcytosine antibody (Supplementary Table 3) at 4°C for 2 h in 1x 
immunoprecipitation (IP) buffer (10 mM sodium phosphate pH 7.0, 140 mM NaCl, 0.05% 
Triton X-100). Immuno-complexes were precipitated by the addition of 20 µl M-280 sheep 
anti-mouse IgG antibody coupled Dynabeads (Invitrogen) and incubation at 4°C for 2 h 
followed by three washes in IP buffer. Bound material was treated with 250 µl proteinase K 
digestion buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 0.5% SDS and 0.25 mg ml−1 
proteinase K) at 50°C for 3 h. Immunoprecipitated methylated DNA was purified by 
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phenol/chloroform extraction followed by NaCl/ethanol precipitation and re-suspended in 
10 mM Tris-HCl pH 8.0.  
5-hmC containing DNA fragments were captured with the Hydroxymethyl Collector kit from 
Active Motif as described in the manufacturer’s instructions.  
qPCR analysis of sonicated genomic input DNA and Me/caCDIP/GLIB DNA with target 
specific primers (Supplementary Table 4) was performed using Quantitect SYBR Green 
(Qiagen) with a Rotor-Gene 3000 thermocycler (Qiagen). Statistical analysis was performed 
on Graphpad Prism Software. 
 
Chromatin Immunoprecipitation 
To crosslink protein-bound DNA, ES cells were incubated in 1% formaldehyde/PBS at room 
temperature. The reaction was quenched after 10 min by addition of glycine to a final 
concentration of 125 mM. After washing three times with ice cold PBS, cells were collected 
using a cell scraper and subsequent centrifugation at 600xg and 4 °C. Supernatant was 
discarded and the cells snap-frozen until further processing. After thawing on ice, nuclei were 
isolated by incubation in 400 µl of cold ChIP Lysis Buffer I (10 mM HEPES pH 6.5, 10 mM 
EDTA, 0.5 mM EGTA, 0.25% Triton X-100, 1 mM PMSF) for 5 min on ice followed by two 
incubations of 5 min on ice in 400 µl cold ChIP Lysis buffer II (10 mM HEPES pH 6.5, 10 mM 
EDTA, 0.5 mM EGTA, 200 mM NaCl, 1mM PMSF). All centrifugation steps were conducted 
at 600xg and 4°C for 5 min. Pelleted nuclei were lysed in 400 µl ChIP Lysis buffer III (50 mM 
Tris-HCl pH 8.0, 1 mM EDTA, 0.5% Triton X-100, 1% SDS, 1 mM PMSF) for 10 min on ice 
followed by sonication for 15 min (15 sec on, 30 sec off, power high) using a Bioruptor 
sonicator (Diagenode) to yield fragments of ~200-500 bp. The solution was cleared of 
remaining cell debris by centrifugation at 14’000xg and 4°C for 10 min. For ChIP of TDG and 
TET1, 150 µg of chromatin were diluted 1:10 in ChIP dilution buffer (50 mM Tris-HCl pH 8.0, 
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1 mM EDTA, 150 mM NaCl, 0.1% Triton X-100, 1x protease inhibitor cocktail, 1 mM PMSF). 
After removing 1% (volume) for input analysis, diluted chromatin was pre-cleared at 4°C for 
1 h with 30 µl of a 50% slurry of magnetic Protein G beads (Invitrogen) pre-blocked with 
1 mg ml−1 BSA and 1 mg ml−1 tRNA. Pre-cleared chromatin was incubated with 1-2 µg of the 
respective antibody (Supplementary Table 3) overnight at 4°C under slow rotation. Immuno-
complexes were precipitated with 40 µl of a 50% slurry of blocked Protein G beads and 
further incubated at 4°C for 2 h. Beads were then serially washed with 500 µl ChIP wash 
buffer I (20 mM Tris-HCl pH 8.0, 2 mM EDTA, 150 mM NaCl, 0.1% SDS, 1% Triton X-100), 
twice with 500 µl ChIP wash buffer II (20 mM Tris-HCl pH 8.0, 2 mM EDTA, 500 mM NaCl, 
0.1% SDS, 1% Triton X-100). After two additional washes with 500 µl TE buffer (10 mM Tris-
HCl pH 8.0, 1 mM EDTA), bound complexes were eluted by two sequential incubations with 
250 µl elution buffer (1% SDS, 0.1 M NaHCO3) at 65°C for 10 min shaking. Crosslink reversal 
of eluates and respective input samples was done in the presence of 200 mM NaCl at 65°C 
for 4 h followed by proteinase K digestion (50 µg ml−1) in the presence of 10 mM EDTA and 
40 mM Tris-HCl pH 6.5 at 45°C for 1 h. DNA was purified by phenol/chloroform extraction 
and NaCl/ethanol precipitation, and resuspended in 10 mM Tris-HCl pH 8.0. qPCR analysis 
with target specific primers (Supplementary Table 4) was performed using Quantitect SYBR 
Green (Qiagen) with a Rotor-Gene 3000 thermocycler (Qiagen). Statistical analysis was 
performed on Graphpad Prism Software.  
 
Western Blot analyses 
Denaturing protein extracts were prepared by washing the ES cells twice in cold PBS before 
addition of lysis buffer (50 mM Tris-HCl pH 7.5, 1% SDS, 5 mM DTT). The lysate was 
collected using a cell scraper and processed by two cycles of heating to 65°C and sonication 
for 5 min (15 sec on, 30 sec off, power high), followed by 10 min centrifugation at 20’000xg 
and 4°C. The concentration of the supernatant was estimated by a standard Bradfort assay 
by diluting the extract 1:800 in ddH2O before adding Bradfort reagent (final volume 1 ml). 
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40 µg of protein extract was separated on a 10% PAA gel (for AID) or a Mini-Protean pre-
cast gradient gel (BioRad) and transferred to a nitrocellulose membrane (Millipore). For 
TET1, TET2 and TDG, 10% methanol and 0.002% SDS were added to the transfer buffer 
(25 mM Tris, 192 mM Glycine), for AID no SDS but 20% methanol. Membranes were washed 
once with TBS-T (100 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.2% Tween-20), blocked with 
blocking buffer (TBS-T, 10% low fat dry milk) at room temperature for 1 h and incubated with 
the primary antibody at 33°C (anti-mTDG) or room temperature (anti-TET1, anti-TET2, anti-
AID, anti-DNMT3b, anti-β-actin) for 1 h in 7.5% dry milk/TBS-T. Dilutions were 1:10’000 for 
the rabbit anti-mTDG and the mouse anti-β-actin antibodies; 1:2’000 for the rabbit anti-TET1 
(Millipore) antibody; 1:500 for the monoclonal mouse anti-AID (gift by S.K. Petersen-Mahrt) 
and 1:100 for the monoclonal rat anti-TET2 antibody (gift by H. Leonhard). Washing steps 
after hybridization were once at 33°C and twice at room temperature for 15 min for anti-
mTDG, or three times at room temperature for 10 min for all other antibodies. Membranes 
were incubated with secondary HRP-conjugated antibodies diluted 1:5’000 (goat anti-rabbit 
and goat anti-mouse) or 1:20’000 (anti-rat) in 5% dry milk/TBS-T at room temperature for 1 h. 
After three washing steps of 10 min at room temperature, detection of the signals was 
performed using the WesternBright Quantum Chemiluminescent HRP Substrate (Advansta). 
 
Quantitative RT-PCR  
1 µg total RNA extracted with TRI Reagent (Sigma) was reverse transcribed with the 
RevertAidTM H Minus First Strand cDNA Synthesis Kit (Fermentas) according to the 
manufacturer’s protocol. qPCR with target specific primers (Supplementary Table 5) was 
performed using Rotor-Gene SYBR Green PCR mix with a Rotor-Gene 3000 thermocycler 
(Qiagen). Conditions for each target were validated by standard and melting curve analyses. 
Target-specific amplifications were normalized to the average of TBP, B2m and β-actin. Data 
of three independent experiments were analyzed by Anova to test for differences between 
genotypes. 
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Figure Legends 
 
Figure 1: Differentiated Tdg-/- cells accumulate aberrant methylation patterns. a) 
MeDIP-sequencing revealed an increasing number of differentially methylated regions 
(DMRs) arising with in vitro differentiation of Tdg+/- and Tdg-/- ES cells to neuronal 
progenitors. b) Volcano-plot of methylation fold change versus FDR-adjusted p-value (narrow 
peaks), CpG islands (CGIs) in red. 99% of the DMRs that overlap with a CGI are 
hypomethylated in knockout NPs, non-overlapping ones (other) are mostly hypermethylated. 
c) Overlap of CGIs hypomethylated in knockout versus wildtype with CGIs that become de 
novo methylated with differentiation; p<0.0001, Chi-square with Yates correction. 
Hypomethylation at these CGIs is caused by diminished differentiation-driven methylation. d) 
Overlap of broad peaks with published datasets. To test for enrichment or depletion of a 
feature in the hypomethylated CGIs, we compared the proportion of CGI DMRs overlapping 
(positive) or not overlapping (negative) with a feature to the analogous proportion within CGIs 
that were not differentially methylated. Percentages of CGIs overlapping (positive, grey) or 
not overlapping (negative, white). ** p<0.005; *** p<0.0001, Chi-square with Yates correction. 
 
Figure 2: Hairpin bisulfite-sequencing of representative CGI DMRs in NPs. Strand-
specific methylation (5-mC and 5-hmC) and mutation analysis of CGI DMRs, specified with 
characteristics in Supplementary Table 1, in Tdg knockout NPs complemented with wildtype 
TDG (wt), a catalytically dead mutant (TDGΔcat) or the empty complementation vector (ko). 
Insulin growth factor 2 (Igf2) served as a control (Arand et al., 2012). The bars indicate 
average percentage of fully methylated, hemi-methylated and mutated CpGs, the according 
numbers are presented in the tables. The heat maps display neighboring CpG dinucleotides, 
and each line represents one sequencing read. Catalytic activity of TDG is essential to 
establish methylation. Hypomethylation at these CGIs appears to not be caused by 
deamination of 5-mC, as the rate of C→T mutation is within the error rate of the method. 
 
Figure 3: Global levels of 5-mC and its derivates in a 24 h differentiation timecourse. 
a) Scheme of experimental setup. ES cells preconditioned in 2i medium were seeded in ESC 
medium (ECM) with LIF 14-16 h prior to differentiation, then transferred to ECM without LIF 
and with 5µM retinoic acid (RA). Samples were harvested at the indicated timepoints. b) 
LCMSMS analysis of global C-modification and 5-hmU levels in genomic DNA prepared at 0, 
8 and 24 h of differentiation. We observe a significant rise of the global levels of 5-mC, 5-fC 
and 5-caC with differentiation in knockout and TDG∆cat (for statistics see Fig. S3). Shown are 
Log2 fold changes compared to wildtype (mean with s.e.m.); statistical analysis was 
performed on absolute numbers (Fig. S3), asterisks indicate significant difference to the 
respective timepoint in wt, * p<0.05, **p<0.005, *** p<0.0001, one-way Anova. 
 
Figure 4: Targeted MeDIP, GLIB and caCDIP analysis of CGI DMRs. a) Relative 
enrichment (RE) of 5-mC (n=2) and 5-caC (n=3) normalized to a randomly chosen CpG-poor 
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region (neg.contr.). TDG and TDG∆cat accumulate 5-mC and 5-caC over time, 5-caC 
especially accumulates in TDG∆cat. Mean with s.e.m. Asterisk, significant difference of RE 
between 0 h and 24 h within a genotype, * p<0.05, one-way Anova. Statistical comparison of 
genotypes with regard to the log2-transformed 24 h versus 0 h fold change across targets: 
aggregated p-value < 0.0001. b) Biochemical analysis of TDG and TDGΔcat glycosylase 
activity on 5-mC derivates. Double-stranded 60mer oligonucleotide substrates containing a 
single T, 5-mC, 5-hmC or 5-caC on a fluorescence labeled strand were incubated with 
recombinant wildtype TDG or TDG∆cat. Glycosylase activity on the indicated substrates 
produces an abasic site which is converted to a single-strand break by heating under alkaline 
conditions, giving rise to a shorter fragment of 23 nt. Shown are reaction products separated 
on a denaturing polyacrylamide gel and quantification of 3 independent experiments (mean 
with standard deviation). c) Electrophoretic mobility shift assay with labeled 60mer 
oligonucleotides with the indicated modification (Substrate*), incubated with wildtype TDG or 
TDG∆cat and varying amounts of unlabeled competitor substrate containing an unmodified C 
or 5-caC. See also text. 
 
Figure 5: TET1 fails to stably associate with CGI DMRs during differentiation in 
absence of TDG activity. TET1-ChIP on chromatin prepared at 0, 8 or 24h of differentiation. 
a) Log2 fold changes of relative enrichment (RE) at 8 or 24 h versus the respective RE at 0 h 
(median with range). TET1 loses affinity to the CGI DMRs with ongoing differentiation in 
absence of TDG activity. For RE values and controls, refer to Fig. S5. Asterisks, significant 
difference between the genotypes with regard to their fold change versus 0h, *p<0.05, ** 
p<0.005, one-way Anova with Bonferroni post-test. b) TET1 and β-actin protein levels in SDS 
protein extracts detected by Western blot. c) TDG-ChIP, analogous to a. Log2 fold changes 
of relative enrichment (RE) versus the respective relative enrichment in TDG ko cells serving 
as a background control (median with range). TDGΔcat is enriched at CGI DMRs due to its 
high affinity to 5-caC present at these loci. Wildtype TDG is capable of rapid turnover on 5-
caC and appears to be associated very transiently with the CGI DMRs. For RE values and 
statistical analysis, refer to Fig. S6. d) TDG and β-actin protein levels in SDS protein extracts 
detected by Western blot. 
 
Figure 6: Model for a dual function of TDG in a differentiation-driven DNA methylation 
and demethylation cycle. At the onset of differentiation, a cycle of DNA methylation and 
demethylation is triggered. CpG methylation is catalyzed by Dnmts. 5-mC is oxidized by the 
TET proteins in a stepwise manner and the final products 5-fC/caC are excised by TDG (wt, 
top). With ongoing differentiation, the equilibrium of the different C-modifications is shifted 
towards 5-mC, evident as CGI de novo methylation in early NPs (“normal methylation”). We 
propose that apart from its active function in catalyzing the final step of demethylation TDG 
additionally provides a structural scaffold to allow the recruitment of the key factors involved. 
In absence of TDG, initiation of the cycle fails or stops immediately after initiation (Tdg ko, 
middle), resulting in lower methylation levels in ko NPs than in wt NPs (“hypomethylation”). 
TDGΔcat on the other hand provides the scaffold for assembly and coordination of the different 
steps of the cycle but upon binding to 5-caC fails to turn over (bottom). The lacking catalytic 
activity of TDG leads to the accumulation of 5-caC which is bound with high affinity by 
TDG∆cat. As the cycle fails to proceed, TET1 association is destabilized. Removal of 5-caC by 
dilution through DNA replication eventually leads to the hypomethylation observed in NPs. 
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Supplementary Figure Legends 
 
Figure S1: Characterization of NP DMRs 
a) In vitro differentiation of Tdg+/- and Tdg-/- ES cells to neuronal progenitors; Tdg-/- cells 
rapidly lose viability at later stages of NP differentiation (24-48h). b) DMRs that are 
hypomethylated in knockout NPs are associated with higher CpG density, whereas CpG poor 
DMRs are almost exclusively hypermethylated; CpG density and methylation fold change 
refer to narrow peaks. c) Density plot of the log10 distance of hypo- or hypomethylated NP 
DMRs (center of broad peaks) to the nearest TSS (Ensembl), **p<0.005, Mann-Whitney T-
test on average of distances (linear). d) Promoter-association of hypo- versus 
hypermethylated NP DMRs (broad peaks). e) CGI DMRs (hypo) or not differentially 
methylated CGIs (all) overlapping (positive) or not overlapping (negative) with sites of binding 
or enrichment of the indicated factor. ** p<0.005; *** p<0.0001, Chi-square with Yates 
correction. 
 
Figure S2: mRNA and protein levels in a 24h differentiation timecourse. a) mRNA levels 
of the pluripotency markers Oct4, Nanog and Rex1, and the differentiation-induced 
transcription factor Gata6, detected by qRT-PCR, confirm loss of pluripotency within 24h of 
differentiation. All three cell lines appear to differentiate with similar efficiency. TET1 mRNA 
levels decrease towards 24h but protein levels remain stable throughout this time window 
and are equal between cell lines (Fig.6b). mRNA levels were normalized to the average of 
TBP, B2m and β-actin. b) TET2 mRNA and protein levels, detected by qRT-PCR and 
Western blot, respectively, show no differences between the cell lines. Note that mRNA 
levels of TET2 are 5-10 times lower than those of TET1. c) mRNA and protein levels of AID. 
AID mRNA levels are extremely low and protein levels are below the detection limit of 
Western blot. Activated B-cells served as a positive control for detection of AID in Western 
blot. Shown are means with s.e.m.; statistical analysis by one-way Anova revealed no 
significant differences across genotypes. 
 
Figure S3: Global C-modification levels measured by LCMSMS at 0, 8 and 24h of 
differentiation. a) Absolute numbers per 106 unmodified nucleotides. b) 5-mC levels 
decrease with culturing in 2i medium. Without 2i, n=1, with 2i n=3. c) Control for unspecific 
effects, 0h or 24h incubation with DMSO; n=2. DMSO does not induce any significant change 
of C-modification levels. Error bars, s.e.m.; statistical test between time points, * p<0.05, ** 
p<0.005, *** p<0.0001, Anova. 
 
Figure S4: Targeted analysis of 5-mC, 5-caC and 5-hmC at CGI DMRs. a) 5-mC and 
5-caC proportions of the sum of both average RE. In Tdg∆cat the equilibrium of 5-mC and 5-
caC is tipped towards 5-caC upon differentiation. 
 
Figure S5: TET1-association at CGI DMRs. Relative enrichment normalized to a randomly 
chosen CpG-poor region (neg.contr.). Bars indicate the mean, error bars the s.e.m. The 
promoter regions of Oct4, Nanog and HoxA10 served as control regions. See also Fig.7. 
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Figure S6: TDG-association at CGI DMRs. Relative enrichment normalized to a random 
CpG-poor region (neg.contr.). Bars indicate the mean, error bars the s.e.m. The promoter 
regions of Oct4, Nanog and HoxA10 served as control regions. Statistical analysis, two-way 
Anova: genotypes significantly different, 3 p<0.05, ** p<0.005. See also Fig.8. 
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Supplementary Tables 
 
 
 
Supplementary Table 1: Targets of hairpin BS-seq with characteristics 
DMR genic/intergenic gene CGI genomic features NP vs ES 
8 5' exon Tbx3 weak TET1 hyper 
9 intron Kdm2b strong TET1, H3K4me1, H3K4me3, NP-LMR hyper 
10 3' exon Zfp282 strong TET1, H3K4me1, H3K4me3 hyper 
36 intron Gm5089 strong TET1, H3K4me1, H3K4me3, NP-LMR hyper 
39 5' exon Ldoc1l strong TET1, H3K4me1, H3K4me3, NP-LMR hyper 
49 intergenic  ------ strong TET1, H3K4me1, H3K4me3, NP-LMR hyper 
54 exon Mgat4b strong CTCF, H3K4me1, H3K4me3, NP-LMR hyper 
 
 
 
Supplementary Table 2: Enzymes and primers used in hairpin BS-sequencing 
DMR restriction enzyme Primer sequences 
8 MspI F GATAAGGATATTGAGTTAGAGGA 
  
R AAAAACACTAAACCAAAAAAC 
9 TaqI F TTTTAGGAGATATAAAGAATAGTTT 
  
R AAAAACACAAAAAACAACTC 
10 PstI F AGAAGAGTTTTAATTGTTATTTTGG 
  
R AAACTTCAACTACCACTCTAACC 
36 BamHI F TTTGATATTTTTTTTTAGTTTT 
  
R CCTAACACTTTCTCTTAATTT 
39 TaqI F GGATGTAGGTATTGATTAT 
  
R ACCTACCAAACTTTACAA 
49 TaqI F GTGTATAGTTGGGTTTGTAGTG 
  
R TAAAAAACTAAAATATCCCCTC 
54 MspI F TAGGATTGTGTTGTTTTTAGATTT 
  
R CACCTATACCTTTCTCAACCA 
Igf2 according to (Arand et al. 2012).   
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Supplementary Table 3: Antibodies used in this study 
Antibody Product Nr. Manufacturer 
Anti-5mC monoclonal antibody 33D3 Mab-081-100 Diagenode 
Anti-5-Carboxylcytosine antibody 61225 Active Motif 
Anti-Methylcytosine dioxygenase TET1 antibody 09-872 Millipore 
Anti-β-actin monoclonal ab8226 Abcam 
Anti-TET2 monoclonal  H. Leonhard 
Anti-AID monoclonal 4.26.1  S.K. Petersen-
Mahrt 
Anti-Dnmt3b ab2851 Abcam 
Anti-TDG L58 polyclonal  our laboratory 
Anti-mouse Ig (horse radish peroxidase linked)  NXA931 GE Healthcare 
ECL™ Anti-rabbit IgG (HRP linked) NA934V GE Healthcare 
Anti-rat Ig (HRP linked) A9037-1ML Sigma 
 
The anti-TDG antibody used for ChIP was produced and affinity purified in our lab, for further 
information see (Neddermann et al. 1996; Hardeland et al. 2002). 
 
 
 
 
Supplementary Table 4: Primers used in ChIP, MeDIP, GLIB and caCDIP qPCR 
Primer 5’-3’ sequence 
neg. contr. F AGC ACA GCC TGA AGC CTC TA 
neg. contr. R ACA CAG CAT GGC ATC TTG AA 
DMR 54 F ACCCAGCAAAATCTCACCTG 
DMR 54 R GACACTGGACAGGGCTCCA 
DMR 39 F GAGCTGGATAGCCCTTGTAGAATG 
DMR 39 R TTGGCAGCGGAGGGAGCAG 
DMR 8 F CTGGCCACAGCTTTACCATC 
DMR 8 R AAGGACACTGAGCCAGAGGA 
DMR 49 F GCTGGGTTTGTAGTGGGAAC 
DMR 49 R GCAGGACCACACCTCACATC 
Nanog P_2 F GAGGATGCCCCCTAAGCTTTCCCTCCC 
Nanog P_2 R CCTCCTACCCTACCCACCCCCTATTCTCCC 
Oct4_PP F GTGAGGTGTCGGTGACCCAAGGCAG 
Oct4_PP R GGCGAGCGCTATCTGCCTGTGTC 
pHoxA10_T1 F CACTCCCAGTTTGGTTTCGT 
pHoxA10_T1 
R 
GGGGGTACAGGTTCAAGAGC 
F forward primer; R reverse primer. 
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Supplementary Table 5: Primers used in quantitative RT-PCR  
Primer 5’-3’ sequence 
AID RT fw TTC GGC GCA TCC TTT TGC CCT 
AID RT rev GGC GGT CCT GTG CAG CTC AA 
β-actin RT fw CGT CGA CAA CGG CTC CGG CAT 
β-actin RT rev CCA CCA TCA CAC CCT GGT GCC TAG 
G 
B2m RT fw TCA CGC CAC CCA CCG GAG AA 
B2m RT rev TCT CGA TCC CAG TAG ACG GTC TTG 
G 
Gata6 RT fw TCG AAA CGC CGG TGC TCC AC 
Gata6 RT rev CCG TGA TGA AGG CAC GCG CT 
Nanog RT fw CCT TCC CTC GCC ATC ACA CTG ACA 
Nanog RT rev GAG GAA GGG CGA GGA GAG GCA GC 
Oct4 RT fw GTC CCC CAA GTT GGC GTG GAG 
Oct4 RT rev CAT GTC CTG GGA CTC CTC GGG AG 
Rex1 RT fw GGA CTA AGA GCT GGG ACA CG 
Rex1 RT rev TCC TGC TTT TTG GTC AGT GGT 
TBP RT fw CCT AAA GAC CAT TGC ACT TCG TG 
TBP RT rev ACT GAA AAT CAA CGC AGT TGT CC 
TET1 RT fw ACA CAC CTT GGG GCA GGA CCA 
TET1 RT rev TCT GAT CAC CCA CTT GGC GAC C 
TET2 RT fw GGA AGC AAG ATG GCT GCC CTG TA 
TET2 RT rev GAA TGA ATC CAG CAG CAC CGT CCC 
 
 
Arand, J., et al. (2012). "In vivo control of CpG and non-CpG DNA methylation by DNA 
methyltransferases." PLoS Genet 8(6): e1002750. 
Hardeland, U., et al. (2002). "Modification of the human thymine-DNA glycosylase by 
ubiquitin-like proteins facilitates enzymatic turnover." EMBO J 21(6): 1456-1464. 
Neddermann, P., et al. (1996). "Cloning and expression of human G/T mismatch-specific 
thymine-DNA glycosylase." J Biol Chem 271(22): 12767-12774. 
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Abstract 
The establishment of developmental stage-specific gene expression programs is 
crucial for successful mammalian development. DNA methylation and demethylation 
processes play an important role in this context, and involve, besides DNA 
methyltransferases, TET proteins and the DNA glycosylase TDG that oxidize and 
excise 5-methylcytosine from the DNA. We performed ChIP-seq experiments to 
investigate the engagement and co-operation of these factors in mouse embryonic 
stem cells undergoing differentiation. We found TDG to localize with high preference 
to gene regulatory elements, including transcriptional start sites and enhancers, as 
well as to CpG islands (CGIs). TET1, TET2 and TDG co-operate in a locus-specific 
manner. They preferentially co-localize at genomic regions showing increased levels 
of DNA demethylation intermediates, a bivalent chromatin environment and an 
enrichment of the dynamic histone variants H3.3 and H2A.Z. These sites 
predominantly represent gene regulatory elements associated with developmental 
genes, including CGIs. A large fraction of TDG peaks is not co-occupied by TET 
proteins. These regions are depleted of CGIs as well as low-methylated regions 
(LMRs), contain less activating and bivalent chromatin marks, and show lower co-
occupancy with DNA demethylation intermediates and with the dynamic histone 
variants H3.3 and H2A.Z, indicating reduced nucleosomal dynamics. Based on our 
results, we propose a mechanistic model where TDG associates with regulatory 
elements of developmental genes to promote epigenetic plasticity required in 
programming of cell identity. It does so together with TET1 and TET2 by oxidation 
and excision of 5mC, thereby generating DNA single-strand breaks that trigger 
changes in nucleosomal dynamics. 
 
Introduction  
The spatio-temporally accurate establishment of DNA methylation patterns plays a 
crucial role in transcriptional regulation, embryonic development, cell lineage 
commitment and other vital biological processes (Kraushaar and Zhao, 2013). DNA 
methylation is catalyzed by DNA methyltransferases (DNMTs). In mammals this 
occurs predominantly in CpG dinucleotide sequences (Klose and Bird, 2006). 
Genome-wide analysis of the distribution of DNA methylation in differentiated cells 
  Appendix II 
 
2 
 
revealed that the bulk genome is highly methylated, whereas certain islands of CpG-
rich regions remain unmethylated. These unmethylated regions often overlap with 
transcription start sites (TSS) and are known as CpG-islands (CGIs; (Illingworth et 
al., 2010)). There are two events of epigenetic reprogramming which involve global 
DNA demethylation; the first takes place in pre-implantation embryos to set up 
pluripotency and the second in migrating primordial germ cells to erase parental-
specific imprints (Hajkova et al., 2002; Mayer et al., 2000). Mechanisms and 
pathways underlying DNA demethylation have been subject of intense research, and 
there seem to occur both passive and active mechanisms. One emerging concept for 
active DNA demethylation entails a multi-step process involving the enzymatic 
oxidation and excision repair of 5-methylcytosine (5mC). This is achieved by a 
concerted action of Tet dioxygenases (TET1/2/3) that iteratively oxidize 5mC to 5-
hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC; 
(Ito et al., 2011; Pastor et al., 2013; Tahiliani et al., 2009)), and the Thymine DNA 
Glycosylase (TDG), which excises 5fC and 5caC from the DNA and thereby initiates 
the replacement of the modified with an unmodified C by repair synthesis (He et al., 
2011; Maiti et al., 2013). Consistent with a role of non-canonical, TDG-dependent 
DNA repair in DNA methylation control, we and others showed previously that 
homozygous Tdg knockout mice display developmental failure associated with 
aberrant epigenetic programming of developmental gene promoters (Cortazar et al., 
2011; Cortellino et al., 2011; Jacobs and Schar, 2012; Saito et al., 2012). 
Intermediates of oxidative DNA demethylation may have epigenetic functions, 
particularly 5hmC, which was proposed to play a role in ES cell fate, regulation of 
gene expression and neurodevelopment (Ito et al., 2010; Kriaucionis and Heintz, 
2009; Szulwach et al., 2011). How the transition from 5mC to 5hmC and finally 5caC 
is controlled, is currently not known; one possibility constitutes the differential 
engagement of TET and TDG proteins. 
Genome-wide analyses showed that TET1 and TET2 associate with chromatin in a 
non-random but targeted manner. Gene bodies, transcription start sites (TSS) and 
enhancers are preferred sites of interaction for TET1; however, TET1 binding does 
not predict transcriptional activity of a TSS (active, poised, inactive), but it might be 
an early event of enhancer activation (Serandour et al., 2012; Williams et al., 2011). 
There is less evidence available for genome-wide TET2 association, however, it 
appears that TET2 also preferentially interacts with TSS and gene bodies (Chen et 
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al., 2013b). Loss of TET2 causes a decrease of 5hmC predominantly in gene bodies 
and at the boundaries of highly expressed exons (Huang et al., 2014). There appear 
to be differential patterns of TET protein association and their oxidation products, 
relating to chromatin state and transcriptional activity. For instance, 5hmC is 
generally more enriched in exons and active enhancers compared to introns and 
poised enhancers, respectively (Neri et al., 2013). In mouse embryonic stem cells 
(ESCs) a fraction of TET1 is centered around the TSS of target genes enriched only 
for H3K4 trimethylation (H3K4me3) marks while another fraction is centered 
downstream of the TSS together with the bivalent histone marks H3K4me3 and 
H3K27me3. Also, TET proteins have been reported to associate with histone 
modifying enzymes; TET1 was shown to form a complex with the suppressor of zeste 
12 (SUZ12), a component of the Polycomb repressive complex 2 (PRC2; (Neri et al., 
2013; Wu et al., 2011)). Furthermore, TET1 interacts with SIN3a, a transcriptional co-
repressor (Williams et al., 2011). Consistently, at H3K27me3-negative gene 
promoters, TET1 enrichment coincides with SIN3a enrichment whereas at 
H3K27me3-marked genes, TET1 appears bimodally distributed showing overlaps 
with SIN3a at the TSS and with SUZ12 downstream of the TSS (Neri et al., 2013). 
TET2 was shown to interact with the O-linked β-N-acetylglucosamine transferase 
(OGT), which glycosylates the canonical histones H2B, H3 and H4, thereby 
regulating transcription (Chen et al., 2013b; Deplus et al., 2013; Vella et al., 2013; 
Zentner and Henikoff, 2013). Importantly, the target genes for TET proteins in ESCs 
are prevalently associated with cell morphogenesis, (neural) development and 
differentiation (Raiber et al., 2012; Stadler et al., 2011; Williams et al., 2011). At the 
same time, gene ontology analysis revealed exactly these processes as 
predominantly impaired upon the knock-out of TDG (Cortazar et al., 2011). Similar to 
the TET proteins, TDG was shown to physically and functionally interact with 
chromatin associating and modulating proteins, including transcription factors such 
as retinoid- and estrogen-receptors (Chen et al., 2003; Kim and Um, 2008; Missero et 
al., 2001; Um et al., 1998), the histone acetyl transferase CBP/p300, and the de novo 
DNA methyltransferases DNMT3A and DNMT3B (Boland and Christman, 2008; Li et 
al., 2007; Tini et al., 2002). However, genome-wide analysis of chromatin association 
has not been reported for TDG. 
The accumulation of the DNA demethylation intermediates 5fC and 5caC at proximal 
and distal gene regulatory elements indicates that the TET proteins may engage at 
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these loci to induce DNA demethylation and hence facilitate gene expression (Raiber 
et al., 2012; Shen et al., 2013; Song et al., 2013). However, since not all TET-bound 
sites become DNA demethylated, it can be envisioned that the TET proteins and 
TDG operate at these regulatory elements as well as in gene bodies in different 
ways, either to fully demethylate or to generate 5hmC, which might serve as an 
epigenetic mark itself. The quick and dynamic adaptation of gene expression 
programs to developmental clues is of particular importance for pluripotent cells. 
ESCs therefore maintain gene regulatory regions, such as promoters and enhancers, 
in a state of epigenetic plasticity. At promoters, bivalent chromatin domains (marked 
by H3K4me3 and H3K27me3) can be instructed to become constitutively active or 
silent in the context of lineage restriction (Aloia et al., 2013); similarly, enhancers 
become additionally marked by H3K27ac besides H3K4me1 upon activation 
(Creyghton et al., 2010; Zhu et al., 2013). Interestingly, gene promoters in a bivalent 
chromatin state usually have RNA polymerase II bound in a stalled configuration, 
thus, indicating that they are poised for transcription (Brookes et al., 2012). The 
histone variants H3.3 and H2A.Z were also reported to be highly enriched at gene 
regulatory regions like promoters and enhancers, where they display high turnover 
(Barski et al., 2007; Chen et al., 2013a; Kraushaar et al., 2013). Interestingly, H3.3 
and H2A.Z preferentially associate in conjunction with each other in nucleosomes 
(Yukawa et al., 2014). Notably, H3.3 was suggested to serve as a chromatin 
bookmark to promote transcription recovery after genotoxic stress (Adam et al., 
2013), consistent with a reported interaction of the H3.3-specific chaperone HIRA 
with the RNA Polymerase II (Ray-Gallet et al., 2011). The transient occupancy of 
H3.3 and H2A.Z at gene promoters and enhancers implicates a general role in gene 
regulation (Henikoff, 2009). This, together with the finding of highly dynamic DNA 
methylation and demethylation at actively transcribed promoters (Kangaspeska et al., 
2008; Metivier et al., 2008) suggests that DNA oxidation and excision repair mediated 
DNA demethylation promotes chromatin dynamics required to maintain 
transcriptional plasticity in differentiating cells. The evolution of a targeted mechanism 
to regulate DNA methylation and demethylation at gene regulatory elements thus 
appears logical. Such a system would ideally target further chromatin modifying 
proteins and transcriptional co-factors to facilitate the silencing of certain genes and 
the initiation of transcription at others. How the targeting of e.g. TET proteins and 
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TDG is orchestrated is not known to date, further, it is unclear how the accompanying 
changes in chromatin are induced.  
To address whether and how TET1, TET2 and TDG chromatin association is 
coordinated in differentiating mouse ESCs and whether differential occupancy can 
account for differential patterns of 5mC oxidation and nucleosomal composition, we 
set out to perform comprehensive TET1-, TET2-, and TDG-ChIP-seq analyses in 
mESC, generating the first chromatin association profiles for wildtype and catalytic-
dead TDG in mESCs. We investigated genomic and chromatin features determining 
the enrichment of TET and TDG to refine the understanding of the respective 
functional interactions. We found that TDG preferentially associates with a chromatin 
environment, which is either bivalent or marked by the characteristic histone marks of 
enhancers. Furthermore, we found that the common peaks for TET1, TET2 and TDG 
are characterized by elevated levels of DNA demethylation intermediates as well as 
dynamic histone variants.  
 
Results 
To elucidate genome-wide chromatin association patterns for TDG, and correlate 
these with TET1 and TET2 occupancy, we performed chromatin immunoprecipitation 
followed by deep-sequencing (ChIP-seq) analyses for all proteins. As a cell model, 
we used TDG-deficient mouse embryonic stem cells (mESCs), complemented with 
TDG minigenes expressing either a wildtype TDG or a catalytically inactive variant 
(N151A) or the empty vector (Tdg[wt], [cat] and [null], respectively; (Cortazar et al., 
2011)). Since TDG function becomes apparent in differentiating mESCs rather than 
in the pluripotent state (Jacobs et al., manuscript in preparation, 2014), and because 
TDG ChIP from pluripotent mESCs was inefficient and highly variable (data not 
shown), we performed our experiments with mESCs preconditioned in 2i medium and 
then subjected to a short differentiation for 24 hours induced by all-trans retinoic acid 
(RA). Importantly, TDG, TET1 and TET2 are present both in mESCs before and after 
RA exposure (Supplementary Figure 1). With this experimental setup, we generated 
ChIP-seq datasets for TDG from Tdg[wt] and Tdg[cat] mESCs, and for TET1 and 
TET2 from Tdg[wt], Tdg[cat] and Tdg[null] mESCs. For the TET proteins, we also 
performed ChIP-seq before RA exposure of the cells. 
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ChIP-seq analysis reveals a predominant association of TDG with transcription 
start sites as well as with intergenic regions 
We then focused our analyses on the datasets obtained from mESCs at 24h RA. 
Peak calling for the TDG ChIP-seq data (MACS) first confirmed a good reproducibility 
of TDG enrichments in two independent experiments with Tdg[cat] mESCs (R = 0.85; 
Supplementary Figure 2). Further analyses identified a total of 14’144 sites in Tdg[wt] 
and 28’164 sites in Tdg[cat] mESC showing a higher than 2 fold enrichment (log2>1). 
Notably, only a small fraction of peaks in the two datasets overlapped; 21.6% of 
Tdg[wt] peaks are also present in Tdg[cat] and the correlation between the two was 
negative (R = -0.3; Figure 1a). This discrepancy may be explained by the different 
enzymatic properties of the wildtype and catalytic-dead TDG. While the wildtype TDG 
will excise a substrate base, i.e. 5fC or 5caC, and dissociate to give way for excision 
repair, the catalytic-dead enzyme will bind but fail to dissociate und turn over due to 
its inability to excise the base ((Hardeland et al., 2000; Waters and Swann, 1998) and 
Jacobs et al., manuscript in preparation, 2014). Hence, the catalytic-dead TDG will 
be caught at sites accumulating unprocessed substrate and, thus, more efficiently 
cross-link in ChIP. Given this, the higher number of peaks in Tdg[cat] compared to 
Tdg[wt] is expected and it seems likely that peaks showing up with the catalytic-dead 
TDG only are bound by the wildtype protein as well but, due to its higher turnover, 
are not detectable under the ChIP conditions applied. On the other hand, peaks 
appearing only with the wildtype TDG may reflect the limited dynamic capacity of the 
catalytic-dead TDG, which would affect the re-localization of TDG to newly activated 
sites of 5fC and 5caC generation in the course of ESC differentiation. 
To proceed in an unbiased way, we kept Tdg[wt] and Tdg[cat] peaks separate in all 
subsequent analyses. Both, wildtype and catalytic-dead TDG showed a similar 
bimodal distribution with regard to their distance to the nearest transcriptional start 
site (TSS; RefSeq; Figure 1b), one distinct fraction of peaks showing in a narrow 
window encompassing the TSS and a second located roughly between 1 kb and 
1000 kb away from the TSS. Consistent with this distribution pattern, most TDG 
peaks in both Tdg[wt] and Tdg[cat] were located in introns (41.4 % and 42.4%, 
respectively) and intergenic region (45.4% and 44.2%, respectively; Figure 1c). Less 
than 10% of TDG peaks were located in coding sequences (7.5% and 8.0%, 
respectively) and less than 5% were located in 5’ (4.1% and 3.1%, respectively) and 
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3’ untranslated regions (1.8% and 2.4%, respectively). Addressing the DNA 
sequence context, we found a preferential association of TDG with an intermediate 
CpG density, both in Tdg[wt] and Tdg[cat]. Nevertheless, we found a significant 
enrichment of CGIs within the TDG peaks (in Tdg[wt] and Tdg[cat]) compared to the 
overall genome (Figure 1d), supporting the notion that TDG associates to key sites 
for gene regulation. Figure 1e depicts the HoxD cluster as an example (Genome 
Browser). Altogether, these chromatin association patterns of both wildtype and 
catalytic-dead TDG could reflect a role in the regulation of transcription, both at the 
TSS and at distal regulatory elements, or in co-transcriptional processes. 
 
TDG preferentially associates with DNAse I hypersensitive sites and chromatin 
marked by active histone marks, RNA Polymerase II and dynamic nucleosomes  
We showed before that differentiating TDG-deficient mESCs accumulate aberrant 
DNA methylation and histone modifications at CG-rich promoters of developmental 
genes (Cortazar et al., 2011). To decipher the chromatin environment disposing for 
TDG association, we investigated the coincidence of TDG peaks with distinct 
chromatin features, including histone modifications and nucleosome composition, 
and functional genomic elements implicated by DNAse I hypersensitive sites or 
CTCF, p300 and RNA Polymerase II occupancy (Figure 2 and Supplementary Figure 
5). This revealed very high enrichments for specific features in both Tdg[wt] and 
Tdg[cat] peaks when compared to the overall genome. Regarding genomic elements, 
the enrichment was most significant for DNAse I hypersensitive sites (7.5 and 6.9 fold 
in Tdg[wt] and Tdg[cat], respectively) and RNA Pol II occupancy (9.8 and 5.6 fold, 
respectively), whereas p300 and CTCF binding sites were less prominently enriched. 
This indicated that TDG primarily occupies genomic regions characterized by low 
nucleosome occupancy and associated with transcription. Regarding repressive 
chromatin features, the H3K27me3 polycomb mark showed the highest enrichment in 
Tdg[wt] and Tdg[cat] peaks (14.3 and 9.0 fold, respectively), whereas the H3K9me3 
heterochromatin mark showed little co-occupancy (1.2 and 1.7 fold, respectively; 
Figure 2b, Supplementary Figure 5b). This clearly associated TDG with the polycomb 
repressive system, consistent with its role in maintaining developmental genes in a 
poised state. Histone marks associated with active transcription, i.e. H3K4me3, 
H3K36me3 and H3K9ac, were all enriched in Tdg[wt] and Tdg[cat] peaks, although 
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this was more prominent for H3K4me3 and H3K9ac (7.3 to 10.2 fold enrichments) 
than for the transcriptional elongation mark H3K36me3 (1.8 to 2.3 fold enrichments; 
Figure 2c, Supplementary Figure 5c). Notably, strong enrichments were also 
apparent for the characteristic enhancer marks H3K4me1 (3.4 to 5.6 fold 
enrichments) and H3K27ac (3.4 to 4.4 fold enrichments). When we combined the 
latter with DNAse I hypersensitivity to interrogate the chromatin environment of active 
enhancers (Thurman et al., 2012), we again found a significantly enriched occurrence 
of these in Tdg[wt] and Tdg[cat] peaks. The Low-methylated regions (LMRs), which 
represent a further distinct class of distal gene regulatory elements, were only 
moderately enriched within the TDG peaks, both in Tdg[wt] and Tdg[cat] (1.2 and 2.7 
fold enrichment, respectively; Figure 2d, Supplementary Figure 5d). LMRs are 
characterized by a lower CpG content and reduced length compared to CGIs and 
they are occupied by DNA-binding factors in a cell-type-specific manner (Stadler et 
al., 2011). Furthermore, we found a significant enrichment of the dynamic histone 
variants H3.3 and H2A.Z in the Tdg[wt] and Tdg[cat] peaks. Enrichment was 
particularly high for H2A.Z (10.6 to 12.7 fold enrichment, for Tdg[wt] and Tdg[cat], 
respectively), further strengthening the link to gene regulatory elements (Figure 2e, 
Supplementary Figure 5e). We conclude from these results that TDG preferentially 
localizes to DNAse I hypersensitive sites which are further characterized by presence 
of RNA Polymerase II and dynamic histone variants. These sites are marked by 
histone modifications which are indicative of gene regulatory elements, as for 
instance found at active and bivalent gene promoters as well as enhancers. 
Contrarily, we do not observe an enrichment of TDG at genomic sites which are 
characterized by heterochromatic histone marks. 
 
A substantial fraction of TDG peaks is co-occupied by the TET proteins and 
these sites are significantly enriched for CGIs 
We next explored the coincidence of chromatin associations of TDG, TET1 and 
TET2. Thus, after peak calling from the TET1 and TET2 ChIP-seq datasets (MACS; 
Supplementary Figures 3 and 4) we asked how many TDG peaks (Tdg[wt] and 
Tdg[cat]) are co-occupied by TET1 or TET2 in Tdg[wt] ESCs (showing a higher than 
2 fold enrichment; log2>1). Overall, we found TET1 and TET2 peaks to be 
significantly enriched in regions of Tdg[wt] and Tdg[cat] chromatin association in 
  Appendix II 
 
9 
 
mESC (Figure 3a), the co-occupancy being more pronounced for TET1 than for 
TET2 (37.7% versus 10.2% in Tdg[wt], respectively). Notably, the co-occupancy of 
TDG with TET1 and TET2 is higher in Tdg[wt] compared to Tdg[cat] mESC, 
indicating that the catalytic activity of TDG facilitates TET binding. Next, we examined 
the mutual co-occupancies of all three proteins, intersecting the TDG peaks obtained 
for Tdg[wt] and Tdg[cat] with TET1 and TET2 peaks obtained from the Tdg[wt] 
background (Figure 3b). Of all TDG peaks in Tdg[wt], 67% were uniquely bound by 
TDG, 24% were additionally bound by TET1, 4% by TET2, and 5% were triple-
positive. Similarly, of all TDG peaks in Tdg[cat], 66% were uniquely bound by TDG, 
30% were additionally bound by TET1, 1% by TET2 and 3% were triple-positive. It is 
fair to assume that the fractions of unique, double- or triple-positive peaks reflect 
different functional engagements of TDG alone or together with TET1 and/or TET2. 
Notably, only a minor fraction of TDG-TET1 peaks is additionally associated with 
TET2, but a major fraction of TDG-TET2 peaks is additionally bound by TET1. 
Hence, if TET2 associates with TDG it does so mainly together with TET1, whereas 
TET1 and TDG appear to form an independent functional unit. There are also 
considerable differences in the genomic locations of these two distinct pools: While 
more than 32% of triple-positive peaks both in Tdg[wt] and Tdg[cat] mESC coincide 
with CGIs, less than 3.1 % of unique TDG peaks do so. By contrast, triple-positive 
and unique TDG peaks associate equally with active enhancers, both in Tdg[wt] 
(1.1% and 1.5%, respectively) and in Tdg[cat] mESCs (1.8% and 7.1%, respectively; 
Figure 3c). Furthermore, we found a significant fraction of triple-positive peaks in 
Tdg[wt] and Tdg[cat] (14.1% and 18.2%, respectively) to overlap with LMRs, as 
identified by Bis-seq ((Stadler et al., 2011); Figure 3d).  
We then addressed potential differences in the molecular and cellular functions 
associated with the TET1-TET2-TDG positive sites and the TDG only peaks. Gene 
ontology analysis of the genes (Ingenuity Pathway Analysis) nearest to triple-positive 
peaks in both Tdg[wt] (633) and Tdg[cat] (825) revealed gene expression and cellular 
development as the most significant functions. Nearest genes to the peaks uniquely 
bound by TDG in Tdg[wt] (9431) and Tdg[cat] (18’468) yielded predominant functions 
in cellular assembly and organization as well as cellular function and maintenance 
(Figure 3e). These associations are consistent with previously reported findings that 
the loss of TDG in differentiating mESCs affects expression of genes involved mainly 
in embryonic, tissue, organ and organismal development, many of which were 
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encoding for transcription factors (Cortazar et al., 2011). From these data we 
conclude that TET1, TET2 and TDG show different patterns of genome-wide co-
occupancy, depending on the DNA sequence context and functional sequence 
elements. While triple-positive peaks locate predominantly in CpG-rich regions (e.g. 
CGIs), TDG only enrichments are present at sites of intermediate CpG density 
(Figures 1d and 3c). 
 
TET1 and TET2 associate with chromatin independent of TDG – but active TDG 
may regulate TET2 association with chromatin upon differentiation  
Next, we asked if the chromatin association of TET1 and TET2 in mESC following 
24h of RA-induced differentiation is affected by the presence or absence of TDG 
protein and/or its catalytic activity. We identified a total of 22’318 TET1 peaks in 
Tdg[wt] mESCs, which is in the range of previously reported results (Williams et al., 
2011). Of these, 14’436 were also apparent in Tdg[cat] (64.7% of TET1 peaks in 
Tdg[wt]) and 16’218 in Tdg[null] mESC (72.6%, Figure 4a). This high overlap is 
consistent with TET1 associating with chromatin independently of TDG or its catalytic 
activity, and in agreement with TDG acting downstream of TET in the DNA 
demethylation process. Yet, there is a substantial fraction of TET1 peaks uniquely 
appearing in Tdg[wt], Tdg[cat] or Tdg[null] mESCs (5178, 2553 and 4384, 
respectively), possibly representing distinct pools of chromatin-associated TET1 
engaged in processes with different dissociation and association kinetics of both 
TET1 and TDG. Examining TET2, we identified 5129 enrichment peaks in Tdg[wt], 
9458 in Tdg[cat] and 14’623 in Tdg[null] (Figure 4b). The overlap between TET2 
chromatin associations in the different TDG backgrounds was lower than that 
observed for TET1; 41.7% and 47.7% of TET2 peaks in Tdg[cat] and Tdg[null], 
respectively, coincided with the total TET2 peaks in the Tdg[wt] cells (Figure 4b). 
Also, it appears that the absence or catalytic inactivity of TDG stimulates TET2 
chromatin association in mESCs at 24h RA, which is unlike the situation with TET1. 
Notably, this dependency seems to arise only upon differentiation since pluripotent 
mESCs (0h RA) show slightly more TET2 in the presence of active TDG 
(Supplementary Figure 6b), and this goes in line with another difference between 
TET1 and TET2: while the total number of TET1 chromatin associations increased 
during the 24h of RA-induced differentiation irrespective of the TDG status, it was 
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reduced for TET2, most dramatically in the Tdg[wt] background (Figure 4, 
Supplementary Figure 6). From these data, we conclude that TET1 and TET2 
association with chromatin is largely independent of TDG, but that the turnover of 
TET2 in particular may be regulated by TDG. In the context of differentiation-induced 
DNA demethylation, active TDG appears to reduce TET2 association with chromatin. 
 
A significant fraction of sites co-occupied by TET1, TET2 and TDG is marked 
by DNA demethylation intermediates and dynamic histone variants 
To clarify, whether and how differential TET1, TET2 and TDG co-occupancy is 
related to DNA demethylation activity, we correlated our ChIP-seq profiles with 
publicly available datasets on genome-wide DNA demethylation intermediates, 
including 5hmC and 5fC (hMe-Seal-seq and fC-Seal-seq by (Song et al., 2013)). For 
5fC, the analysis was performed in a TDG-deficient background to be able to 
measure enrichments. Comparing unique TDG peaks with a higher than 2 fold 
enrichment (log2>1) with the triple-positive peaks in Tdg[wt] mESCs, we observed a 
significantly higher overlap of 5fC accumulating sites with triple-positive peaks than 
with TDG only peaks, while the overlap with 5hmC was more pronounced in TDG 
only peaks (Figure 5a). Hence, higher oxidation of 5mC occurs preferentially at sites 
where TET1, TET2 and TDG are tightly associated. The overlap of 5hmC and/or 5fC 
was similar for triple-positive peaks in Tdg[wt] and Tdg[cat]. However, it was 
significantly different for TDG only peaks; TDG only peaks in Tdg[cat] mESC showed 
a striking enrichment of sites double-positive for 5hmC and 5fC at the expense of 
unmodified C, 5mC or 5caC (“None”; Figure 5a). We conclude from these results 
first, that there is a functional separation between uniquely TDG-bound and triple-
positive sites and second, that catalytic-dead TDG blocks the progression of the DNA 
methylation cycle.  
We next addressed the chromatin states associated with TDG only and TET1, TET2 
and TDG occupied sites, focusing on the activating and silencing histone 
modifications H3K4me3 and H3K27me3 that are prominently enriched at sites of 
TDG chromatin association. This revealed a very strong enrichment of bivalent 
chromatin marks in triple-positive peaks compared to TDG only peaks (23.8-fold and 
12.0-fold in Tdg[wt] and Tdg[cat], respectively), in fact, bivalent chromatin marks 
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were nearly absent in TDG only peaks. Concomitantly, we noticed a remarkable 
increase of H3K4me3-positive sites in the triple-positive peaks (8.8-fold and 2.8-fold, 
respectively, Figure 5b). Similarly to the distribution of DNA demethylation 
intermediates, triple-positive peaks in Tdg[wt] and Tdg[cat] were nearly identical with 
respect to the representation of H3K4me3 and H3K27me3 marks. Differences were 
greater in the unique TDG peaks, where Tdg[cat] shows a higher fraction of 
H3K4me3-positive peaks compared to Tdg[wt]. This may again be a reflection of the 
failure of the catalytic-dead TDG to turn over at sites where 5fC and 5caC substrate 
is generated, which would in this case be at sites activating chromatin marks. 
Importantly, sites in a bivalent chromatin state are most significantly enriched in 
TET1, TET2, and TDG triple-positive peaks. In differentiating mESCs, bivalent 
chromatin marks are found predominantly at developmental genes (Bernstein et al., 
2006).  Developmentally regulated loci are also characterized by deposition of the 
dynamic histone variant H3.3 (Goldberg et al., 2010), the turnover of which is 
particularly high at enhancer and promoter regions (Kraushaar et al., 2013). 
Moreover, active enhancers are marked by H3K4me1 and H3K27ac and occupied by 
5hmC, 5fC and 5caC (Serandour et al., 2012; Shen et al., 2013; Song et al., 2013). 
Notably, all these characteristics are enriched in the TET1, TET2, and TDG triple-
positive peaks. We therefore tested whether deposition of the histone variants H3.3 
and H2A.Z is associated with TET and TDG occupancy (Figures 5c and 5d). This 
revealed a very high coincidence of H3.3 with both triple-positive and unique TDG 
peaks, both in Tdg[wt] and Tdg[cat] mESCs. In the Tdg[wt] background, the H3.3 co-
occupancy was increased in the triple-positive peaks when compared to the TDG 
only peaks. This suggests that H3.3 deposition is higher at sites of triple-positive 
TDG peaks. Again, the H3.3 co-occupancy in the triple-positive peaks in both Tdg[wt] 
and Tdg[cat] were nearly identical (91.5% and 90.7%, respectively), whereas the 
most significant difference was in the comparison of the TDG only peaks in Tdg[wt] 
and Tdg[cat] (84.6% and 95.9% co-occupancy, respectively; Figure 5c). A similar 
pattern was found for H2A.Z co-occupancy: 62.9% and 58.5% of the TET1, TET2 
and TDG triple-positive peaks were co-occupied by H2A.Z in Tdg[wt] and Tdg[cat], 
respectively (Figure 5d). H2A.Z co-occupancy was reduced in TDG only peaks in 
both Tdg[wt] and Tdg[cat] (24.1% and 35.9%, respectively), however, the reduction 
was more pronounced in a Tdg[wt] background, as is the case for H3.3 co-
occupancy. This seems comprehensible by the argument that the catalytic-dead TDG 
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accumulates at sites where 5fC and 5caC is generated and thereby inhibits active 
DNA demethylation, and thus repair-mediated DNA strand-break formation, which in 
turn may affect H3.3 and H2A.Z deposition and turnover. We thus propose a 
mechanistic model, where in differentiating cells, TDG together with the TET proteins 
associate at CpG-rich gene regulatory regions to induce DNA demethylation and 
thereby facilitate nucleosome turnover and accompanying changes in chromatin 
modifications (Figure 6).  
 
Discussion 
Dynamic regulation of DNA methylation and gene expression is a hallmark of cell 
differentiation and development. The recent discovery of DNMT-TET-TDG-mediated 
cyclic methylation, oxidation and excision of cytosine constitutes a novel possibility 
for fine-tuning of gene expression. To address the co-operation of TET and TDG 
proteins at a genomic scale, we set out to establish genome-wide association 
patterns of these proteins in differentiating mESCs. We found a preference for 
intermediate to high CpG density and a bimodal distribution of TDG chromatin 
association sites; one peak was encompassing the TSS and one peak was located 1 
to 1000 kb away from the TSS. TDG preferentially associated to a chromatin 
environment marked by DNAse I hypersensitive sites, RNA Pol II occupancy, and 
histone marks characteristic for bivalent or active chromatin. Further, TDG peaks 
showed a significant co-occupancy with TET1 and TET2 chromatin association. 
Interestingly, the TET1-TET2-TDG triple-positive peaks were clearly enriched for 
CGIs, bivalent chromatin, DNA demethylation intermediates and dynamic 
nucleosomes, such as H3.3 and H2A.Z. Contrarily, unique TDG peaks were 
associated with active enhancers, not marked by bivalent chromatin and showed a 
lower fraction of DNA demethylation intermediates and dynamic nucleosomes, 
suggesting a functional separation between distinct TDG protein fractions. 
ChIP-seq data for wildtype and catalytic-dead TDG variants revealed different 
genomic distributions. These can largely be explained by different biochemical 
properties of the proteins, i.e. a reduced turnover of the catalytic inactive TDG and an 
increased accumulation of unprocessed substrates in Tdg[cat] mESCs. Consistently, 
the genomic characteristics of the interaction sites identified with active and inactive 
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TDG were largely identical, although the actual overlap between enrichment peaks 
was rather small. It is thus likely that active TDG does associate with many sites 
observed in Tdg[cat], but because of its turnover, it more frequently escapes 
crosslinking and, hence, detection by ChIP. We found most TDG peaks located in 
regions of intermediate to high CpG density; functional characterization revealed a 
preference for gene bodies (mostly introns) and intergenic regions (such as 
enhancers), indicating that TDG is associated with the transcription machinery upon 
induction of differentiation. The high percentage of intergenic peaks, together with the 
prominent occurrence of TDG peaks in the vicinity of the TSS and between 1kb and 
1000kb away from it, indicates a preference for association with gene regulatory 
elements. This is supported by other features coinciding at TDG peaks such as the 
enrichment of the histone modifications H3K4me3, H3K9ac, H3K4me1 and H3K27ac, 
the former two characterizing active promoters, the latter two active enhancers.  
Moreover, TDG peaks also correlate with DNAse I hypersensitive sites, as well as 
p300 and RNA Polymerase II enrichment, pointing towards an interaction with 
nucleosome depleted, transcriptionally active chromatin, another feature of gene 
promoters. Interestingly, we also found a clear enrichment of bivalent chromatin 
marks (H3K4me3 and H3K27me3), indicating that many developmental genes are 
targeted by TDG, which is in line with a previous report from our lab (Bernstein et al., 
2006; Cortazar et al., 2011). By contrast, TDG does not interact with constitutively 
silenced genomic regions, as H3K9me3 was not comparably enriched in TDG peaks, 
showing that TDG is not randomly distributed in chromatin. 
TDG peaks were also significantly enriched in TET1 and TET2 binding sites, 
implicating a functional interaction between these proteins. Notably, TET1 and TET2 
association with chromatin is largely independent of TDG. However, the turnover of 
TET2 in particular appears to be regulated by TDG: upon differentiation-induced DNA 
demethylation, active TDG seems to reduce TET2 association with chromatin, which 
was not observed for TET1. This is in line with the finding that most TET2 peaks are 
co-occupied with TDG and TET1, whereas TET1 peaks occur largely independently 
of TET2. Thus, TET2-TDG appear to be more intimately linked compared to TET1-
TDG. Nevertheless, there is a substantial number of both TET1 and TET2 peaks 
which is observed exclusively in Tdg[wt], Tdg[cat] or Tdg[null], respectively. 
Presumably, TET1 peaks in a Tdg[wt] background represent sites which become 
activated upon differentiation by DNA demethylation, in contrast to Tdg[null]-specific 
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TET1 peaks, which may rather reflect targets of TET1-mediated gene regulation. We 
conclude from these findings that the targeting of the distinct protein pools (e.g. TDG 
only, TET1-TDG, TET2-TDG, TET1-TET2-TDG) depends at least partly on its 
composition and may thus reflect functional differences of the proteins. 
Triple-positive peaks, showing enrichments for TET1, TET2 and TDG, accounted for 
roughly 5% of the total TDG peaks. It was reported before that TET1 associates with 
chromatin in two distinct patterns, the first centered at the TSS together with the 
transcriptional co-repressor Sin3a, the second located downstream and co-localizing 
with 5-hmC and PRC2 (Neri et al., 2013). Similarly, our data show a differential 
association of TET proteins with TDG throughout the genome, implicating the 
existence of locus-specific physical and functional interactions. Triple-positive peaks 
are significantly more often located in CGIs compared to the unique TDG peaks. 
Thus, it is possible that the triple-positive peaks reflect ongoing active DNA 
demethylation at sites of transcriptional initiation. Contrarily, unique TDG peaks are 
rather associated with enhancers, possibly reflecting sites of lower turnover. We 
conclude that the triple-positive peaks clearly associate with promoter CGIs, where 
TET activity is high and unique TDG peaks associate with enhancers, where TET 
activity might be lower. The positive correlation between TET1, TET2, TDG and the 
DNA demethylation intermediates is a strong argument for the constant, highly 
orchestrated turnover of DNA methylation at CGIs. The enhanced binding of 
catalytically inactive TDG at sites of 5fC and 5caC accumulation might reflect an 
inhibition of de novo methylation and TET association.  
So far, we conclude that during differentiation, the cycling DNA methylation and 
oxidative demethylation is required to maintain epigenetic plasticity at gene 
regulatory elements (e.g. CGI promoters) that ultimately need to be programmed for 
cell-type specific expression. This may contradict the conventional view that CGIs are 
unmethylated regions in the genome, but is supported by an increasing body of 
evidence, at least for CGIs associated with the regulation of developmental genes. 
Several studies demonstrate a modulation of the DNA methylation status of intra- and 
intergenic enhancer regions during differentiation and specifically show massive DNA 
demethylation at enhancers during cell differentiation (Aran and Hellman, 2013; 
Schmidl et al., 2009; Xie et al., 2013). The high dynamics of DNA methylation at the 
triple-positive loci coincided with a bivalent chromatin environment. Bivalent domains 
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mark gene promoters characterized by a high degree of regulatory plasticity; they can 
rapidly become activated or silenced in response to appropriate transcriptional 
instructions (Aloia et al., 2013). Unlike the unique TDG peaks, the triple-positive 
peaks show a clear enrichment for both bivalent and H3K4me3-positive chromatin. 
Both H3K4me3-marked sites and bivalent chromatin are positively correlated with 
CGIs as well as TSS (Bernstein et al., 2006). The lack of enrichment of both bivalent 
chromatin as well as CGIs in the unique TDG peaks compared to the triple-positive 
peaks thus further supports a functional separation of the distinct TDG fractions. 
This goes in line with the high co-occupancy of both the triple-positive but also 
unique TDG peaks with the dynamic histone variants H3.3 and H2A.Z. Roughly 90% 
of the triple-positive peaks were positive for H3.3, irrespective of the TDG 
background. Contrarily, the unique TDG peaks showed a difference between TDG 
backgrounds: in Tdg[wt], H3.3 occurred less compared to Tdg[cat], hinting at a role 
for TDG’s catalytic activity in nucleosome turnover. Notably, H3.3 occupancy was 
shown to change at cell-type specific genes and regulatory elements during cell 
differentiation, as evidenced by enhanced nucleosome exchange (Goldberg et al., 
2010). Thus, deposition of the rapidly turning-over H3.3 has been implicated in a 
mechanism that poises chromatin for transcriptional activation (Huang and Zhu, 
2014). H3.3 was further demonstrated to facilitate the association of PRC2 with 
developmental genes, thus establishing the correct setting for H3K27 methylation in 
bivalent chromatin (Banaszynski et al., 2013). Interestingly, a solid body of 
circumstantial evidence indicates that DNA demethylation at gene regulatory regions 
in the context of transcriptional activation includes the formation of DNA single-strand 
breaks (Fry et al., 2006; Kress et al., 2006; Wossidlo et al., 2010). It is thus appealing 
to think of a mechanism for gene activation during development, where the TET-
TDG-mediated DNA demethylation is followed by the generation of a single-strand 
break, presumably by APE1, which in turn facilitates nucleosome exchange and the 
opening up of chromatin. Nucleosome exchange could either be achieved by the 
sheer relaxation of DNA around the histone octamers induced by the single-strand 
break. Alternatively, single-strand breaks were shown to attract PARP1 which would 
PARylate the surrounding histones, enhancing their turnover (Meyer-Ficca et al., 
2011a; O'Donnell et al., 2013). How common this is and how the strand break is 
repaired and prevented from generating a double-strand break is currently unknown.   
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We describe two functionally different fractions of chromatin associated TDG: the first 
is strongly co-occupied by the TET proteins and the second consists of TDG only. 
The TET associated fraction correlates with (presumably promoter) CGIs at genes 
involved in gene expression and cellular development, the TDG only fraction 
correlates rather with regions characterized by an intermediate CpG-densitiy and is 
enriched for active enhancers. Based on our findings, we postulate the existence of a 
mechanism which uses highly coordinated DNA demethylation and specifically 
targets gene regulatory elements of developmental genes to establish epigenetic 
plasticity during cell lineage commitment. This process is initiated at lineage-specific 
proximal and distal gene regulatory elements, where the presence of TET1-TET2-
TDG promotes transient cycling of DNA methylation and demethylation. This 
facilitates the deposition and turnover of the histone variants H3.3 and H2A.Z at 
enhancers and gene promoters, presumably through PARP1-mediated histone 
PARylation upon the generation of a BER-mediated DNA single-strand break (Kress 
et al., 2006; Meyer-Ficca et al., 2011b; O'Donnell et al., 2013). TET1-TET2-TDG 
peaks are further significantly enriched for active histone marks (H3K4me1, 
H3K4me3, H3K9ac, H3K27ac), all of which were shown to positively correlate with 
DNA looping events between TSS and distal regulatory elements (Sanyal et al., 
2012). We envision TET1-TET2-TDG to operate in the context of promoter-enhancer- 
interaction loops to facilitate nucleosomal dynamics at both sites. The deposition of 
the dynamic histone variants H3.3 and H2A.Z is central as this was shown to regulate 
the transcriptional outcome of inducible genes (Chen et al., 2013a).  
For the first time, we could show the genome-wide distribution of TDG chromatin 
association and demonstrate a differential co-occupancy with TET1 and TET2. It will 
be important to further investigate the relationship between cyclic DNA methylation 
and active, TET-TDG mediated demethylation as well as nucleosomal composition 
and turnover, and how this mechanism is targeted to specific sites in the genome. 
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Material & Methods 
Cell culture 
Complemented ES cell lines were derived by transfection of TDG-/- ES cells with the 
complementation vectors pTCO2 TDG wt, pTCO2 TDG∆cat and empty pTCO2 
(Cortazar et al., 2011) using jetPEI® (Polyplus Transfections) according to the 
manufacturer’s recommendations. Cells were cultivated in ES cell medium (ECM; 
DMEM, 15% heat-inactivated FCS, 1x non-essential amino acids, 1 mM Na-pyruvate, 
2 mM L-glutamine and 90 µM β-mercaptoethanol) and LIF (1’000Uml-1) 
supplemented with 1.5 µg ml-1 puromycin to select stable clones. 
For the 24 h RA differentiation, complemented ES cells were cultured on Feeders for 
2 passages and then conditioned for 4 passages without Feeders in 2i medium 
(Neurobasal medium and DMEM/F-12 1:1, 1x N2 supplement, 1x B27 supplement, 
LIF (1’000 Uml-1), 2 mM L-glutamine, 90 µM β-mercaptoethanol, 3 µM CHIR99021 
and 1 µM PD0325901 (University of Dundee) and 1x penicillin/streptomycin). Prior to 
RA differentiation, ESCs were seeded at suitable cell numbers onto two 140 mm 
dishes (for Chromatin) or two 60 mm dishes (for Protein and RNA extraction) in ECM. 
For differentiation, the medium was exchanged for ECM supplemented with 5 µM RA 
(5 mM stock in DMSO). Chromatin, protein and RNA were harvested at 0 and 24 h. If 
not indicated otherwise, cell culture components were obtained from Gibco® Life 
Technologies, chemicals from Sigma and LIF from Merck Millipore. 
 
Chromatin immuno-precipitation (ChIP) 
To crosslink protein-bound DNA, ES cells were incubated in 1% formaldehyde/PBS 
at room temperature. The reaction was quenched after 10 min by addition of glycine 
to a final concentration of 125 mM. After washing three times with ice cold PBS, cells 
were collected using a cell scraper and subsequent centrifugation at 600xg and 4 °C. 
Supernatant was discarded and the cells snap-frozen until further processing. After 
thawing on ice, nuclei were isolated by incubation in 400 µl of cold ChIP Lysis Buffer I 
(10 mM HEPES pH 6.5, 10 mM EDTA, 0.5 mM EGTA, 0.25% Triton X-100, 1 mM 
PMSF) for 5 min on ice followed by two incubations of 5 min on ice in 400 µl cold 
ChIP Lysis buffer II (10 mM HEPES pH 6.5, 10 mM EDTA, 0.5 mM EGTA, 200 mM 
NaCl, 1mM PMSF). All centrifugation steps were conducted at 600xg and 4°C for 5 
min. Pelleted nuclei were lysed in 400 µl ChIP Lysis buffer III (50 mM Tris-HCl pH 8.0, 
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1 mM EDTA, 0.5% Triton X-100, 1% SDS, 1 mM PMSF) for 10 min on ice followed by 
sonication for 5x10 min (30 sec on, 30 sec off, power high) using a Bioruptor 
sonicator (Diagenode) to yield fragments of ~200-500 bp. The solution was cleared of 
remaining cell debris by centrifugation at 14’000xg and 4°C for 10  min. For ChIP of 
TDG, TET1 and TET2, 150 µg of chromatin were diluted 1:10 in ChIP dilution buffer 
(50 mM Tris-HCl pH 8.0, 1 mM EDTA, 150 mM NaCl, 0.1% Triton X-100, 1x protease 
inhibitor cocktail, 1 mM PMSF). After removing 1% (volume) for input analysis, diluted 
chromatin was pre-cleared at 4°C for 1  h with 30 µl of a 50% slurry of magnetic 
Protein G beads (Invitrogen) pre-blocked with 1 mg ml−1 BSA and 1 mg ml−1 tRNA. 
Pre-cleared chromatin was incubated with 1-2 µg of the respective antibody 
(Supplementary Table 1) overnight at 4°C under slow  rotation. Immuno-complexes 
were precipitated with 40 µl of a 50% slurry of blocked Protein G beads and further 
incubated at 4°C for 2  h. Beads were then serially washed with 500 µl ChIP wash 
buffer I (20 mM Tris-HCl pH 8.0, 2 mM EDTA, 150 mM NaCl, 0.1% SDS, 1% Triton X-
100) and twice with 500 µl ChIP wash buffer II (20 mM Tris-HCl pH 8.0, 2 mM EDTA, 
500 mM NaCl, 0.1% SDS, 1% Triton X-100). After two additional washes with 500 µl 
TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA), bound complexes were eluted by 
two sequential incubations with 250 µl elution buffer (1% SDS, 0.1 M NaHCO3) at 
65°C shaking for 10  min. Crosslink reversal of eluates and respective input samples 
was done in the presence of 200 mM NaCl at 65°C for 4  h followed by proteinase K 
digestion (50 µg ml−1) in the presence of 10 mM EDTA and 40 mM Tris-HCl pH 6.5 at 
45°C for 1  h. DNA was purified by phenol/chloroform extraction and NaCl/ethanol 
precipitation, and resuspended in 10 mM Tris-HCl pH 8.0. qPCR analysis with target 
specific primers (Supplementary Table 2) was performed using Quantitect SYBR 
Green (Qiagen) with a Rotor-Gene 3000 thermocycler (Qiagen). Statistical analysis 
was performed on Graphpad Prism Software.  
 
Deep-sequencing and bioinformatical analysis 
Several ChIP experiments were pooled and 10 ng of ChIP elution was sent to the 
Genome Technology Access Center (GTAC; https://gtac.wustl.edu/index.php) in the 
Department of Genetics at Washington University School of Medicine in St. Louis, 
Missouri, USA. After quality control (Bioanalyzer, Agilent Technologies Inc.), ChIP 
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DNA was blunt ended, Adenosine was added to the 3’ end and sequencing adapters 
were ligated to the ends. The fragments were size selected to 200-600 bp and 
underwent amplification for 15 cycles. The resulting libraries were sequenced using 
the Illumina HiSeq-2500 as single reads extending 50 bases (Illumina Inc.). The raw 
data was demultiplexed and the reads were mapped to the mouse genome 
(NCBI37/mm9) using the Bowtie (version 1.0.0; (Langmead et al., 2009)) 
implemented in QuasR package (www.bioconductor.org) allowing up to 10 best 
alignment positions in the genome. The sample specific fragment sizes were 
estimated from cross correlation profiles of read density on both chromosomal 
strands using the Chipcor software (ref: http://ccg.vital-it.ch/chipseq). Reads were 
shifted by half of the fragment size (90bp) towards the middle of the fragment.  
Peaks were detected using MACS (version 1.3.7.1., with parameters --tsize=50 --
pvalue=1e-5 --mfold=8 –lambdaset=’1000,5000,10000’ --nomodel --shiftsize=90; 
(Zhang et al., 2008)) using a pool of read alignments from all biological replicates and 
time points in combination with pooled input controls. Peaks were filtered based on 
the enrichment over the input control samples. ChIP enrichment of each peak was 
calculated as 
e=log2((n_fg/N_fg*min(N_fg,N_bg)+p)/(n_bg /N_bg*min(N_fg,N_bg)+p) ), where n_fg 
and n_bg are the number of overlapping foreground and background (input 
chromatin) read alignments, respectively. N_fg and N_bg are the total number of 
aligned reads in foreground and background samples, and p is a pseudocount 
constant (p=8) used to minimize the sampling noise for peaks with very low counts. 
Only peaks with log2 fold enrichment higher than 1 were used for further analysis.  
For comparative analysis, the following GEO Datasets were downloaded: GSE37074 
(DNAse), GSE49847 (H3K4me3, H3K4me1, CTCF, RNA Pol II, p300, H3K27me3, 
H3K27ac, H3K36me3, H3K9ac, H3K9me3), GSE41545 (5-hmC, 5-fC), GSE16893 
(H3.3), GSE40065 (H2A.Z) and GSE30206 (LMRs). 
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Supplementary Table 1: Antibodies used in this study 
Antibody Product Number Manufacturer 
Anti-Methylcytosine dioxigenase TET1 antibody 09-872 Millipore 
Anti-TET2 (N2) antibody R1086-4 Abiocode 
The anti-TDG antibody used for ChIP was produced and affinity purified in our lab, for further 
information see (Cortazar et al., 2011; Hardeland et al., 2002; Neddermann et al., 1996). 
 
Supplementary Table 2: Primers used in this study 
Primer Forward (5’ – 3’ sequence) Reverse (5’ – 3’ sequence) 
chr2neg AGCACAGCCTGAAGCCTCTA AGAGGGCATTTCCGTCTTTT 
HoxA10 CACTCCCAGTTTGGTTTCGT GGGGGTACAGGTTCAAGAGC 
Oct4 GTGAGGTGTCGGTGACCCAAGGCAG GGCGAGCGCTATCTGCCTGTGTC 
Nanog GAGGATGCCCCCTAAGCTTTCCCTCCC CCTCCTACCCTACCCACCCCCTATTCTCCC 
DMR 8 CTGGCCACAGCTTTACCATC AAGGACACTGAGCCAGAGGA 
DMR 39 GAGCTGGATAGCCCTTGTAGAATG TTGGCAGCGGAGGGAGCAG 
DMR 49 GCTGGGTTTGTAGTGGGAAC GCAGGACCACACCTCACATC 
DMR 54 ACCCAGCAAAATCTCACCTG GACACTGGACAGGGCTCCA 
All primers were from Microsynth, Switzerland. 
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Figure Legends 
 
Figure 1: TDG ChIP-seq reveals a preferential association of TDG with 
intergenic regions as well as introns 
A: Density plot depicting the negative correlation between total TDG peaks (MACS) 
in Tdg[wt] and Tdg[cat] (left; density: red > blue). The VENN diagram (right) reveals 
little overlap between TDG peaks (log2>1) in Tdg[wt] and Tdg[cat]. B: Density 
diagram showing TDG peaks in relation to TSSs (RefSeq). C: Pie charts showing the 
percentage of TDG peaks (Tdg[wt] top and Tdg[cat] bottom) uniquely in the indicated 
genomic feature (cds: coding sequence; UTR: untranslated region). D: Density plot 
showing the correlation between TDG enrichment and CpG density (left). Bar charts 
indicating the percentage of TDG peaks located in a CGI (top, right) and the fold 
enrichment of CGIs within the TDG peaks compared to the occurrence of CGIs in the 
total genome (bottom, right). E: Genome Browser snapshot as an illustrating 
example. 
 
Figure 2: The enrichment of active as well as bivalent chromatin marks is most 
pronounced in TDG-targeted sites 
Bar charts are depicted, showing the fold enrichment of the indicated feature 
compared to the occurrence of the respective feature in the total genome (left): in 
Tdg[wt] (middle) and in Tdg[cat] (right). A: DNAse hypersensitive sites, RNA 
Polymerase II, p300 and CTCF. B: Repressive histone marks: H3K27me3 and 
H3K9me3. C: Activating histone marks associated with transcription: H3K4me3, 
H3K36me3, H3K9ac. D: Features associated with active enhancers: H3K4me1, 
H3K27ac as well as the combination of these two marks together with DNAse 
hypersensitivity in “active enhancers”, low-methylated regions (LMRs). E: Histone 
variants: H3.3, H2A.Z.  
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Figure 3: Co-localization of TDG with TET1 and TET2 indicates a coordinated 
function in gene regulation 
A: Barplot on the left shows the comparison between the percentage of TET1 
occupancy (in Tdg[wt]) in the total genome (top) as a reference, compared to the 
percentage of TET1 occupancy within TDG peaks (Tdg[wt]: middle, Tdg[cat]: 
bottom). The barplot on the right shows the same for TET2. B: Barplot illustrating the 
different overlaps between TDG, TET1 and TET2 in both Tdg[wt] (left) and Tdg[cat] 
(right). C: The percentage of the triple-positive peaks from 3B located in a CGI or 
active enhancer (aE) is shown in a pie chart (left; Tdg[wt]: top and Tdg[cat]: bottom). 
As a comparison, the percentage of TDG only peaks in the respective genomic 
features is also shown (right). D: The fraction of TDG only and triple-positive peaks 
overlapping with an LMR is shown for Tdg[wt] (left) and Tdg[cat] (right). E: Gene 
ontology analysis (Ingenuity Pathway Analysis) of the fractions generated in 3B. The 
p values of the five most significant molecular and cellular functions are depicted.  
 
Figure 4: Distinct subgroups of TET1 and TET2 associate to chromatin – one 
subgroup depends on functional TDG, others do not  
A: VENN diagram showing the overlap between all TET1 peaks in different TDG 
backgrounds (Tdg[wt] green, Tdg[cat] red, Tdg[vec] blue; left) at 24h RA. Bar 
diagram indicating the total number of peaks for TET1 in the different TDG 
backgrounds (right). B: VENN diagram showing the overlap between all TET2 peaks 
in different TDG backgrounds (Tdg[wt] green, Tdg[cat] red, Tdg[vec] blue; left) at 24h 
RA and Bar diagram indicating the total number of peaks for TET2 in the different 
TDG backgrounds (right).   
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Figure 5: TDG-TET1-TET2 co-localize at sites of active DNA demethylation and 
co-localize with dynamic histone variants 
A: Barplot showing the fraction of unique TDG peaks and triple-positive peaks in 
Tdg[wt] (left) and Tdg[cat] (right) overlapping with DNA demethylation intermediates. 
Fractions are indicated for neither 5hmC nor 5fC containing DNA (None); 5fC only; 
5hmC only; as well as the double-positive for 5fC and 5hmC. B: Barplot showing the 
fraction of unique TDG peaks and triple-positive peaks in Tdg[wt] (left) and Tdg[cat] 
(right) backgrounds overlapping with bivalent chromatin modifications. Fractions are 
indicated for neither H3K4me3 nor H3K27me3 containing histones (None); H3K4me3 
only; H3K27me3 only; as well as the bivalent chromatin marks H3K4me3 together 
with H3K27me3. C: Barplot showing the fraction of unique TDG peaks and triple-
positive peaks in Tdg[wt] (left) and Tdg[cat] (right) backgrounds overlapping with the 
histone variant H3.3. D: Barplot showing the fraction of unique TDG peaks and triple-
positive peaks in Tdg[wt] (left) and Tdg[cat] (right) backgrounds overlapping with the 
histone variant H2A.Z. 
 
Figure 6: Model  
Model describing the association of the TET proteins and TDG at CpG-rich sites 
(promoter CGIs) and enhancers, where they induce active DNA demethylation and 
presumably nucleosome exchange. We propose that the TET proteins and TDG 
thereby facilitate enhancer-promoter contacts, and hence gene expression, of 
developmental genes during differentiation. 
 
Supplementary Figure 1: Protein levels of TDG, TET1 and TET2 in mESCs 
Western blots for TDG (A), TET1 (B) and TET2 (C) in mESCs with different TDG 
backgrounds (Tdg[wt], Tdg[cat] and Tdg[null]; denaturing protein extracts). Different 
conditions are shown: mESCs from 2i preconditioning medium (2i) and 0h, 4h, 8h 
and 24h after RA-induced differentiation. β-Actin is shown as a loading control. 
Cross-reference: these Western blots are also shown in Jacobs et al., manuscript in 
preparation, 2014. 
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Supplementary Figure 2 (to Figure 1): Correlation between TDG ChIP samples 
The correlation of all called peaks is shown for all TDG ChIP-seq samples in Tdg[cat] 
and Tdg[wt] at 24h RA-induced differentiation in a density plot. R values are 
indicated. 
 
Supplementary Figure 3 (to Figure 3): Correlation between TET1 ChIP samples 
The correlation of all called peaks is shown for all TET1 ChIP-seq samples in 
Tdg[cat], Tdg[wt] and Tdg[null] at 0h and 24h RA-induced differentiation in a density 
plot. R values are indicated. 
 
Supplementary Figure 4 (to Figure 3): Correlation between TET2 ChIP samples 
The correlation of all called peaks is shown for all TET2 ChIP-seq samples in 
Tdg[cat], Tdg[wt] and Tdg[null] at 0h and 24h RA-induced differentiation in a density 
plot. R values are indicated. 
 
Supplementary Figure 5 (to Figure 2): TDG preferentially localizes in an active 
and nucleosome-poor chromatin environment 
Bar charts are depicted, showing the percentage of coverage in the genome of the 
indicated feature as a reference (left), the percentage of the indicated feature 
occurring in Tdg[wt] peaks (middle) and Tdg[cat] peaks. A: DNAse hypersensitive 
sites, RNA Polymerase II, p300 and CTCF. B: Repressive histone marks: H3K27me3 
and H3K9me3. C: Active histone marks associated with transcription: H3K4me3, 
H3K36me3, H3K9ac. D: Features associated with active enhancers: H3K4me1, 
H3K27ac as well as the combination of these two marks together with DNAse 
hypersensitivity in “active enhancers”, low-methylated regions (LMRs). E: Histone 
variants: H3.3 and H2A.Z. 
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Supplementary Figure 6 (to Figure 4): TET2 association to chromatin is 
regulated by active TDG during differentiation 
A: VENN diagram showing the overlap between all TET1 peaks in different TDG 
backgrounds (Tdg[wt] green, Tdg[cat] red, Tdg[null] blue; left) at 0h RA. Bar diagram 
indicating the total number of TET1 peaks in the different TDG backgrounds (right).            
B: VENN diagram showing the overlap between all TET2 peaks in different TDG 
backgrounds (Tdg[wt] green, Tdg[cat] red,Tdg[null] blue; left) at 0h RA. Bar diagram 
indicating the total number of TET2 peaks in the different TDG backgrounds (right).   
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Contribution: Contribution to the preparation of chromatin extracts from MEFs and mESCs and to 
ChIP experiments (H3K4me2, H3K9me3 and H3K27me3 in MEFs; Appendix III, Figure 1e; with DC). 
ChIP experiments in wildtype-complemented MEFs for all histone marks shown (Appendix III, Figure 
2b) as well as for XRCC1 and CBP in MEFs (Appendix III, Figures 4a and 4b). ChIP experiments for 
H3K4me2 and H3K27me3 in mESCs (Appendix III, Supplementary Figure 8). ChIP experiments for 
H3K4me2, H3K9me3 and H3K27me3 in TDG catalytically dead MEFs (data not shown). Assistence 
with qPCR analysis of TDG ChIPs in MEFs and XRCC1 ChIPs in NPs (with DC). 
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Embryonic lethal phenotype reveals a function of
TDG in maintaining epigenetic stability
Daniel Corta´zar1*, Christophe Kunz1*, Jim Selfridge2, Teresa Lettieri3{, Yusuke Saito1, Eilidh MacDougall2, Annika Wirz1,
David Schuermann1, Angelika L. Jacobs1, Fredy Siegrist4, Roland Steinacher1{, Josef Jiricny3, Adrian Bird2 & Primo Scha¨r1
Thymine DNA glycosylase (TDG) is a member of the uracil DNA
glycosylase (UDG) superfamily of DNA repair enzymes. Owing to
its ability to excise thymine when mispaired with guanine, it was
proposed to act against the mutability of 5-methylcytosine (5-mC)
deamination in mammalian DNA1. However, TDG was also found
to interact with transcription factors2,3, histone acetyltransferases4
and de novo DNAmethyltransferases5,6, and it has been associated
with DNA demethylation in gene promoters following activation
of transcription7–9, altogether implicating an engagement in gene
regulation rather than DNA repair. Here we use a mouse genetic
approach to determine the biological function of this multifaceted
DNA repair enzyme. We find that, unlike other DNA glycosylases,
TDG is essential for embryonic development, and that this pheno-
type is associated with epigenetic aberrations affecting the expres-
sion of developmental genes. Fibroblasts derived from Tdg null
embryos (mouse embryonic fibroblasts, MEFs) show impaired
gene regulation, coincident with imbalanced histone modification
and CpG methylation at promoters of affected genes. TDG asso-
ciates with the promoters of such genes both in fibroblasts and in
embryonic stem cells (ESCs), but epigenetic aberrations only appear
upon cell lineage commitment. We show that TDG contributes to
the maintenance of active and bivalent chromatin throughout
cell differentiation, facilitating a proper assembly of chromatin-
modifying complexes and initiating base excision repair to counter
aberrantdenovomethylation.WethusconcludethatTDG-dependent
DNA repair has evolved to provide epigenetic stability in lineage
committed cells.
TDG is one of four enzymes with UDG activity inmammalian cells,
but its biological function has remained enigmatic10.We thus set out to
generate and phenotypically investigate a Tdg knockout mouse (Sup-
plementary Fig. 1a–c). ESC clones carrying the targeted allele gave rise
to healthy heterozygous Tdg knockout mice but attempts to generate
homozygous null mutants failed, indicating that TDG-deficiency may
cause embryonic lethality. This was unexpected, given the generally
mildphenotypeofotherDNAglycosylase knockouts11. In timedmatings,
Tdg null embryos isolated up to embryonic day (E) 10.5 appeared alive
and normal, whereas those isolated at E12.5 were dead, and none were
detectable at E16.5 (Fig. 1a andSupplementaryFig. 1d).Tdgnull embryos
at E10.5 produced viable fibroblasts (MEFs) but only a third of E11.5
embryos did so, suggesting that by this stagemost of themwere dead.We
thus concluded that lethality in Tdg null embryos occurs around E11.5.
For the actual cause of lethality, closer examination of the Tdg null
embryos at E10.5 indicated internal haemorrhage, and evidence for
haemorrhagic necrosis (data not shown), but otherwise did not reveal
an informative pathology.
We then explored the essential function of TDG inMEFs and ESCs,
first addressing a potential DNA repair defect by classical genotoxicity
and mutator analyses. The TDG status did not affect cell survival
following ionizing radiation or H2O2 exposure, both of which induce
DNA base lesions processed by TDG in vitro10, nor did it affect muta-
tion frequencies in a Big Blue transgenic mutation assay (Supplemen-
tary Fig. 2). We therefore concluded that the role of TDG in the repair
of canonical base damage is minor and therefore unlikely to account
for its essential function in mouse embryogenesis.
We next investigated a possible involvement of TDG in gene regu-
lation by expression profiling of TDG-proficient and -deficient MEFs.
To limit potential clonal biases, we compared the transcriptomes of
early passages of litter-matched populations of SV40 immortalized
MEFs. This identified 461 differentially transcribed genes (P# 0.05,
fold change (FC)$ 1.5, Fig. 1b), comprising many transcription
factors and, thus, likely reflecting both direct and indirect con-
sequences of TDG loss. Global pathway analyses revealed gene net-
works associated with embryogenesis and development as being most
significantlymisregulated in theabsenceofTDG(SupplementaryFig.3a).
Four out of six target genes analysed showed TDG-dependent differ-
ential expression also in independently isolated primary MEFs (Sup-
plementary Fig. 3b).
Considering its putative involvement in DNA demethylation7–9, we
next investigated a possible occurrence of aberrant promoter methyla-
tion in TDG-deficient cells. We examined the CpG islands in the pro-
moters of Hoxa10, Hoxd13, Sfrp2, Twist2 and Rarb, all of which were
downregulated in TDG-deficient MEFs (Fig. 1b and Supplementary
Fig. 3a). These genes are developmentally regulated by the polycomb
repressive system12 and their promoter CpG islands are unmethylated
in most normal tissues but subject to aberrant de novomethylation in
human cancers13,14. Na-bisulphite sequencing of the respective CpG
islands revealed an increased occurrence of de novo methylation in
the TDG-deficient MEFs (Fig. 1c and Supplementary Figs 4 and 5a).
The patterns and frequency of these methylation events indicated that
the loss of TDG generates hotspots of de novo methylation in certain
gene promoters. We then used chromatin immunoprecipitation
(ChIP) to examine a possible association of TDG with the promoters
of these and additional differentially expressed genes. Comparedwith a
randomly chosen intergenic sequence or the silent promoters of Oct4
and Tuba3, DNA fragments surrounding the promoters of all genes
examinedwere significantly enriched in the TDGprecipitates (Fig. 1d).
This indicated thatTDG is targeted to specific gene promoters, possibly
toprotect them fromacquiring aberrantCpGmethylation and eventual
epigenetic silencing. Consistently, further examination of the chro-
matin status revealed a general loss of activating (H3K4me2) and a
concomitant increase of repressive histone marks (H3K27me3,
H3K9me3) in TDG-deficient cells with promoter-specific patterns
(Fig. 1e): a complete loss of H3K4 dimethylation was accompanied
by a strong increase of H3K27 and/or H3K9 trimethylation at the
Hoxd13 and Hoxa10 promoters; a partial reduction of H3K4me2
coincided with an enrichment of H3K27me3 but not H3K9me3 at
*These authors contributed equally to this work.
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the Sfrp2 and Twist2 promoters; and reduction of H3K4me2 was
coupled with an increase in H3K9me3 but not H3K27me3 at the
Rarb promoter. Thus, promoter de novomethylation in TDG-deficient
cells is associatedwith a loss ofH3K4dimethylation and a concomitant
increase in trimethylation of H3K27 more than H3K9.
Stable expression of a TDG encoding complementaryDNA (cDNA)
in Tdg2/2 MEFs (Supplementary Fig. 1f) restored activity to the Sfrp2
and Twist2 genes (Fig. 2a). This correlated with a loss of H3K27
trimethylation in their promoters and an increase in H3K4 dimethyla-
tion in the case of Twist2 (Fig. 2b). Expression ofHoxd13 andHoxa10,
however, was not restored although a partial reduction of H3K27
trimethylation also occurred. This indicated that, once H3K4methyla-
tion is lost (Hoxd13,Hoxa10), the repressive chromatin maintained by
H3K9 and H3K27 methylation and aberrant CpG methylation cannot
be reversed to an active state by re-expression of Tdg. If residual H3K4
methylation is present, however, promoter reactivation is possible, and
this requires the catalytic function of TDG15 as shown for Sfrp2 and
Twist2 (Fig. 2a).
To address the origin of the epigenetic aberrations inTdgnullMEFs,
we investigated gene expression and chromatin states in TDG-
proficient and -deficient ESCs before and after retinoic-acid-induced
in vitro differentiation to neuronal progenitor cells16 (Supplementary
Fig. 6a). Strikingly, gene expressiondifferences wereminor in ESCs (16
genes, P# 0.05, FC$ 1.5) but increased significantly upon differenti-
ation to neuronal progenitor cells (297 genes, P# 0.05, FC$ 1.5)
(Fig. 3a). This was not due to an inability of TDG-deficient ESCs to
respond transcriptionally to retinoic acid (Supplementary Fig. 6b),
although they showed somewhat faster kinetics of silencing pluri-
potency genes (Oct4, Nanog) and activating developmental genes (for
example,Gata6,Pax6) (Supplementary Fig. 6c). Similar to the situation
in MEFs, the genes most significantly misregulated in TDG-deficient
neuronal progenitor cells control developmental functions, most of
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Figure 1 | Embryonic essential function of Tdg in epigenetic gene
regulation. a, Whole mount images of typical examples ofTdg1/1 and Tdg2/2
littermate embryos taken at E10.5 and E12.5. b, Scatter plot comparing gene
expression levels ofmatchedTdg1/2 andTdg2/2MEFs.Differentially expressed
genes at P, 0.05 and P, 0.01 are indicated by green and red dots, respectively,
and examples of developmental genes affected are denoted. c, Na-bisulphite
sequencing of theHoxd13 and Sfrp2 promoters in Tdg1/1, Tdg1/2 and Tdg2/2
MEFs. White and black circles indicate unmethylated and methylated CpGs,
respectively. P values indicate statistical difference ofmethylation frequencies as
determinedby contingency tables and x2 test.d, ChIP–quantitative PCR (qPCR)
analysis of TDG association with the promoters of the genes indicated in
chromatin from Tdg1/1 and Tdg2/2 MEFs. Shown are relative enrichments of
TDG at these promoters normalized to a randomly chosen intergenic control
region (means6 s.e.m.;n$ 3; *P, 0.05; **P, 0.01, unpaired Student’s t-test).
e, ChIP–qPCR analyses in Tdg1/1 and Tdg2/2 MEFs to assess the presence of
activating (H3K4me2) and repressive (H3K9me3, H3K27me3) histone
modifications at the promoter regions indicated. Shownare enrichments relative
to appropriate negative controls: intracisternal A-particle (Iap) transposon for
active chromatin marks and the Hprt promoter for silencing marks
(means6 s.e.m.; n$ 3; *P, 0.05; **P, 0.01; unpaired Student’s t-test).
Subscript T, target region; subscript C, control region.
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Figure 2 | Complementation of the loss of gene expression depends on the
chromatin state of the promoter. a, Hoxd13, Hoxa10, Sfrp2 and Twist2
expression in Tdg1/1 and Tdg2/2 MEFs complemented with vectors
expressing either a wild-type (pTdg) or a catalytically deficient Tdg (pTdgcat-,
N151A), or a vector control (pV). Target-specific messenger RNA (mRNA)
levels were assessed by qRT–PCR and normalized to Gapdh mRNA; values
represent arbitrary units (means6 s.d.; n$ 3; *P, 0.05; unpaired Student’s
t-test). b, ChIP–qPCR analyses to detect H3K27me3 and H3K4me2 marks at
the gene promoters indicated in chromatin of Tdg1/1, Tdg2/2 and Tdg2/2
MEFs complemented with a wild-type Tdg cDNA. IAP and theHprt promoter
were used as normalizers for active and repressive chromatin marks,
respectively (means6 s.e.m.; n5 3; *P, 0.05; **P, 0.01; unpaired Student’s
t-test).
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them having CpG islands in their promoters and being targets of the
polycomb repressive system (Supplementary Fig. 7a). Using ChIP, we
confirmed an enrichment of TDG at the promoters of differentially
expressed genes both in ESCs and in neuronal progenitor cells (Fig. 3b).
This also revealed that TDG associates with the promoters ofOct4 and
Nanog in ESCs but not in neuronal progenitor cells and MEFs (Fig. 3b
and Supplementary Fig. 6d), suggesting that its interaction is lost upon
heterochromatinization of these promoters. Notably, the inability to
associate with heterochromatized promoters may explain why re-
expression of TDG in Tdg null MEFs failed to restore Hoxd13 and
Hoxa10 transcription (Fig. 2).
Next, we examined the status of CpG methylation in gene pro-
moters downregulated in TDG-deficient neuronal progenitor cells,
making use of Na-bisulphite (pyro)sequencing and methylated
DNA-immunoprecipitation (MeDIP). AlthoughMeDIP only detected
trends for methylation differences at specific promoters (Supplemen-
tary Fig. 7b and unpublished observations), pyrosequencing revealed
significantly increased DNA methylation in Tdg null neuronal pro-
genitor cells at three out of five gene promoters tested (Hoxa10, Pax6,
Tgfb2). Notably, these methylation differences were not present in
ESCs nor in freshly dissociated embryonic bodies, they arose within
48 h of cultivation of the neuronal progenitor cells in progenitormedium
(Fig. 3c and Supplementary Fig. 7c), and the phenotype was comple-
mentedby ectopic expressionofTdgduring cell differentiation. Similarly,
histone methylation marks were not different between TDG-proficient
and -deficientESCsbut arose inneuronal progenitor cellswithanenrich-
ment of H3K27me3 at the promoters of Hoxd13, Hoxa10 (Supplemen-
tary Fig. 8) and Pdgfra (unpublished observations). Thus, differences in
DNA methylation and histone modifications became apparent at the
neuronal progenitor cell stage but were not as pronounced as in MEFs,
indicating an epigenetic phenotype that may progress upon further dif-
ferentiation and/or cultivation. Consistently, attempts to differentiate
TDG-deficient neuronal progenitor cells to terminal neurons failed
because of a rapid loss of cell viability in neuronal-rich medium.
We thenwonderedwhether this epigenetic functionofTDG involves
active DNA repair, as implicated by the inability of a catalytic-dead
TDG (N151A) to complement the loss of Sfrp2 and Twist2 expression
in Tdg null MEFs (Fig. 2). To monitor a possible engagement of down-
streambase excision repair, we first performedChIP for XRCC117. This
revealed a specific, TDG-dependent enrichment of this critical base
excision repair protein at the Hoxd13, Hoxa10, Sfrp2 and Twist2 pro-
moters in MEFs but not in ESCs (Fig. 4a and Supplementary Fig. 5b).
Hence, in MEFs, where TDG helps maintain these promoters in an
active state, its presence correlates with an enrichment of XRCC1. In
ESCs, however, where TDG also associates with these promoters but
does not affect their chromatin status, XRCC1 enrichment is not
observed. Besides XRCC1, we also found APE1, another component
of base excision repair, to associate with these promoters in a TDG
dependentmanner inMEFs (Fig. 4a).Moreover, retinoic acid treatment
of ESCs for 8 h increased the number of chromatin-associated XRCC1
foci in the presence but not in the absence of TDG (Supplementary Fig.
9), and TDG-proficient cells were significantly more sensitive to
poly(ADP-ribose) polymerase (PARP) inhibition than TDG-deficient
cells upon retinoic-acid-induceddifferentiation (Supplementary Fig. 10).
These observations strongly suggest that cell differentiation-induced
TDG activity feeds into PARP and XRCC1-dependent DNA single-
strand break repair18.
Addressing thephenotypeonhistonemodifications,we then foundby
ChIP that the absence of TDG also compromises the association of the
H3K4-specific methyltransferase MLL1 with the promoters of Hoxd13,
Hoxa10, Sfrp2 andTwist2 (Fig. 4b). This was apparent in TDG-deficient
MEFs but not in ESCs, with the former indeed showing a loss of H3K4
methylation and an occurrence of aberrant CpG methylation at gene
promoters reminiscent of the phenotype of MLL defects19–21. Similar to
MLL, the binding of CBP/p300 to these promoters was significantly
reduced in the Tdg null MEFs (Fig. 4b). CBP/p300 is a transcription-
activating histone acetyltransferase known to interact with TDG4 and,
notably, its associationwith gene promoters has been reported to protect
from polycomb-mediated H3K27 trimethylation22.
Taken together, our data suggest structural and catalytic functions of
TDG in epigenetic maintenance (Fig. 4c). As a structural component,
TDG complexes with activating histone modifiers (for example, MLL,
CBP/p300) to maintain states of active (H3K4me2) and bivalent
(H3K4me2, H3K27me3) chromatin during cell differentiation. In
the absence of TDG, the assembly and function of such complexes is
distorted and, consequently, chromatin modifications imbalanced
towards repressive states. TDG also provides DNA repair capacity to
erase CpGmethylation locally. Aberrantmethylation arises at GC-rich
promoters in TDG-deficient cells following lineage commitment, and
the frequencies and patterns of these events indicate an underlying
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Figure 3 | TDG-dependent differences in gene expression and chromatin
status arise during cell differentiation. a, Scatter plots comparing gene
expression profiles of Tdg1/2 and Tdg2/2 ESCs or in vitro differentiated
neuronal progenitors. Green and red dots indicate differentially expressed
genes at P, 0.05 and P, 0.01, respectively. b, ChIP–qPCR analysis of TDG
association with the gene promoters indicated in chromatin from Tdg1/2 and
Tdg2/2 ESCs and neuronal progenitor (NP) cells. Shown is the relative
enrichment of TDG at these promoters normalized to a randomly chosen
intergenic control region (means6 s.e.m.; ESCs, n5 3; neuronal progenitor
cells, n5 3; *P, 0.05, **P, 0.01; unpaired Student’s t-test). c, DNA
methylation states at the Hoxa10 and Pax6 promoters in TDG-deficient ESCs
and neuronal progenitor cells analysed by bisulphite pyrosequencing.
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indicate CpG sites, bent arrows transcription start sites, and horizontal brackets
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stochastic process of de novomethylation. Hence, TDG keeps de novo
DNMT activities in check to avoid erroneous methylation, and the
engagement of XRCC1 and APE1 suggests that it operates through
base excision repair. Several previous studies have implicated TDG in
active DNA demethylation8,9,23. Mechanistically, it may do so on its
own, acting as a 5-mC DNA glycosylase23, or it may cooperate with a
5-mC deaminase (for example, AID/Apobec24,25 or DNMTs8), or a
5-mC hydroxylase (for example, TET126,27) that would convert 5-mC
into a favourable substrate for TDG. Numerous efforts to reproduce
5-mC glycosylase activity for mouse and human TDG have failed
(Supplementary Fig. 11 and unpublished observations). We therefore
consider a deamination or hydroxylation-mediated, TDG-dependent
repair process a preferable model for active cytosine demethylation.
The mouse Tdg knockout phenotype shows that such an epigenetic
control system has evolved to protect critical DNA sequences from de
novomethylation and heterochromatinization during development.
METHODS SUMMARY
Tdg knockout mouse and cell lines. The Tdg-targeting construct (Supplemen-
tary Fig. 1)was generated by replacement of aNarI–PacI fragment enclosing exons
6 and 7 by a neomycin resistance cassette in a cloned fragment spanning exons
5–10 of theTdg locus. This construct was used to target theTdg allele in 129mouse
ESCs, which were then used to generate chimaeras and, ultimately, Tdg1/2
heterozygotes by backcrossing to C57BL/6. The generation and establishment of
MEFs and Tdg2/2 ESCs was previously described28.
In vitro differentiation. In vitro differentiation of ESCswas performed essentially
according to the protocol published in ref. 16. RNA isolation for transcriptome
analysis of MEFs or ESCs and neuronal progenitor cells was performed using the
RNeasy Mini Kit (Qiagen) or the Trizol reagent (Invitrogen), respectively.
Antibodies and sequences of oligonucleotides used for PCR with reverse tran-
scription (RT–PCR), bisulphite sequencing and ChIP are listed in Supplementary
Tables 1–4.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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Figure 4 | Structural and catalytic functions of TDG in epigenetic
maintenance. a, ChIP–qPCR analysis of XRCC1 and APE1 association with
the gene promoters indicated in chromatin of TDG-proficient and -deficient
MEFs and ESCs. Shown are relative enrichments of XRCC1 and APE1 at these
promoters normalized to a randomly chosen intergenic control region
(means6 s.e.m.; n$ 3; *P, 0.05; **P, 0.01; unpaired Student’s t-test).
b, ChIP–qPCR analysis of MLL1 and CBP/p300 association with the gene
promoters indicated in chromatin of TDG-proficient and -deficient MEFs and
ESCs. Shown are relative enrichments of MLL1 and CBP/p300 at these
promoters normalized to a randomly chosen intergenic control region
(means6 s.e.m.; n$ 3; *P, 0.05; **P, 0.01; unpaired Student’s t-test).
c, Model summarizing epigenetic aberrations and implicated functions
observed in the absence of TDG. In ESCs TDG associates with gene promoters
in an active ‘open’ (H3K4me2, for example; Sfrp2 and Twist2, left side) or
transiently silent ‘bivalent’ chromatin conformation (H3K4me2 and
H3K27me3, for example;Hoxd13 andHoxa10, right side). In active chromatin,
the lack of TDG results in a partial loss of H3K4 dimethylation and a gain of
H3K27 trimethylation as well as in sporadic DNAhypermethylation (red balls)
upon cell differentiation. Differentiation-associated activation of promoters in
‘bivalent’ chromatin involves the demethylation of H3K27me3 and
transcription factor binding. The absence of TDG results in an aberrant loss of
H3K4 dimethylation accompanied by a gain in repressive H3K9 and H3K27
trimethylation and in DNA methylation, eventually directing irreversible
transcriptional silencing. In both cases, the loss of active and the gain in
repressive histone marks can be accounted for by a failure of TDG-deficient
cells to targetMLL and CBP to these promoters. We propose that TDG, as part
of transcription regulatory complexes, assures the establishment and the
maintenance of proper epigenetic states at developmentally regulated gene
promoters. As a DNA glycosylase, it protects these regions from aberrant CpG
methylation in a process that engages XRCC1 and APE1, factors essential for
downstream base excision repair.
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METHODS
Tdg knockout strategy. The Tdg-targeting construct (Supplementary Fig. 1) was
generated by replacement of a NarI–PacI fragment enclosing exons 6 and 7 by a
neomycin resistance cassette in a cloned fragment spanning exons 5–10 of theTdg
locus. This construct was used to target the Tdg allele in 129 mouse ESCs, which
were then used to generate chimaeras and, ultimately, Tdg1/2 heterozygotes by
backcrossing to C57BL/6. The generation and establishment of MEFs and Tdg2/2
ESCs was previously described28.
Cell culture and ESC differentiation. SV40-immortalized MEF cell lines were
previously described29 and cultivated in growthmedium(DMEM, 10%FCS, 2mM
L-glutamine) at 37 uC in a humidified atmosphere containing 5%CO2. For growth
of cell lines complemented with Tdg-expressing vectors, the growth medium was
additionally supplemented with 1mgml21 puromycin.
For isolation of primary MEFs, 10.5 days post-coitum embryos were dissected,
homogenized and cells dissociated in 0.05% trypsin-EDTA for 5min before plat-
ing inmodified ES cell mediumwithout LIF (DMEM, 10% FCS seraplus, 13 non-
essential amino acids, 1mM sodium pyruvate, 2mM L-glutamine and 50mM
b-mercaptoethanol, 13 penicillin/streptomycin) and cultivation for 10 days.
ESCs were grown in the presence of feeder cells at 37 uC in ES cell medium
(ECM: DMEM, 15% heat-inactivated FCS, LIF (1,000Uml21), 13 non-essential
aminoacids, 1mMNa-pyruvate, 2mML-glutamine and90mMb-mercaptoethanol)
in a humidified atmosphere containing 5% CO2.
Before starting retinoic-acid-induced differentiation , ESCs were grown in the
absence of feeder cells for two passages. For embryoid body formation during
neuronal differentiation, 43 106 Tdg1/2 or Tdg2/2 ESCs were plated into non-
adherent bacterial dishes (Greiner Bio-one) in differentiation medium (ECM
without LIF and with 10% FCS) and grown at 37 uC with a medium exchange
after 2 days. After 4 days, 5mM all-trans retinoic acid was added and cells were
further incubated for 4 days with a medium exchange after 2 days. Embryoid
bodies were washed twice with 13 PBS and dissociated with freshly prepared
trypsin solution (0.05% TPCK-treated trypsin in 0.05% EDTA/13 PBS) at
37 uC for 3min. Dissociated embryoid bodies were re-suspended in 10ml differ-
entiation medium and collected by centrifugation at 700g for 5min at room
temperature. The pellet was re-suspended in N2 medium (DMEM-F12 nutrient
mixture 1:1, 13 N2 supplement) and the cell suspension filtered through a 40-mm
nylon cell strainer (BD). Filtered cells were immediately plated onto poly-L-lysine
and laminin-coated dishes at a density of 53 106 cells per 60-mmdish or 1.53 107
cells per 100-mm dish. The N2 medium was exchanged 2 and 24h after plating,
and cells were collected after 4 and 48h for further analysis.
Retinoic-acid-induced differentiation of ESCs for time course, PARP inhibitor
and immunofluorescence experiments was induced in ECM without LIF in the
presence of 1 or 5mM retinoic acid. The retinoic-acid-containing medium was
exchanged every 24 h, and cells were collected at the indicated time points. For
immunofluorescence experiments, 105 ESCs were seeded onto gelatin-coated
cover slips 1 day before differentiation. For the analysis of PARP inhibition on
cell survival during differentiation, 105 ESCswere seeded into gelatin-coated 12-well
dishes, 1 day before the addition of 5mMretinoic acid or further cultivation in ECM.
After 24 h, increasing concentrations of the PARP inhibitor AG-014699 (a gift of
SelleckChem)were added and cell numbers determined 24h laterwith theCASYcell
counter. The 50% lethal dose of the inhibitor and statistical differences betweenTdg-
proficient and -deficient cells were calculated on triplicate experiments by linear
regression with 95% confidence intervals using GraphPad Prism software.
Microarray gene expression analysis. For the analysis of differential gene
expression between Tdg1/2 and Tdg2/2 MEFs, total RNAwas isolated from three
independent cultures of each cell line using the RNeasy Mini Kit (Qiagen), cDNA
synthesized from 13mg RNA with the SuperScript double-Stranded cDNA
Synthesis Kit (Invitrogen) followed by in vitro transcription reactions using the
MEGA Script T7 Kit (Ambion) supplemented with 1.5mMBio-11-CTP and Bio-
16-UTP (Enzo Life Sciences). cDNAs and cRNAs were purified using the
GeneChip Sample Cleanup Module (Qiagen). cRNA (15mg) was fragmented
and hybridized to GeneChip Mouse Expression Arrays 430A (Affymetrix).
Hybridized arrays were stained and washed according to the manufacturer’s pro-
tocol and scanned with an Affymetrix Scanner 3000 7G. Scanned images were
processed with Microarray Suite software and obtained ‘cel’-files used for further
data analysis.
For gene expression analysis of ESCs and in vitro differentiated neuronal pro-
genitor cells, total RNA was extracted from independent triplicates using the
Trizol reagent (Invitrogen). RNA was quantified using the Quant-iT RiboGreen
RNAAssay (Invitrogen) and500ng of total RNA subjected to cDNAsynthesis and
subsequent in vitro transcription to biotiylated cRNA using the Illumina
TotalPrep RNAAmplification Kit (Ambion, USA). cRNA (1.5mg) was hybridized
to MouseWG-6v2 slides (Illumina) according to the manufacturer’s protocol.
Bead arrays were washed and stained using FluoroLink Cy3 Streptavidin (GE
Healthcare). Fluorescent signals were imaged using the iScan system (Illumina).
Scanner images files were processed to probe intensity files by the manufacturer’s
software and further processedwith the genome studio software (Illumina)without
normalization and background correction.
Affymetrix data and Illumina probe intensity data were either processed by
robust multi-array average or variance stabilization transformation, respectively,
using R/Bioconductor software and ‘affy’ or ‘lumi’ libraries, followed by quantile
normalization. Significanceof effects for probes (Illumina) or probe-sets (Affymetrix)
was tested in R/Bioconductor (‘limma’ library) using a moderated t-test and the
false discovery rate (55%)methodofBenjamini andHochberg formultiple testing
correction. No unspecific filter was applied and multiple probe-sets per gene or
probe-sets with ambiguous genomic targets were retained.
Methylation analyses.GenomicDNA fromMEFs, ESCs and neuronal progenitor
cells was isolated with the QIAamp DNA Mini Kit (Qiagen). DNA (2mg) was
subjected to bisulphite conversion using the EZ DNA Methylation Kit (Zymo
Research). Respective target regions were amplified from bisulphite-treated DNA
withTrueStartTaqpolymerase (NewEnglandBiolabs). For conventionalbisulphite
sequencing, Hoxd13 or Sfrp2 promoter regions were amplified from converted
DNA and cloned into the XhoI and BamHI restriction sites of pBluescript SK-
before sequencing of individual clones. For pyrosequencing, potential regions of
hypermethylation were first identified by COBRA. Pyrosequencing primers
(Supplementary Table 1) were designed using the PyroMark Assays Design soft-
ware (version 2.0.1.15, Qiagen). Primer pairs included either one biotinylated
primer or one primer containing a universal region. In the latter case, products
were subjected to a second amplification using a biotinylated universal primer and
Phusion Hot Start High-Fidelity DNA Polymerase (Finnzymes). PCR products
were purified using the QIAquick PCR Purification Kit (Qiagen), quantified and
300–500ng were used for pyrosequencing in a PyroMark Q24 (Qiagen). Reactions
were analysedusingPyroMarkQ24 software (version 2.0.6,Qiagen). Significanceof
methylation differences between different Tdg-proficient and -deficient cell lines at
individual CpG sites was evaluated by unpaired, two-tailed t-tests.
ChIP. To crosslink protein-bound DNA, MEFs, ESCs and neuronal progenitor
cells were incubated in freshly prepared crosslinking solution (PBS pH 7.4, 1%
formaldehyde) at room temperature. The reaction was quenched after 10min by
addition of glycine to a final concentration of 125mM. After washing twice with
cold PBS, cells were collected using a cell scraper and subsequent centrifugation at
600g and 4 uC. Nuclei were isolated by incubation in 200ml of cold ChIP Buffer I
(10mM HEPES pH 6.5, 10mM EDTA, 0.5mM EGTA, 0.25% Triton X-100) for
5min on ice followed by two incubations of 5min on ice in 200ml cold ChIP buffer
II (10mMHEPES pH 6.5, 1mM EDTA, 0.5mM EGTA, 200mMNaCl). Pelleted
nuclei were lysed in 400ml ChIP buffer III (50mMTris-HCl pH 8.0, 1mMEDTA,
0.5%TritonX-100, 1%SDS, 1mMPMSF) for 10min on ice followed by sonication
for 15min (15 s on, 30 s off, power high) using a Bioruptor sonicator (Diagenode)
to produce random chromatin fragments ranging from 300 to 1,000 base pairs.
The solution was cleared by centrifugation at 14,000g and 4 uC for 10min and the
concentration of chromatin was estimated by absorbance at 260nm. For ChIP of
TDG, MLL and APE1 100–150mg of chromatin were diluted ten times in ChIP
dilution buffer I (50mM Tris-HCl pH 8.0, 1mM EDTA, 150mM NaCl, 0.1%
Triton X-100, 1mM PMSF). For histone ChIPs, 25–75mg of chromatin were
diluted in ChIP dilution Buffer II (16.7mM Tris-HCl pH 8.0, 1.2mM EDTA,
167mM NaCl, 1.1% Triton X-100, 0.01% SDS, 1mM PMSF). Diluted chromatin
was pre-cleared at 4 uC for 1 h with 40ml of a 50% slurry of magnetic Protein G
beads (Invitrogen) preblocked with 1mgml21 BSA and 1mgml21 tRNA (TDG,
XRCC1, APE1 and MLL-ChIPs) or salmon sperm single-stranded DNA (histone
ChIPs). Precleared chromatinwas incubatedwith 2–5mg of the respective antibody
(Supplementary Table 2) overnight at 4 uC under slow rotation. Immuno-
complexes were precipitated with 40ml of a 50% slurry of blocked Protein G beads
and further incubated at 4 uC for 2 h. Beads were then serially washed with 500ml
ChIP wash buffer I (20mM Tris-HCl pH 8.0, 2mM EDTA, 150mM NaCl, 0.1%
SDS, 1%TritonX-100), 500ml ChIPwash buffer II (20mMTris-HCl pH8.0, 2mM
EDTA, 500mMNaCl, 0.1%SDS, 1%TritonX-100) and 500ml ChIPwash buffer III
(10mM Tris-HCl pH 8.0, 1mM EDTA, 250mM LiCl, 1% sodium deoxycholate,
1%NP-40). For TDG, APE1 andMLL ChIPs, beads were washed once with 500ml
ChIP wash buffer I and twice with 500ml ChIP wash buffer II. After two additional
washes with 500ml TE buffer (10mM Tris-HCl pH 8.0, 1mM EDTA), bound
complexes were eluted by two sequential incubations with 150ml elution buffer
(1% SDS, 0.1 M NaHCO3) at 65 uC for 10min. Crosslink reversal of eluates and
respective input samples (1% of chromatin used for ChIP)was done in the presence
of 200mMNaCl at 65 uC for 4 h followed by proteinase K digestion (50mgml21) in
the presence of 10mM EDTA at 45 uC for 1 h. DNA was purified by phenol/
chloroform extraction and Na-acetate/ethanol precipitation, and re-suspended
in 10mM Tris-HCl pH 8.0. qPCR analysis with target specific primers (Sup-
plementary Table 3) was performed using Quantitect SYBR Green (Qiagen) with
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a Rotor-Gene 3000 thermocycler (Qiagen). The significance of different ChIP
efficiencies among Tdg-proficient and -deficient cell lines was evaluated from
triplicate experiments by non-paired, two-tailed t-tests.
MeDIP. MeDIP assays were performed as described in ref. 30. Briefly, genomic
DNA was prepared from 53 106 cells by incubation in lysis buffer (20mM Tris-
HCl pH 8.0, 4mM EDTA, 20mM NaCl, 1% SDS and 1mgml21 proteinase K) at
55 uC for 5 h and subsequent phenol/chloroformextraction andNa-acetate/ethanol
precipitation. DNA pellets were re-suspended in TE containing 20mgml21 RNase.
DNA was sonicated as described for ChIP followed by NaCl (400mM)/EtOH
precipitation in the presence of glycogen-carrier. Fragmented DNA (4mg) in
450ml TE was denatured at 95 uC for 10min and immediately chilled on ice.
After addition of 103 immunoprecipitation buffer (100mM sodium phosphate
pH 7.0, 1.4 M NaCl, 0.5% Triton X-100), the DNA was incubated with 10mg of a
monoclonal anti 5-methylcytidine antibody (clone 33D2, Eurogentec) at 4 uC for
2 h. Immuno-complexes were precipitated by the addition of 40ml M-280 sheep
anti mouse IgG antibody coupled Dynabeads (Invitrogen) and incubation at 4 uC
for 2 h followedby threewashes in 700ml IPbuffer. Boundmaterialwas treatedwith
250ml proteinase K digestion buffer (50mMTris-HCl pH 8.0, 10mMEDTA, 0.5%
SDS and 0.25mgml21 proteinase K) at 50 uC for 3 h. Immunoprecipitated methy-
lated DNA was purified by phenol/chloroform extraction followed by Na-acetate/
ethanol precipitation and re-suspended in TE. qPCR analysis of sonicated genomic
inputDNA andMeDIPDNAwith target specific primers (Supplementary Table 3)
was performed as described for ChIP, and significance ofMeDIP efficiencies tested
by non-paired, two-tailed t-tests.
Quantitative RT–PCR analyses. Total RNA (2–4mg) extracted by RNeasy Mini
Kit or by Trizol methods was reverse transcribed with the RevertAid H Minus
M-MuLV Kit (Fermetas) according to the manufacturer’s protocol. qPCR with
target specific primers (Supplementary Table 4)was performed using Power SYBR
Green Master Mix (Applied Biosystems) with a Rotor-Gene 3000 thermocycler.
Conditions for each target were validated by standard andmelting curve analyses.
Target-specific amplificationswere normalized to aGAPDHcontrol and data of at
least three independent experiments were analysed by unpaired, two-tailed t-tests.
Tdg genotype-specific target gene expression in primaryMEFswas analysed by the
non-parametric Kruskal–Wallis test and post hoc Dunn’s multiple comparison.
Western blot analyses.Whole-cell extractswerepreparedbycell lysis in lysis buffer
(50mM Na-phosphate pH 8.0, 125mM NaCl, 1% NP-40, 0.5mM EDTA, 1mM
PMSF, 1mM DTT, 13 complete protease inhibitor, 23 phosphatase inhibitor
cocktail 1 and 2) on ice for 30min and clarification by centrifugation (15min,
20,000g, 4 uC). Chromatin extracts were isolated as described for ChIP assays.
Soluble proteins (50mg) were separated on 7% or 10% SDS–polyacrylamide gels
and transferred to a nitrocellulosemembrane (Millipore).Membranes were washed
once with TBS-T (100mM Tris-HCl pH 8.0, 150mM NaCl, 0.1% Tween-20),
blocked with blocking buffer (TBS-T, 5% dry milk) at room temperature for 1 h
and incubated with the primary antibody at 33 uC (anti-mTDG) or room temper-
ature (anti-DNMT1, anti-DNMT3a, anti-XRCC1, anti-APE1, anti-MLL, anti-b-
actin) for 1 h in blocking buffer. Dilutions were 1:10,000 for the rabbit anti-
mTDG, the mouse anti-b-actin and the anti-DNMT1 antibodies; 1:1,000 for the
anti-DNMT3a and anti-XRCC1 antibodies; 1:500 for the anti-APE1 and anti-MLL
antibodies.Washing steps after hybridization were once at 33 uC and twice at room
temperature for 15min for anti-mTDG, or three times at room temperature for
10min for all other antibodies. Membranes were incubated with secondary HRP-
conjugated antibodies diluted 1:5,000 in blocking buffer and at room temperature
for 1 h. After three washing steps of 10min at room temperature, detection of the
signals was performed using the Immobilon Western Chemiluminescent HRP
Substrate (Millipore).
Cytotoxicity assays. For measurement of c-ray sensitivity, MEF single-cell sus-
pensions at a cell density of 23 105 cellsml21 in PBS were irradiated with the
indicated doses in a Gammacell 40 irradiator using 137Cs as a radioactive source.
Irradiated cells were plated in 96-wellmicrotitre plates at a density of 1000 cells per
well in growth medium, and survival was measured after 3 days using the Cell
Counting Kit-8 (Dojindo). Alternatively, survival was determined by clonogenic
growth by plating 500–2000 cells in triplicate in 10-cm dishes containing growth
mediumand counting ofGiemsa-stained colonies after 10 days. Tomeasure sensi-
tivity to H2O2, cells were plated at 2,500 cells per well in 96-well plates. After 24 h
cells were treated for 15min with the indicated concentrations of H2O2, washed
with PBS and incubated in fresh growth medium for a further 24 h before mea-
surement of survival with the Cell Counting Kit-8. Survival was determined as the
percentage of mock-treated cells.
Base release assay. For base release assays, 25–50mg of ESC whole-cell extracts
were incubatedwith 0.5 pmol of a fluorescein-labelledGC/TG,GCm/CGorGCm/
mCG DNA substrate in reaction buffer (50mM Tris-HCl pH 8.0, 1mM EDTA,
1mM DTT, 1mgml21 BSA) at 37 uC for 1 h (GC/TG) or overnight (methylated
substrates). Resulting AP-sites were cleaved by the addition of NaOH to a final
concentration of 100mMandheating to 95 uC for 10min. Subsequently,DNAwas
ethanol-precipitated overnight at 220 uC in the presence of 0.3M Na-acetate pH
5.2 and 0.4mgml21 carrier t-RNA. DNAwas collected by centrifugation (20min,
20,000g, 4 uC) and washed with 80% ethanol. Air-dried pellets were re-suspended
in loading buffer (13 TBE, 90% formamide), heated at 95 uC for 5min and
immediately chilled on ice. Reaction products were separated on denaturing
8M urea/15% polyacrylamide gels in 13 TBE. The fluorescein-labelled DNA
was visualized with a Typhoon 9400 and quantified using ImageQuant TL soft-
ware (GE Healthcare).
Immunofluorescence. For detection of XRCC1 foci during retinoic acid stimu-
lation, cells were fixed in ice-cold methanol for 5min, then permeated in 0.2%
Triton X-100/PBS pH 7.4 and 0.2% Triton X-100/0.2%NaBH4/PBS pH 7.4 on ice
for 5min each. The induceability of XRCC1 foci formation in ESCs was tested by
incubationwithH2O2 (50mMinPBS) or PBS for 15min at 37 uCandan additional
5min in ECM with LIF before further processing. Coverslips were blocked in
blocking buffer (1% BSA/0.05% Tween20/PBS pH 7.4), stained with rabbit anti-
XRCC1 antibody (1:100 in blocking buffer) at room temperature for 1 h and
washed three times for 10min with blocking buffer before labelling with goat
anti-rabbit Alexa Fluor 594 (1:200 in blocking buffer) for 30–60min. After two
washes of 10min with blocking buffer, cells were again fixed in 220 uC cold
methanol, incubated in blocking buffer for 1 h and stained with a mouse mono-
clonal anti-PCNA antibody (1:100 dilution) in blocking buffer overnight at 4 uC.
Slides were counterstained for DNA with 50ng ml21 DAPI and mounted in
VectaShieldmountingmedium (Vector Lab). Slides were randomized and blinded
before z-stacks were acquired on a Leica SP5with the 405-nmdiode, argon 488nm
and He–Ne 594-nm laser lines. XRCC1 foci numbers for individual cells were
determined by visual inspection of the three-dimensional stacks. One hundred
and fifty (retinoic acid stimulation) or 50 (H2O2) cells per sample were analysed.
For co-staining of PAR and XRCC1 during retinoic acid differentiation, cells were
fixedwith2% formaldehyde/PBS at roomtemperature for 30minandpermeabilized
with PBS/0.2% Triton-X100 for 30min. Antigene detection was done with a 1:250
diluted monoclonal a-PAR antibody 10H (Enzo Life Sciences) and a polyclonal
a-XRCC1 as described above, but using 1:250 diluted anti-rabbit Alexa Fluor 594
and anti-mouse Alexa Fluor 488 secondary antibodies (Invitrogen). Pictures were
acquired with a Nikon Diaphot 300 epifluorescence microscope using identical
settings for all slides.
29. Kunz, C. et al. Base excision by thymine DNA glycosylase mediates DNA-directed
cytotoxicity of 5-fluorouracil. PLoS Biol. 7, e91 (2009).
30. Weber,M.et al.Chromosome-wideandpromoter-specific analyses identify sites of
differential DNA methylation in normal and transformed human cells. Nature
Genet. 37, 853–862 (2005).
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Summarizing Figure. The role of TDG in epigenetic control. TDG sustains proper 
(permissive) epigenetic states at gene promoters. As a structural component of 
transcription regulatory complexes, it contributes to the establishment and/or 
maintenance of accurate histone modification patterns (1), as a DNA repair enzyme, it 
corrects occasional aberrant de novo methylation of cytosine bases (2). 
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Supplementary Figure 1 | Tdg knockout strategy and validation. a, Schematic of the 
mouse Tdg locus representing exons 5-10. The insertion of the neomycin-resistance 
cassette to replace exons 6-7 is indicated, as well as the positions of probes used for 
Southern blotting (b) and primers for genotyping (c). b, Southern blot of EcoRI digested 
genomic DNA extracted from three E14 ESC clones (C49, C57, C77) with targeted Tdg 
locus. EcoRI digestion generated 9 kbp and 7.8 kbp DNA fragments for the wild-type 
and targeted Tdg alleles, respectively, here detected with a flanking probe external to 
the targeting construct as indicted in (a). c, PCR genotyping of Tdg knockout embryos. 
DNA was isolated from portions of embryos and analyzed by PCR using a primer pair 
amplifying both the targeted (1.7 kbp) and wild-type Tdg alleles (1.1 kbp). Shown are 
the PCR results of consecutive samples representing two Tdg+/+, one Tdg+/- and two Tdg-
/- genotypes. d, Pre-natal recovery of Tdg+/+, Tdg+/- and Tdg-/- embryos after timed 
matings. Note that the Tdg null embryos isolated at E12.5 were all dead. e, Northern 
blot analysis of Tdg expression in MEFs isolated from Tdg+/+, Tdg+/-, and Tdg-/- embryos. 
Blots were probed using a cDNA fragment spanning Tdg exons 8 to 10, amplified by 
RT-PCR. e, Western blot analysis of whole-cell protein extracts derived from SV40 
immortalized Tdg+/+ and Tdg-/- MEFs and Tdg-/- complemented with wild-type (pTdg) 
and catalytically deficient (pTdgcat) TDG or a vector control (pC). TDG was stained 
with a highly specific polyclonal anti-mouse TDG antibody (TDG) and staining for β-
ACT served as loading control. 
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Supplementary Figure 2 | Lack of DNA repair associated phenotypes in TDG 
deficient cells. a, Sensitivities towards ionizing radiation (ɣ-ray) or hydrogen peroxide 
(H2O2) of Tdg+/-, Tdg-/- or complemented Tdg-/- MEFs. Shown are survival curves as 
percentages of mock-treated cells (means ± s.e.m., n=3). pV, vector control; pTdg, Tdg-
expressing vector. c, cII mutation frequencies in Tdg and Mbd4 single or double mutant 
MEFs. The cII mutant frequency is the ratio of cII− plaques to the total number of λ 
phage screened. Shown are mutation frequencies with 95% confidence intervals as 
calculated from the binominal proportions, with M indicating the actual number of 
mutant plaques scored for each genotype. 
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Supplementary Figure 3 | Gene ontology analysis and expression of selected targets 
in primary MEF isolates. a, Gene ontology (GO) annotations of the 200 most 
differentially regulated genes (p<0.05) reveal a significant enrichment of developmental 
pathways (Ingenuity Pathway Analysis). b, Expression levels of selected genes in 
primary MEFs isolated from Tdg+/+, Tdg+/-, and Tdg-/- embryos at 10.5 dpc and cultured 
for 10 days. Gene expression was assessed by qRT-PCR, mRNA levels were 
normalized to Gapdh mRNA. Values represent arbitrary units with medians of six 
independent MEF isolates indicated by horizontal bars. 
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Supplementary Figure 4 | CpG methylation states of selected target promoters in 
MEFs. DNA methylation analysis by bisulfite pyrosequencing of Hoxd13, Twist2, 
Hoxa10 and Rarb promoter regions in Tdg+/+, Tdg+/- and Tdg-/- MEFs. Promoter regions 
are depicted schematically with vertical tick marks indicating CpG sites, bent arrows 
denoting transcription start sites, and horizontal brackets highlighting the CpGs for 
which methylation data is presented in the graphs below. Methylation levels are given 
as percentage of methylated cytosines at each CpG analyzed. Shown are means with 
95% confidence intervals (bars) as obtained from at least 3 independent DNA isolations 
and bisulfite conversions for each genotype. *, p<0.05; **, p<0.01; ***, p<0.001; 
unpaired Student’s t-test. 
Supplementary Fig. 5
MEF Extracts
TDG
DNMT1
DNMT3a
β-ACT
+/+ +/- -/-
Genotype
ß-act
Dnmt1
Tdg
Dnmt3a
+/+
p
C
p
T
d
g
p
T
d
g
ca
t
-/-
ß-act
Tdg
Complementation
- -
a
c
MEFs 
+/+ +/- -/- +/- -/- 
Genotype 
ESC 
MLLc 
!-ACT 
!-ACT 
MEFs 
+/+ +/- -/- +/- -/- 
Genotype 
ESC 
!-ACT 
APE1 
XRCC1
b
 
Supplementary Figure 5 | Validation of proteins levels and ChIP analysis of 
DNMT3a in TDG proficient and deficient MEFs. a, Western blots showing protein 
levels of TDG, DNMT1 and DNMT3a in whole cell extracts (WCE) of Tdg+/+, Tdg+/- 
and Tdg-/- MEFs with β-ACT as loading control. 50 µg of WCE were loaded in parallel 
on 10% (TDG, β-ACT) or 7% (TDG, DNMT1, DNMT3a) polyacrylamide gels and 
proteins detected with the respective antibodies after protein transfer. b, Western blots 
showing XRCC1, APE1 protein levels in 50 µg chromatin extract of Tdg+/+, Tdg+/- and 
Tdg-/- MEFs and Tdg+/- and Tdg-/- ESCs. β-ACT was used as loading control. c, Western 
blot showing MLLc protein levels in 50 µg of chromatin extracts of Tdg+/+, Tdg+/- and 
Tdg-/- MEFs and Tdg+/- and Tdg-/- ESCs with β-ACT as loading control. 
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Supplementary Figure 6 | In vitro differentiation of ESCs to the neuronal lineage. 
a, Schematic of the protocol used for in vitro differentiation of ESCs to NPs. ESCs were 
differentiated into embryoid bodies (EB) in the absence of LIF. EBs were treated with 
RA prior to dissociation and plating in N2 medium. ESCs and NPs at 4 or 48 hours after 
EB dissociation and plating were harvested for ChIP, DNA methylation and gene 
expression analyses. All differentiation experiments were done in biological triplicates. 
LIF, leukemia inhibitory factor; RA, all-trans retinoic acid. b, Scatter plots comparing 
gene expression before and after differentiation of Tdg+/- or Tdg-/- ESCs to NPs. Green 
(p<0.05) and red (p<0.01) dots represent differentially expressed genes. c, Validation of 
regulation of Oct4 and Gata6 expression following a time course of RA-induced cell 
differentiation. Shown are expression levels (qRT-PCR) relative to undifferentiated 
ESCs of the same genotype (mean±s.e.m., n=3, * p<0.05, unpaired Student’s t-test). d, 
ChIP analysis of TDG association with the promoters of Hoxd13, Oct4 and Nanog in 
chromatin of Tdg+/- and Tdg-/- ESCs, 48h NPs and MEFs. Shown are relative 
enrichments normalized to a random intergenic control region as determined by qPCR 
(mean±s.e.m., n=3; *, p<0.05; **, p<0.01; unpaired Student’s t-test). 
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Supplementary Figure 7 | Gene ontology and DNA methylation analyses of TDG 
controlled genes during ESC - NP differentiation. a, Gene ontology (GO) 
annotations of the 200 most differentially regulated genes (all p<0.05) reveal a 
significant enrichment of developmental pathways (Ingenuity Pathway Analyses). b, 
The DNA methylation status at the Oct4, Pax6, Pdgfra, Gata6 and Tgfb2 promoters was 
analysed by MeDIP-qPCR in Tdg+/- and Tdg-/- ESCs and 4h NPs. The promoter region of 
Gapdh was used as internal normalizer (means±s.e.m., n=3, **p<0.01, unpaired 
Student’s t-test), T, target region; C, control region. c, Bisulfite pyrosequencing analysis 
of CpG methylation in the Tgfb2 promoter region in ESCs and NPs at 4 and 48h after 
plating of embryoid bodies in N2 medium. Promoter regions are depicted schematically 
with vertical tick marks indicating CpG sites, bent arrows denoting transcription start 
sites, and horizontal brackets highlighting the CpGs for which methylation data is 
presented in the graphs below. Methylation levels are given as percentage of methylated 
cytosines at each CpG analyzed. Shown are means with 95% confidence intervals (bars) 
as obtained from three differentiation experiments. *, p<0.05; **, p<0.01; ***, p<0.001 
(unpaired Student’s t-test). 
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Supplementary Figure 8 | Histone modification states in TDG deficient ESCs and 
NPs. ChIP-qPCR analyses performed on chromatin derived from Tdg+/- and Tdg-/- ESCs 
and NPs to assess the chromatin status at the TDG target promoters indicated. Data is 
expressed as relative enrichment normalized to Iap and the Hprt promoter for active and 
repressive chromatin marks, respectively (means±s.e.m., n=3; *, p<0.05; unpaired 
Student’s t-test). T, target region; C, control region. 
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Supplementary Figure 9 | TDG dependent DNA repair activity upon RA induced 
ESC differentiation. Immunofluorescence staining of XRCC1 and PCNA in Tdg+/- and 
Tdg-/- ESCs before (RA-, LIF+) and after 8 hours induction of differentiation by 5 µM 
retinoic acid (RA+, LIF-). a, Maximum intensity projections of confocal z-stacks for 
XRCC1 and PCNA immunofluorescence and for DNA counterstaining with DAPI. 
PCNA staining was used as an indicator of S-phase cells to monitor and control for 
potential proliferation difference. b, Induction of XRCC1 foci following RA exposure. 
Shown are numbers of XRCC1 foci per cell as determined in 5 independent 
experiments. 150 cells per sample and experiment were analyzed for the number of 
XRCC1 foci. c, Positive control of damage dependent induction of XRCC1 foci. Shown 
are numbers of XRCC1 foci per cell after treatment with 50 µM H2O2 in PBS (+) or 
PBS alone (-), as determined in 3 independent experiments. 50 cells per sample and 
experiment were analyzed. Note that the higher background of XRCC1 foci in the H2O2 
experiments results from the prolonged incubation of the cells in PBS. Dots indicate 
individual cells, red lines the medians, and asterisks statistical significance determined 
by the Mann-Whitney-U-test (*, p<0.05; **, p<0.01; ***, p< 0.001). 	
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Supplementary Figure 10 | TDG sensitizes differentiating cells to the inhibition of 
PARP activity. a, ES cells were kept undifferentiated (+LIF, -RA) or differentiated (-
LIF, +5 µM RA) for 48 hours in the presence of increasing concentrations of the PARP 
inhibitor (PARPi) AG-014699. Survival of Tdg proficient and deficient cells was 
measured and the LD50 determined by regression analysis (box, 95% confidence 
interval; line, LD50; *, p<0.05). Shown are representative epifluorescence images (100x 
magnification) of immunostainings for XRCC1 and poly(ADP)-ribose (PAR) in TDG 
deficient ES (b) and differentiating cells (c) treated without or with 10 µM PARP 
inhibitor. 
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Supplementary Figure 11 | TDG has no 5-mC DNA glycosylase activity on its own. 
Base release assays with whole cell extracts from Tdg+/-, Tdg-/- and Tdg-/- ESC 
expressing either TdgA, TdgB or harbouring the vector only. Synthetic 60-mer DNA 
duplexes containing either a GC/TG mispair (left panel), or hemi- (GCm/CG) or fully 
methylated (GCm/CmG) CpGs (right panel) were incubated with 25 µg and 50 µg of cell 
extracts at 37°C for 1 hour or overnight, respectively. Shown is a representative 
denaturing polyacrylamide gel showing the intact substrate (S) and cleaved product (P) 
at the top and bottom respectively with numbers at the bottom of the lanes representing 
the amounts of cleaved substrate (%). Neg. control = no extract. 
Supplementary Table 1: Pyrosequencing primers 
Primer 5’-3’ Sequence 
HoxA10 F GAGGGGTAGGGAGGAAAAGTGGT 
HoxA10 R b-AACCATTCCTAAATTTTCAACTCTAAACCCA 
HoxA10 S TTTGTAAGGTATTTAAAATAAGTAG 
HoxD13 F GGGTTATGAGTAGTTAGGGGATTTGGGATATGGATGG 
HoxD13 R GTCAGTCCAGTCCAGGTCAGGGTGAAGTATAGTATAGAGGTTGAGGTTGAATTTTAAAT 
HoxD13 S1 GGGGATTTGGGATATG 
HoxD13 S2 GTAGTAGAGTTTGGTTAG 
Pax6 F GAGTGGGGTGGGGGGAAAAT 
Pax6 R b-TTCACCCTAACTTCCCACCCCTTATCC 
Pax6 S1 GGGAAAATGGGTAGG 
Pax6 S2 GGTTTAGGTATAGTTGTGTTA 
Rarß F GTTAGATTGGTTGGGTTATTTGAAGGTTAG 
Rarß R GTCAGTCCAGTCCAGGTCAGGATCTTTTTCCCAACCCCCAATCATAAATTATAACAA 
Rarß S1 GGGTTATTTGAAGGTTAGTA 
Rarß S2 GTTTGGAAGGGAGAAT 
Rarß S3 GATTGGGATGTAGAGG 
Rarß S4 GGGGGGATTAGAGTTT 
Tgfß2 F TAATAGTATTAGGGATTTATTGTAGGAGAAGGTAAG 
Tgfß2 R b-AATTTACAAACCTATAAATCCCTCTCCATC 
Tgfß2 S GGGATTTATTGTAGGAGAAG 
Twist2 F GTCAGTCCAGTCCAGGTCAGGGTTGTGATGTTTAAGTTATAAAGTATTTAGGGGGTAG 
Twist2 R TCTCCTAAAACAAATTTAACCCTACCAAAATTC 
Twist2 S1 TTTCTAAACTACTTCAACCTA 
Twist2 S2 CCAAACCCAAATATACTC 
Unique b-GTCAGTCCAGTCCAGGTCAGG 
b-, biotinylated primer; F, forward primer; R, reverse primer; S, sequencing primer; underlined 
sequence, universal primer 
Supplementary Table 2: Antibodies  
Antibody Product Nr.   Manufacturer 
Anti-H3K4me2 07-030  Millipore, USA 
Anti-H3K9me3 pAb-056-050 Diagenode, UK 
Anti-H3K27me3 07-449 Millipore, USA 
Anti-MLLc 05-765 Millipore, USA 
Anti-Ref-1 (APE1; C-20) sc-334 Santa Cruz Biotechnology, Inc., USA 
Anti-Dnmt3a (H-295) sc-20703 Santa Cruz Biotechnology, Inc., USA 
Anti-CBP (A-22) Sc-369 Santa Cruz Biotechnology, Inc., USA 
Anti-Dnmt3a  ab2850 Abcam, UK 
Anti-Dnmt1 ab5208 Abcam, UK 
Anti-beta Actin ab8226 Abcam, UK 
Anti-5-MeCyd (33D2) BI-MECY-0100 Eurogentec, Belgium 
Anti-XRCC1  X0629 Sigma-Aldrich, USA 
Anti-PAR (10H) ALX-804-220 Enzo Life Sciences 
Anti-PCNA-Fluorescein P105 Leinco Technolgies, USA 
Anti-rabbit-HRP NA934 GE Healtcare, USA 
Anti-mouse-HRP NXA931 GE Healtcare, USA 
Anti-rabbit-Alexa594 A-11012 Invitrogen, USA 
Anti-mouse-Alexa488 A-11017 Invitrogen, USA 
 
Supplementary Table 3: ChIP and MeDIP primers 
Primer 5’-3’ Sequence 
pHoxD13F TGGGCTATGGCTACCACTTC 
pHoxD13R GACACTTCCTTGGCTCTTGC 
pHoxA10F CACTCCCAGTTTGGTTTCGT 
pHoxA10R GGGGGTACAGGTTCAAGAGC 
pSfrp2F GACTTTCGTTGCCTCCTCCT 
pSfrp2R AGGCCGGTCACTACTTTCTG 
pTwist2F TCGCTGTGATGCCTAAG 
pTwist2R CACGATCTCGCCTCTAGGAT 
pRarßF GGGAGTTTTTAAGCGCTGTG 
pRarßR CGGAGCAGCTCACTTCCTAC 
pTgfß2F AAGGGACGAGACGAGAAGGT 
pTgfß2R ACATCCACACGCACACTCAT 
pPax6F CGGTGAAAGAAGCCACTAGG 
pPax6R TAGGGCGTTTGTTTCCAAAT 
pOct4F GTGAGGTGTCGGTGACCCAAGGCAG 
pOct4R GGCGAGCGCTATCTGCCTGTGTC 
pGata6F AGTTTTCCGGCAGAGCAGTA 
pGata6R AGGAGGAAACAACCGAACCT 
pDnm1F ATTCGCGGACTGGTCACTAT 
pDnm1R TTAGCACCCCTAGCCATCAC 
pPdgfraF GGACGAGCGATCTGGAATAA 
pPdgfraR CCGTGCAGAAAAGACTCCAC 
pFgfr2F CTTCCAGAATCCAAGGACCA 
pFgfr2R CATCCCAATGCTGACATCTG 
IapF CTCCATGTGCTCTGCCTTCC 
IapR CCCCGTCCCTTTTTTAGGAGA 
pHprtF CCAAGACGACCGCATGAGAG 
pHprtR CAACGGAGTGATTGCGCATT 
Chr2negF AGCACAGCCTGAAGCCTCTA 
Chr2negR AGAGGGCATTTCCGTCTTTT 
 
Supplementary Table 4: qRT-PCR primers 
Primer Name  5’-3’ Sequence 
GapDH(U) TGCACCACCAACTGCTTA 
GapDH(R) GGATGCAGGGATGTTC 
HoxA10a RT F CTCCCTGGGCAGTTCCAAAG 
HoxA10a RT R CGCTACGGCTGATCTCTAGG 
HoxD13 RT1 F CGACATGGTGTCCACTTTTG 
HoxD13 RT1 R TGGTGTAAGGCACCCTTTC 
RT Sfrp2 fw3 GCCGGCCACAGAGGAAGCTC 
RT Sfrp2 rev3 GGTCCCTTTCGGACACGCCG 
Twist2 RT F CGTCTCAGCTACGCCTTCTC 
Twist2 RT R CTGAGATGTGCAGGTGGGTC 
Rar-b RT F TTAATCTGTGGAGACCGCCAG 
Rar-b RT R TTACACGTTCGGCACCTTTCG 
Pdgfra RT F CGAGGTCGTTGACCTGCAGTGG 
Pdgfra RT R CGACGAAGCCTTTCTCGTGGACC 
Tgfb2 RT F AGAATCGTCCGCTTTGATGT 
Tgfb2 RT R GCTGGGTGGGAGATGTTACG 
Oct3/4(U) GGCGTTCTCTTTGGAAAGGTGTTC 
Oct3/4(R) CTCGAACCACATCCTTCTCT 
Gata6 RT F TCCATGGGGTGCCTCGACCA 
Gata6 RT R ACCCCTGAGGTGGTCGCTTGT 
 
 
  
Curriculum Vitae          Annika Wirz 
 
 
Born on 4th November 1984 in Basel 
 
 
 
Education 
 
10/2009 – 07/2014 Doctoral Thesis in Molecular Genetics at the University of Basel 
 in Prof. Primo Schär’s laboratory 
 Focus: Epigenetics, carcinogenesis, cell biology  
- Managing and guiding different international research projects 
- Performing state-of-the-art laboratory work, e.g. ChIP-sequencing 
- Performing data analysis and basic bioinformatical analysis 
- Presenting my work in front of different audiences (in English) 
- Instructing medical students in practical courses and tutorials 
 
Grade: “summa cum laude” 
 
04/2009 – 09/2009 Internship (100%) in biomedical laboratory 
Prof. Primo Schär (Molecular Genetics), University of Basel 
 
02/2008 – 02/2009 Master Thesis at the Department of Environmental Sciences,  
Section of Conservation Biology, University of Basel 
Grade: 5.0 (of 6.0; good) 
 
08/2007 – 01/2008 Exchange semester in Sweden 
Studies with the Erasmus program at the University of Lund 
 
10/2004 – 07/2007 Bachelor of Science in Biology, University of Basel 
 Grade: 4.9 (of 6.0; good) 
 
08/2000 – 12/2003 Matura with focus on biology and chemistry (Schwerpunkt B) 
at the Gymnasium Münchenstein  
Grade: 4.6 (of 6.0; good) 
 
 
Languages 
German   native speaker 
English   proficient, oral and written (official working language) 
French  good knowledge, oral and written 
Swedish  good knowledge, oral and written 
Spanish  good knowledge, oral and written 
 
 
IT skills 
Office applications Proficient in Word, Excel, PowerPoint 
Statistics  Proficient in Prism GraphPad and basic knowledge of R 
Bioinformatics  Genome Browser, Ingenuity Pathway Analysis (IPA) 
CV  Annika Wirz 
   
Publications in peer-reviewed journals 
Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability    
D. Cortázar*, C. Kunz*, J. Selfridge, T. Lettieri, Y. Saito, E. MacDougall, A. Wirz,         
D. Schuermann, A. L. Jacobs, F. Siegrist, R. Steinacher, J. Jiricny, A. Bird & P. Schär.  
Nature 470, 419-423, 2011.      * contributed equally 
 
 
TDG balances DNA methylation and oxidative demethylation at CpG islands in differentiating 
cells 
A. L. Jacobs*, D. Cortázar*, A. Wirz*, J. Arand, R. Steinacher, C. Broberg Vågbø, P. Giehr, 
A. Weber, G. Wilson, A. Galashevskaya, C. Kunz, W. Reik, S. Beck, J. Walter, H. Krokan & 
P. Schär.      
(Manuscript in preparation, 2014)     * contributed equally 
 
 
TET1, TET2 and TDG cooperate locus-specifically to promote chromatin plasticity by 
oxidative DNA demethylation  
A. Wirz, F. Noreen, R. Ivánek, Z. Barekati, A. L. Jacobs, C. Kunz & P. Schär.   
(Manuscript in preparation, 2014) 
 
 
 
Attended Conferences and Meetings  
 
Talks  - 1st PhD Retreat of the Department of Biomedicine in Saas Grund (CH), 2012 
- DNA Replication, Repair, Recombination Meeting in Zürich (CH), 2013 
Chair  - 2nd PhD Retreat of the Department of Biomedicine in Hasliberg (CH), 2013 
Posters - EMBO conference on Chromatin and Epigenetics in Heidelberg (D) 2011 
- Swiss Meeting on Genome Stability in Weggis (CH) 2012 
- 3rd Erling Seeberg Conference on DNA Repair in Trondheim (N) 2012 
 
  
 
References are available on demand. 
  
 
